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Abstract: 
This thesis reports on the development of a rapid, efficient, and inexpensive pressurised 
hot water extraction (PHWE) technique, and its use to extract valuable natural products 
from plant material. Further, the use of natural products as scaffolds for divergent 
synthesis of known natural products and other complex molecules is described. 
The PHWE method uses a standard benchtop espresso machine, and was developed and 
refined through the extraction of polygodial from Tasmannia lanceolata (Tasmanian 
native pepper) and shikimic acid from Illicium verum (Chinese star anise). The former is a 
relatively non-polar sesquiterpene dialdehyde containing some sensitive functionality, 
and the latter is a much more polar carboxylic acid. These substrates proved to be useful 
for method development, and provide valuable complex scaffolds for synthetic 
applications. 
Applications of the espresso machine extraction method for rapid bioprospecting and 
chemotaxonomic applications were investigated through the extraction of a unique 
population of T. lanceolata, and extraction of Drimys winteri. This novel PHWE method 
was also applied to the extraction of known biologically active extracts such as that of 
Momordia charantia (bitter melon), Eupatorium adenophorum (Crofton weed), and 
Chrysanthemum cinerariaefolium (Dalmatian chrysanthemum, contains pyrethrins). 
Additionally, the use of the PHWE technique for essential oils was investigated. Many 
common plants were extracted, rapidly providing enriched essential oil extracts. The 
extraction of eugenol and acetyleugenol from cloves was implemented into the 
undergraduate laboratory program as a result of this work. 
The reactivity of polygodial was investigated extensively through the synthesis of some 
simple natural products based on this skeleton, in addition to various analogues. More 
complex polycyclic structures based on polygodial were also synthesised to investigate 
the level of stereospecificity achieved in reactions on this scaffold. 
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Chapter 1: The Significance of Natural Products 
1.1 The Importance of Natural Products and Bioprospecting 
Nature is, and will remain, an important source of biologically active compounds. The 
sheer structural diversity of natural products, and the control of chemical synthesis 
achieved by enzymes results in a treasure trove of compounds.1 In 2000, it was estimated 
that ‘<10 % of the world’s biodiversity has been tested for biological activity’.2  
The natural products of today exist as a result of millions of years of biological evolution. 
As life has evolved, a staggering number of classes of natural products have evolved 
along with it, which serve as the regulators and modulators of complex biochemical 
processes.3 Through the processes of evolution, the resulting set of natural products tend 
to possess incredible specificity with regards to the biological macromolecules with 
which they interact, and therefore the response and effects that they cause.4 As natural 
products have evolved for specific bioactivity, many already possess the necessary 
features to be used as a drug. For de novo drug design, on the other hand, many 
parameters are considered in the design of the molecule, highlighted by Lipinski’s ‘Rule 
of 5’, which gives parameters relating to the solubility and permeability of the molecule. 
These parameters are linked to the likelihood of the molecule having appropriate 
bioavailability as a drug.5,6 Natural products, however, tend not to rely on passive 
diffusion for absorption, and so are explicitly exempt from these guidelines.4,5,7,8 
Natural products and natural product inspired drugs are regularly reviewed in the 
scholarly literature, with recurring reviews on the topic. Important examples of these are 
the ‘Natural Products as Sources of New Drugs’, in the Journal of Natural Products by 
Gordon and Cragg with various other contributors.9,10 The most recent of these was 
published in 2016, covering the period of 1981 to 2014. This review reports that over that 
period, an average of ~50% of the new drugs on the market are natural products, derived 
from natural products, or inspired by natural products. Small molecules continue to be 
the dominant form of new drugs on the market, with 1211 new small molecules 
introduced to the drug market between 1981 and 2014 out of a total of 1562 drugs. 
These are a combination of natural products and derivatives, as well as fully synthetic 
molecules, which can be natural product mimics with completely different structural 
properties but with the same mechanism of action as the natural product. The following 
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chart shows categories of small molecule new drugs on the market between 1981 and 
2014. N are unmodified natural products, NB are specific mixtures of unmodified natural 
products, ND are derivatives of natural products, S* are fully synthetic molecules with a 
natural product pharmacophore, and S are fully synthetic.11 Figure 1.1 shows that ~50 % 
of the new small molecule drugs on the market are related in some way to natural 
products, with S being the only category of compounds reported which are termed ‘fully 
synthetic’, and in no way related to natural products. 
Figure 1.1 – Percentage of new drugs on the market, 1981–2014. Data from Newman and 
Cragg, 201611 
The development of more efficient testing methodologies and computing power has led 
to an increase in the number of molecules able to be tested for biological activity. With a 
combination of in vitro and in silico high throughput screening methods, and the 
development of huge libraries of compounds both real and modelled theoretically, it was 
anticipated that the number of drugs reaching the market would continue to increase.12 
This development however, led to a shift away from natural product based inspiration,13 
and the opposite was observed. One factor thought to be involved in this is non-natural 
products having higher levels of unwanted or dangerous side effects discovered during 
testing.4 This has led to a resurgence in natural products-based drug discovery.14,15 
N
6%
NB
1%
ND
26%
S
49%
S*
18%
N – Unmodified natural products 
NB – Defined mixture of natural 
products 
ND – Natural product derivatives 
S* – Synthetic with natural product 
pharmacophore 
S – Fully synthetic, bearing no 
known relation to a natural product 
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There are many historical examples of natural products causing breakthroughs in 
medicine. For example, the antibiotic penicillin G (1), which was discovered in the 
1920’s.16 Penicillin is produced by fungi specifically to kill bacteria, which protects the 
fungus from infection and means the bacteria are not competing for resources.17 The 
mechanism of action of penicillin is very specific, which is part of the cause of its success 
as a drug. This molecule is a β-lactam antibiotic, which has a direct action on an enzyme 
to mediate its effect. The molecule acylates enzymes involved in the synthesis of the 
bacterial cell wall which cause the bacteria to be unable to develop structurally, and 
therefore become non-viable and die.18 The molecule has evolved with such specificity 
that it only acts on certain types of bacteria and does not interact with human enzymes, 
leading to minimal side effects. Penicillin was a serendipitous discovery, when spores of 
Penicillium fungi landed randomly on some agar plates that had been culturing bacteria 
and developed zones of inhibition where the fungi were growing.16 An advantage of using 
natural products from fungi or bacteria is the ease with which the production can be 
scaled up, as many microorganisms can be cultured easily and the exponential 
reproduction means that cultures grow rapidly. 
Figure 1.2 – Penicillin G (1), also known as benzylpenicillin, the originally discovered 
penicillin molecule, showing the reactive β-lactam structural motif. 
Not all natural product discoveries occur in this way, however, and may require a 
concerted and sometimes time- and labour-intensive exploration of nature. The process 
of searching for new valuable materials from natural sources is known as bioprospecting. 
Specifically, the World Health Organisation defines bioprospecting as “…the systematic 
search for and development of new sources of chemical compounds, genes, micro-
organisms, macro-organisms, and other valuable products from nature.”* Natural 
product bioprospecting can lead to new drugs on the market in three major ways:
* http://apps.who.int/medicinedocs/en/d/Jh2996e/6.3.html accessed 06/11/17
O
H
N
N
S
O
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1 – The natural product is extracted and formulated into a drug directly without any 
modification of structure. 
2 – The natural product is the drug, but the biological source is too rare or otherwise 
prohibitive for extraction, which means that the drug is prepared synthetically. This can 
be due to a number of factors - primarily the rarity of the plant, the yield of the 
compound from the plant, and the growth rate of the plant.12  
3 – The natural product serves as a structurally complex starting material/precursor for 
the synthesis of a drug. 
Concerted bioprospecting efforts have led to numerous breakthroughs in natural 
products chemistry. A key example of this is the discovery of natural sources of bulk 
quantities of steroid-based molecules, which could be used to synthesise natural steroids 
and analogues. Prior to this discovery the synthesis of steroids was laborious and 
inefficient.19,20 The sheer structural complexity of the steroid core, with 4 fused rings and 
in the example of testosterone (2), 6 contiguous stereogenic centres, leads to a very 
demanding challenge, particularly regarding stereoselective synthesis. 
Figure 1.3 – Testosterone (2), a key example of a steroid hormone with 6 contiguous 
stereocentres. 
A key step in this process was the elucidation of the true structure of plant derived 
sapogenins, and subsequently ways in which they could be transformed into divergent 
precursors for numerous steroid based molecules for anti-inflammatory and 
contraceptive applications.21 The key reaction sequence in transforming plant derived 
sapogenins into a precursor for the divergent synthesis of medicinally useful steroids is 
known as the Marker degradation, after the chief researcher in the project, Russell E. 
Marker. The Marker degradation is a simple and high-yielding three-step process to form 
a readily functionalisable steroid core from a naturally derived sapogenin scaffold such as 
diosgenin (3), which may be further transformed into many important steroidal 
2 
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compounds such as progesterone, cortisone, testosterone, estrone and estradiol. The 
first step in the Marker degradation is the ring opening of the spiroketal group using 
acetic anhydride at 200 °C to yield the ring-opened acetate 4. Subsequent oxidative 
cleavage with chromic acid effects a further ring opening to yield compound 5, containing 
the tetracyclic ring system common to all steroids. Finally, the use of sodium hydroxide in 
ethanol hydrolyses the resulting ester side chain, which further eliminates water to form 
α,β-unsaturated ketone 6. The previously acetylated hydroxyl functionality is also 
restored during this reaction. The reaction sequence was applied to the numerous plant-
based sapogenins sourced from various plant species.  
 
Scheme 1.1 – Marker Degradation on diosgenin (3) from Dioscoria villosa.  
A subsequent bioprospecting mission carried out through Mexico and the southern USA 
eventually yielded a commercially viable plant for the isolation of significant quantities of 
diosgenin. The Mexican yam (Dioscoria mexicana), an unusual caudiciform plant, became 
the source of kilogram quantities of diosgenin.22 Caudiciform refers to the growth habit 
of the plant, where the base of the plant (caudex) forms a large bulbous mass above and 
below the ground (see Figure 1.4). This large mass of plant material is where the 
diosgenin is found. This result came from the study of ~40,000 kg of plants comprising 
nearly 400 different species,23 and represents a significant achievement in 
bioprospecting. It was not until a plant was discovered that produced large enough 
quantities of this material that the medicinal steroid industry could flourish, leading to 
the development of a lot of new chemistry. 
O
O
HO
H
HH
O
AcO
H
HH
Ac2O
200 °C
OAc
CrO3
AcOH
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Figure 1.4 – Mexican yam, showing the unusual caudiciform growth habit.* 
Another key historical example of the success of bioprospecting is the anti-cancer drug 
Paclitaxel (7, often referred to by a trade name, Taxol). This compound was initially 
isolated as an extremely active component of the extract of the Pacific yew tree (Taxus 
brevifolia). The Pacific yew tree is a very slow growing tree, which produces only minimal 
amounts of this compound from the bark,24 and therefore the use of this compound 
directly from the source is impractical and unsustainable. 
Figure 1.5 – Paclitaxel (7). 
The first total synthesis, reported in 1994 by Holton and colleagues, demonstrates an 
enantioselective total synthesis in 46 linear steps.25,26 This is one of the shorter synthetic 
routes, partly as the starting material is already a C15 compound. The total syntheses of 
this compound are undoubtedly huge achievements in synthetic organic chemistry, but 
were not sufficient to meet the demand for these biologically active molecules for clinical 
trials through to front line treatments. The breakthrough in being able to obtain viable 
quantities of paclitaxel was the discovery that a related species, Taxus baccata, produced 
* Image by Amada44, Wikimedia Commons CC BY 3.0
7 
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significant quantities (~1 g/kg) of the natural product 10-deacetylbaccatin III (8), which 
was used for the semi-synthesis of paclitaxel in 4 steps. 
 
Scheme 1.2 – Semi-synthesis of paclitaxel (7) from 10-deacetylbaccatin III (8) 
Compound 8 represents by far the most complex portion of paclitaxel, and therefore 
significantly reduces the number of steps required to create the molecule. This also 
represents a non-linear synthesis where two parts of the molecule are isolated or 
synthesised independently, and subsequently joined which makes the overall process 
more efficient. A review by Borah and co-workers in 2007 summarises the different 
routes used for the synthesis and attachment of the side chain onto 10-deacetylbaccatin 
III.24 This semi-synthetic approach demonstrates the unavoidable and fundamental link 
between these two areas of chemical research and medicinal chemistry.  
Though these semi-synthetic methods were used for many years for the manufacture 
and supply of paclitaxel, it was still inefficient, so efforts were made towards the 
development of a greener method of production. Paclitaxel is now produced directly 
through plant cell fermentation methods further improving the viability of the industry 
and negating the need for chemical manipulation. This method has a number of 
advantages, outlined in Green Chemistry in the Pharmaceutical Industry – The Taxol® 
Story, Development of a Green Synthesis via Plant Cell Fermentation.27  
The stories of diosgenin and paclitaxel are two well-known examples in which 
bioprospecting of plants led to the discovery of significant quantities of incredibly 
important materials, which in turn solved the supply problem of some very important 
classes of drugs. Sometimes, however, discovery of an abundant source of the natural 
product or a precursor in nature has proven impossible. Some examples of this are 
natural products from sea sponges. In the case of sponges, the natural products are often 
O
O
O OH
HO O
H
O
O
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O
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NHO O
O
O
HO OH
HO O
H
O
HO
OO
4 steps
7 8 
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not secondary metabolites of the sponge itself, but are often produced by symbiotic 
microorganisms.28 These natural products show a huge chemodiversity and a range of 
different biological activities, but tend to be found in very small amounts in the 
organism.29 Two important examples of natural products found in sponges are (+)–
discodermolide (9), and the bryostatins (bryostatin I (10) is shown in Figure 1.6). In these 
two cases, the lack of abundance of the natural product or a natural product precursor 
meant that the supply problem needed to be solved in a different manner. 
 
Figure 1.6 – (+)-Discodermolide (9) and bryostatin I (10), both isolated from marine 
organisms. 
In the case of (+)-discodermolide, the original report from 1990 gave a yield of 0.002 %, 
following the isolation of 7 mg of the compound from 434 g of the sponge Discodermia 
dissoluta. This, in combination with the difficult collection (30 m depth) and the ethical 
and conservation issues surrounding collection of animal species, meant that isolation of 
significant quantities of this compound directly from the organism was not feasible.30 
This compound has shown significant activity in numerous anti-cancer assays, showing a 
similar mechanism of action to Paclitaxel.31 In addition, some paclitaxel-resistant cancer 
cell lines are susceptible to (+)-discodermolide.32 For these reasons, the development of 
a synthetic route to this important compound was desired. Syntheses and improvements 
were developed over the course of ~14 years before significant quantities could be 
produced. Numerous research groups published syntheses during this time, notably 
Smith’s gram scale synthesis reported in 1999,33 with subsequent improvements 
published over time.34 The chemical company Novartis used elements of Smith’s 
approach, in combination with the work of Paterson31 to complete a 60 g synthesis of this 
O
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compound.35 In spite of the overall yield being <1 % for this synthesis compared with 
overall yields of around 7–11 % for other reported syntheses, the sheer scale of the 
reactions represented a significant achievement in chemical process development. 
Bryostatin I (10) was the first of 20 similar structures discovered.36 This molecule has 
been investigated for its therapeutic potential in the treatment of HIV, cancer, and 
Alzheimer’s disease, but maintaining adequate supply has proven a significant 
challenge.37 Originally discovered in the 1960’s, the structure of bryostatin I was 
elucidated and reported in 1982. Isolated from the nudibranch Bugula neritina, this 
compound exists in even lower quantities than (+)-discodermolide, with a report of 500 
kg of the creatures providing a mere 120 mg of the compound, representing a 
staggeringly small yield of 2.4 x 10-5 %.38 Collection in a separate instance of 14 tons of 
these creatures led to a yield of 18 g, representing a much higher but still unsustainable 
yield of 1.4 x 10-4 %.39 Only in 2017, has the supply problem been convincingly solved. 
Wender and co-workers have published a scalable synthesis of bryostatin 1.37 Their 
reaction sequence comprises 29 total steps, a longest linear sequence of 19 steps, >80% 
average yield, and an overall yield of 4.8 %.  
These examples highlight the fundamental and interconnected nature of bioprospecting, 
as well as organic synthesis in the discovery, isolation and ongoing supply of important 
natural products of medicinal significance. For the above reasons, natural products 
research will continue to be hugely important for the discovery of novel biologically 
active molecules. It is therefore desirable that efficient methods of extraction and 
isolation of natural products continue to be developed to facilitate the investigation of 
the remaining ~90% of unexplored natural sources. A key focus of this thesis concerns 
the development of a novel, simple, rapid, and cost-effective method for plant extraction 
based on Pressurised Hot Water Extraction (PHWE), which uses a standard benchtop 
espresso machine. 
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1.2 Tasmania and Australia as Significant Bioprospecting Sites 
As highlighted by the examples provided above, plants are an important class of 
organisms in natural product discovery. Indeed, plants were used by the earliest humans 
as remedies for various ailments with varying levels of success. Many of these traditional 
medicinal plants have been investigated and the active principles identified.40 It is 
recognised that Australia is a location of plant endemism* of international significance, 
with a large number of plant species totally unique to the continent.15,41 An example of 
bioprospecting of Australia’s unique flora is the natural product tigilanol tiglate (11). This 
compound is only found in the species Fontainea picrosperma (Euphorbiaceae), which is 
endemic to Queensland, Australia. Through a bioactivity guided bioprospecting effort, 
this compound was isolated and investigated in pre-clinical trials, showing promising 
activity against certain kinds of tumours.42 
 
Figure 1.7 – Tigilanol tiglate, isolated from F. picrosperma, endemic to Queensland, 
Australia. 
Australia has many areas of highly unique endemic species, and Tasmania is recognised 
as one of these areas.41,43 Indeed, Tasmania is known to be home to many relictual plant 
species, being the only surviving species from formerly large groups of plants.44,45 
Additionally, many of these Tasmanian species have not been examined for their 
chemical content.46 Due to all of these factors, there is a wealth of biodiversity unique to 
Tasmania that merits investigation. To this end, development of an inexpensive and 
efficient bioprospecting method utilising a modern and green technique is of great 
significance. 
                                                          
* A plant species is endemic to a region if it only exists in the wild in that particular region. This is a broad term, without 
specific definition of the size of that area. 
11 
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1.3 Traditional Extraction Methods  
A review from 2013 lists the following three techniques as being the major traditional 
methods of extraction from plants: maceration, Soxhlet extraction and 
hydrodistillation.47 All techniques have various benefits, as well as drawbacks. When new 
extraction techniques or modifications of existing techniques are developed, the reports 
typically include a comparison to, or benchmarking against one or more of these 
traditional extraction methods in determining efficiency.  
1.3.1 Maceration 
Maceration involves soaking the material containing the target compounds in a solvent, 
and is operationally the simplest technique. Maceration can be performed with or 
without stirring/agitation, and can be conducted at any temperature with the usual 
considerations of solvent boiling point and target analyte stability. Due to the simplicity 
of the technique, no specialised glassware or other equipment is required for the 
extraction. This technique suffers from drawbacks which lead to a loss of efficiency 
including relatively long extraction time, no recycling or flow of solvent leading to solvent 
saturation, and little selectivity in extraction.48 Macerations typically suffer from low 
yields and difficulty in purification due to the extraction of plant pigments.49 
1.3.2 Soxhlet Extraction 
Soxhlet extraction is similar to maceration in that the material to be extracted is soaked 
in a solvent. The primary difference between these two techniques however is that 
Soxhlet extraction uses a semi-continuous extraction process where pure solvent is 
distilled into the sample from a solvent reservoir, where effectively a maceration takes 
place until a set volume is reached. The solvent then drains through a siphon mechanism 
back into the solvent reservoir and the process is repeated. In this way, the concentration 
of extract continues to increase, as fresh solvent is recycled over and over. This method 
usually shows a very high overall extraction efficiency but suffers from specialised 
apparatus requirements, particularly for large-scale extractions. The long extraction time 
can also lead to degradation of thermolabile substances.50 
 
 
Chapter 1: The Significance of Natural Products 
 12 
1.3.3 Hydrodistillation 
Hydrodistillation is the immersion of material into water, followed by distillation. This 
process extracts largely the essential oil components of the material within a certain 
vapour pressure range, leaving everything else behind. This method shows a high 
selectivity towards the types of compounds which are extracted leading to a generally 
very clean extract, but can only be used for compounds that meet the criteria. This 
method has continued utility in the perfume, flavour, and essential oils industries47 but 
due to the narrow scope is not a typical technique for more general bioprospecting. 
Drawbacks include narrow extraction scope, relatively long distillation time, and a 
sustained high temperature of the sample material.47 
1.3.4 Modifications to Traditional Methods 
There are some modifications made to traditional extraction methods designed to 
increase their efficiency. These include ultrasound assisted extraction,51-53 microwave 
assisted extraction,54-56 pulsed-electric field extraction and enzyme assisted extraction.47 
These methods involve a physical or chemical mechanism to free up the desired 
components within the plant matrix such that they are more readily extracted into the 
extraction solvent. 
1.4 Modern Extraction Methods 
Trends in green chemistry have pushed the focus towards the use of ‘green’ solvents. A 
review of the ‘greenness’ of solvents from 2007 states that from an environmental 
perspective, simple alcohols and alkanes are favourable solvents to use, along with 
water.57 As traditional plant extraction methods often use large volumes of toxic and 
environmentally unfriendly solvents,58 modern techniques have been developed to 
increase the efficiency, repeatability and overall ‘greenness’ of extractions by reducing 
solvent consumption, or utilising alternative solvents. Two prominent examples of these 
methods are supercritical fluid extraction, and pressurised hot water extraction.  
1.4.1 Supercritical Fluid Extraction 
Supercritical fluid extraction is typically undertaken using solvents which are gases at 
atmospheric pressure and temperature. These include CO2, propane, butane and 
ethylene, with CO2 being by far the most commonly employed.59 Due to the pressures 
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required to keep these solvents in the supercritical fluid state (for CO2, the critical point is 
73.8 bar and 31.1 °C.)60, this technique requires highly specialised equipment. A major 
advantage of this technique is that the solvent evaporates from the resulting extract 
rapidly upon returning to atmospheric pressure. This technique has a major industrial 
application in the decaffeination of tea and coffee.59  
In spite of the advantages of this modern technique, more modern does not always mean 
more efficient for every example. This is highlighted in the extraction of thujones from 
Salvia officinalis, where a direct comparison of hydrodistillation and supercritical fluid 
extraction showed hydrodistillation to be a more efficient extraction technique.61 
Another example of this is the extraction of phenolics from Echinacea purpurea, where a 
Soxhlet extraction was found to be vastly superior in overall extraction yield compared to 
supercritical fluids extraction with CO2, microwave assisted extraction with EtOH, and 
pressurised liquid extraction with water at 60 °C.62 The Soxhlet extraction, however, did 
use large quantities of solvent, and took a much longer time than the other techniques. 
1.4.2 Pressurised Hot Water Extraction 
Pressurised Hot Water Extraction (PHWE) (also known as SWE - subcritical water 
extraction)59 was first reported in 1994 with the investigation of sub- and super-critical 
water as a solvent for extracting organic material from environmental solids,63 and 
remains a popular method of extraction of compounds from complex matrices for 
analytical purposes.64-67 Its popularity is likely in part due to its more ‘green’ nature from 
a solvent perspective,68 and its demonstrated time efficiency compared with more 
traditional techniques.69 There remains, however, room for the application of this 
method to the extraction of natural products on preparative and semi-preparative scale. 
Teo and co-workers published a review on PHWE in 2010, and state in their conclusion 
“PHWE is a feasible green extraction method to be exploited in future technologies for 
more analytes to be used on a bigger scale.” PHWE is preferred for food-type 
applications as toxic solvents are avoided during the process.70 
PHWE is typically undertaken using custom systems64,71-73 composed of the following 
components – solvent reservoir, solvent pump, oven, heating coil, sample compartment, 
backpressure regulator, and extract reservoir.63,71,74 The majority of reports that feature 
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these apparatus are for analytical scale applications, rather than isolation of compounds 
on a semi-preparative to preparative scale.66  
 
Figure 1.8 – Schematic of typical PHWE apparatus, adapted from Ong et al. 2010.66 
1.5 Household Espresso Machine for PHWE 
1.5.1 Espresso Machines for Coffee Extraction 
PHWE is undertaken every day, all over the world, in homes, workplaces, cafes, 
restaurants, etc. for the creation of espresso coffee. Typically, espresso is created using 
the ubiquitous espresso machine, which is relatively inexpensive and readily available. 
Coffee is one of the most popular beverages in the world, and additionally is one of the 
most traded commodities in the world.66a Due to this popularity, extensive research into 
the biologically active components of coffee, as well as research into the flavour profile 
of coffee has been undertaken.66b,66c As a result, the parameters of extraction in the 
espresso machine have been honed and optimised over time to result in today’s espresso 
machine. 
Espresso coffee is an aqueous mixture of compounds, extracted from coffee beans, 
primarily of the species Coffea arabica. A large number of compounds are extracted from 
these beans, which represent a number of different molecule types over a large range of 
polarities from very polar substances such as inorganic salts and sugars, through to 
relatively non-polar substances such as waxes and oils.66a The most popular and well-
known compound extracted from C. arabica is, of course, caffeine. The ability of 
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pressurised hot water to extract such a diverse range of compounds can be explained by 
the mechanisms of PHWE extraction, which involve dissolution of compounds into the 
water, as well as the physical extraction of less polar components.66 
1.5.2 Similarities with Standard PHWE Equipment 
The essential elements of a PHWE apparatus are contained within the espresso machine. 
However, there are some notable differences between typical PHWE apparatus and the 
espresso machine. Firstly, the espresso machine lacks a heated compartment, instead 
having a small heated block for heating the solvent. Secondly, the pressure is controlled 
by a combination of the nature and packing of the sample material, and the restriction of 
flow through the sample basket due to the small holes in the filter. The sample baskets 
are described in more detail in section 1.5.3. 
 
Figure 1.9 – Schematic of the espresso machine used in this study. 
A major advantage of using an espresso machine is that they are readily available and 
inexpensive. They are also small and portable, and have a small footprint. Further, the 
sample compartment can contain around 10 to 20 g of material per run, which combined 
with the rapid nature of the extraction allows for efficient scale-up of extraction.46,75-77 A 
disadvantage, however, is that pressure and temperature cannot be manually controlled, 
with average espresso machine pressure being 9 bar, and temperature around 92 °C.78,79 
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The temperature remains largely constant, whereas the actual extraction pressure is 
determined by the packing of the sample into the coffee machine and the sample basket 
chosen. In a comparison for the specific purpose of producing espresso, it was shown 
that the chemical composition of the coffee produced was essentially the same 
regardless of whether pressure and temperature were constant, or whether these two 
variables fluctuated slightly during the extraction.79  
One significant difference of using an espresso machine for PHWE, compared with 
producing espresso coffee, is that with coffee the optimal shot volume is 25 mL,79 which 
is designed for non-exhaustive extraction of components to give the ideal flavor profile. 
This is in contrast to the aim of natural products extraction, which is to achieve 
exhaustive extraction of the desired compounds. 
Additionally, given the scale of the coffee industry internationally, there may be 
opportunity to scale up PHWE using apparatus used for coffee extraction with already 
available machinery, rather than relying on de novo design of upscaled equipment.  
1.5.3 Espresso Machine Characteristics 
The espresso machine used, a Breville model 800ES, operates at conditions of 
approximately 9 bar pressure, which is variable depending on the sample holder basket 
used, and the characteristics of the plant material extracted. This model does not have a 
temperature gauge, so a separate machine was modified with a thermocouple and 
control box to allow monitoring and adjustment of the extraction temperature. 
Monitoring of the temperature for various extractions revealed that as the extraction 
continues, the temperature drops. This is because much larger volumes of extraction 
solvent are taken than an espresso machine was designed for (100–200 mL vs 30–60 mL), 
which cools the heating block as it flows through. Due to this, a plant extract is taken as a 
sum of smaller volumes (2 x 100 mL vs 200 mL), to allow for the instrument to maintain 
the correct extraction temperature. 
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Figure 1.10 – Espresso machine modified with thermocouple and control box. 
There are two types of sample baskets (Figure 1.11), which differ in their innate ability to 
increase the pressure of the extraction. There is a single–walled basket which has ~550 
holes (~310 μm diameter) for solvent extract to pass through, and there is a double 
walled basket which has two layers. The top layer of the double walled basket contains 
~330 holes (~300 μm diameter) which lead to a small cavity, with a second wall which 
only has one hole (~560 μm diameter). The double–walled basket leads to a higher 
innate pressure as all the solvent is forced through the single ~560 μm diameter hole. 
This basket is used for coarser materials to increase the pressure of the extraction. In 
contrast, the single-walled basket is used when fine plant material causes continual 
blockage of the machine upon extraction. These are also known as the pressurised 
(double-walled) and non-pressurised (single-walled) baskets. 
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Figure 1.11 – Espresso machine sample baskets 
The default basket that typically accompanies inexpensive espresso machines is the 
pressurised basket, and this was used for all method development. Subsequently during 
investigations into applications and scope of the method, the other type of basket was 
trialled. Typically, as pressure is a desired factor of extractions, the non-pressurised 
basket was only used when the pressurised basket was deemed inappropriate due to 
excess pressure which manifests in a very low flow rate or repeated blockages. 
1.5.4 PHWE Solvent Considerations 
The properties of the extraction solvent for the polarity of the compounds of interest 
may be modified by the addition of EtOH, which has been shown previously to influence 
extraction efficiency in PHWE.67 Indeed, EtOH has been also used as a co-solvent in 
supercritical fluid extraction with CO2.62 EtOH is also more compatible with the plumbing 
of the espresso machine, whereas another solvent like dichloromethane is much more 
likely to cause problems with parts and tubing of the machine.  
Top 
Bottom 
 
Double-walled Single-walled 
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Solvent polarity correlates with the dielectric constant of the solvent, which in the 
espresso machine is dependent on temperature and proportion of EtOH, as the low 
pressure of the espresso machine does not influence this parameter.80,81 The dielectric 
constant of water at 92 °C is ~56, and for a 35 % EtOH/water mix (v/v) at 92 °C it is ~44. 
This is equivalent to pure water at approximately 150 °C.82 This allows the PHWE method 
to extract a broader range of compounds, without increasing the risk of compound 
degradation due to high temperature.83-85 While pressure does not have an effect on the 
dielectric constant within this range, it does play a major role in the efficiency of the 
extraction. Higher pressure means that the solvent is forced into tighter spaces in the 
sample matrix, which may not be reached by the extraction solvent under atmospheric 
pressure.63,66,86  
1.6 Summary 
All of the discussed extraction methodologies have their advantages and disadvantages. 
The espresso machine PHWE method is no different in this regard. Development of this 
method is not intended to replace any established method for natural product 
extraction. Instead, the aim is to provide an inexpensive, efficient and green 
complementary method. There will be examples for which this method may not be 
appropriate and another method will be more suitable. Indeed, an example from our 
research group published recently showed the difference between a simple maceration 
in ether compared to espresso machine PHWE for the extraction of ent-labdane 
diterpenoids from Dodonaea viscosa, with the maceration proving a more effective 
technique for some of the less polar metabolites of the plant.87 The physical structure of 
the plant material and the location of the compounds within the plant matrix meant that 
a simple room temperature maceration with diethyl ether was a more efficient 
technique. Subsequently, further investigation of PHWE of D. viscosa with the espresso 
machine was undertaken and the more polar compounds were the major components 
isolated.88 This demonstrates the complementarity of the espresso machine PHWE 
method with other classical extraction methods. It is anticipated that development of 
this method will provide a unique, cost-effective, and efficient tool for the bioprospecting 
of Tasmania’s unique flora, and for the isolation of valuable natural products. 
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1.7 Project Aims 
To determine the viability of using an unmodified benchtop espresso machine for PHWE 
of natural products from plant material. (Chapter 2) 
To investigate the scope and applications of the method through application to various 
plant species. (Chapter 3) 
To utilise the natural product polygodial as a precursor for the divergent synthesis of 
known natural products and analogues, as well as other complex molecules. (Chapter 4) 
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Chapter 2: PHWE Method Development 
2.1 Overview 
In this chapter, the viability of using an unmodified benchtop espresso machine for PHWE 
of natural products from plant material was evaluated. The method was developed 
through the extraction of polygodial from Tasmanian native pepper (Tasmannia 
lanceolata), shikimic acid from Chinese star anise (Illicium verum) and coumarins from 
three species of Correa. These examples represent compounds featuring different 
polarities and functional groups with varying sensitivities, which in combination provide 
proof-of-concept for the use of a benchtop espresso machine for the rapid extraction of a 
wide range of valuable natural products by PHWE. 
2.2 Polygodial from Tasmannia lanceolata 
2.2.1 Background 
For the initial development and characterisation of the PHWE method the extraction of 
the sesquiterpene dialdehyde polygodial (12) from Tasmannia lanceolata ((Poir.) A.C.Sm.) 
(Winteraceae, Tasmanian native pepper) was investigated. T. lanceolata is commonly 
found in the wild, in gardens, and grown commercially in Tasmania primarily for culinary 
applications. 
 
Figure 2.1 – Polygodial (12), showing absolute stereochemistry 
Polygodial is found in plants in the Winteraceae,89 Polygonaceae90 and Cannellaceae91 
families, and has also been found in marine sponges and molluscs.92,93 Polygodial and 
derivatives have demonstrated a variety of biological activity, including activity as an 
antifouling biocide,94 a deterrent and anti-feedant for various insect species,92,95,96 as well 
as showing anti-leishmanial, anti-trypanosomal,97,98 anti-fungal91,99,100 and anti-
bacterial101 activity. The leaves of T. lanceolata are known to contain polygodial in 
varying quantities in wild samples of between 0.1 and >3 % (w/w).102 T. lanceolata has 
12 
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been heavily studied for its phytochemistry and chemotherapeutic potential, as reviewed 
by Cock in 2014.103  
Polygodial is a potentially useful scaffold for synthesis owing to the two distinct 
aldehydes, and numerous natural products with a similar structure, but is expensive to 
source commercially.* Further, polygodial contains an epimerisable stereogenic centre, 
and is therefore potentially susceptible to isomerisation during extraction. In addition, 
this molecule is relatively non-polar, therefore aqueous solvent mixtures would not be 
the typical first choice for extraction. These combined features make polygodial from T. 
lanceolata an excellent target molecule for PHWE method development. 
Previous reports detail the isolation of gram-scale quantities of polygodial, however, the 
methods were not efficient. In one example, 1.73 g  (0.23% w/w) of polygodial was 
isolated from 660 g of T. lanceolata, with 19 L of hexanes used for the initial 
extraction.104 Another more recent report describes the extraction of 896 g of leaf 
material from Drimys brasiliensis (Winteraceae) with an unspecified amount of hexanes, 
and 2 chromatographic steps to yield 1.09 g (0.12% w/w) of polygodial.89 Multiple 
chromatographic steps for the isolation of this compound have been frequently 
reported.89,98,105,106 
2.2.2 Preliminary Extraction Conditions 
Initial test conditions using the benchtop espresso machine were ~15 g of dried plant 
material, 35% v/v EtOH:H2O in the espresso machine, followed by liquid-liquid extraction 
of the ensuing mixture with CH2Cl2. The PHWE solvent composition was chosen due to 
high content of H2O and lower flammability, with the polarity considerations discussed in 
Chapter 1.  
 
 
 
                                                          
*USD$162 for 10 mg as at 25/10/17 from Sigma–Aldrich. 
Chapter 2: PHWE Method Development 
 23 
 
Figure 2.2 – Espresso machine extraction of T. lanceolata (left), leaf material packed into 
the sample basket (right). 
Finely ground plant material* was packed into the sample basket of the espresso machine 
in the same way as for ground coffee (see Figure 2.2, above). The material was extracted 
using the EtOH:H2O solvent mixture, and the extract was cooled in an ice bath to limit 
any thermal degradation that may occur post-extraction. The PHWE extraction was 
carried out in 2 x 100 mL fractions with ~1 min in between to allow the espresso machine 
to maintain temperature, as they are typically designed for up to ~60 mL extraction 
volume. In this way, 15 g of plant material was extracted by this method within 2 
minutes.  
The resulting aqueous extract was then extracted by a liquid-liquid extraction with an 
organic solvent to obtain the crude polygodial extract. Dichloromethane was initially 
used as the secondary extraction solvent. The key signals in the 1H NMR spectrum of the 
resulting crude extract are the aldehyde signals at 9.50 and 9.43 ppm, as well as the 
alkenyl signal at 7.12 ppm, indicating polygodial (12) as the major component of the 
extract.  
 
 
                                                          
* Plant material provided by Diemen Pepper, Tasmania, Australia, www.diemenpepper.com 
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Figure 2.3 – 1H NMR spectrum of commercial T. lanceolata crop dichloromethane 
extract. 
Column chromatography of this initial sample provided 77 mg of polygodial from 15 g of 
plant material (0.5 % w/w) within a matter of hours. This was a significantly higher yield 
than many of the previously reported isolations, which provided a proof-of-concept that 
the espresso machine is a viable instrument for the PWHE of polygodial from T. 
lanceolata. Following from the success these successful initial trials under unoptimised 
conditions, various key parameters and variables were investigated in an effort to 
maximise yields.  
2.2.3 Sample Pressure 
As discussed in Chapter 1, the espresso machine used does not have a pressure gauge or 
an extraction pressure setting. However, pressure can be qualitatively determined by the 
user based on the flow-rate from the machine. During initial investigations, it was noted 
that the espresso machine was susceptible to blockage if the sample was too tightly 
packed or too finely ground. This was overcome in two different ways – the addition of 
sand (2 g sand with 15 g of dried plant material) to a tightly packed sample, and packing 
the sample less tightly. Although both measures alleviated the blockage of the machine, 
a significantly higher yield of crude extract (3.3 vs 1.7 % w/w) was obtained when the 
Hc 
Ha 
Hb 
12 
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sample was packed tightly with the addition of sand, providing evidence that pressure 
does have an effect on the extraction process. 
2.2.4 PHWE Solvent Concentration Optimisation 
The effect of the solvent composition in the espresso machine was investigated to 
determine the effect of ethanol concentration on the extraction yield. Solvent 
compositions of 0, 15, 25, and 35% v/v EtOH:H2O were tested, and the respective masses 
of the crude organic soluble extracts obtained were compared (Table 2.1). As the 
concentration of ethanol increased, the mass of the crude extract increased, with the 
highest yield obtained from extraction with 35 % EtOH (v/v). Pleasingly, the 1H NMR 
spectrum of this crude polygodial extract indicated the highest proportion of polygodial. 
Concentrations of ethanol higher than this were not attempted due to the potential 
hazards arising from the use of flammable solvents. The extract from the 35 % v/v 
EtOH:H2O extraction was purified by flash column chromatography. In a single 
chromatographic run, pure polygodial was obtained in an average of 0.71 % w/w from a 
crude extract yield of 3.9 % w/w. 
 
 
 
 
 
 
Table 2.1 – Crude T. lanceolata extract obtained from varying primary solvent 
composition in PHWE (average yields of two extractions). a – The crude mass obtained 
was sufficient information to compare the extractions at different solvent 
concentrations. 
Entry EtOH %v/v Technique Crude mass, 
% yield w/w 
Purified 
polygodial,  
% yield w/w 
1 0 PHWE 87 mg,  
0.58 % 
not purifieda 
2 15 PHWE 218 mg, 
1.45 % 
not purifieda 
3 25 PHWE 341 mg, 
2.27 % 
not purifieda 
4 35 PHWE 586 mg, 
3.91 % 
106 mg, 0.71 % 
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Figure 2.4 – PHWE extract of T. lanceolata (left) and the resulting isolated polygodial 
(right). 
2.2.5 PHWE Solvent Volume Optimisation 
The volume of solvent through the espresso machine required to achieve exhaustive or 
near exhaustive extraction of the desired compound was then investigated. Using all 
previously defined parameters, an extraction was carried out where three 100 mL 
fractions were taken from the espresso machine during extraction of T. lanceolata (15 g) 
and extracted individually with CH2Cl2. The yields from the three fractions were 355, 156, 
and 31 mg respectively. Additionally, the 1H NMR spectrum showed that the first fraction 
contained the highest proportion of polygodial. This experiment provides evidence that 
200 mL of extraction solvent was sufficient for the efficient extraction of polygodial from 
T. lanceolata. 
2.2.6 Comparison to Maceration 
To provide validation for the applicability of this novel PHWE method to T. lanceolata, a 
comparison was undertaken to a more basic and more traditional extraction technique – 
maceration. Using the same solvent, 35% v/v EtOH:H2O, T. lanceolata was subjected to 
maceration for 24 h at ambient temperature, and in a separate experiment, for 1 h at 
reflux. In both cases, analysis of the 1H NMR spectra showed extracts qualitatively far less 
enriched in polygodial than the PHWE extract, with a significantly reduced crude yield 
compared to PHWE. A maceration was also undertaken with CH2Cl2, which provided a 
significantly increased crude yield, however, analysis of the 1H NMR spectral data for this 
extract showed a significantly diminished proportion of polygodial compared with the 
PHWE extract. Column chromatography of this material provided polygodial as a green 
oil (Figure 2.5), which showed residual impurities by 1H NMR spectroscopic analysis. This 
is consistent with the previously mentioned reports of multiple chromatographic steps 
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required for purification of polygodial. The differing level of extraction of the green 
pigment components during extraction can be seen in Figure 2.6, which shows the colour 
of the plant material after PHWE extraction, and after maceration. This comparison 
provides evidence for the PHWE method being superior in efficiency and extract quality, 
compared with the basic technique of maceration. Further, the insoluble plant material 
proved more difficult to remove following maceration, which highlights another 
advantage this new PHWE method, in that the espresso machine also acts as a filter to 
exclude solid plant materials from the extract. 
 
 
 
 
 
 
Table 2.2 – Crude T. lanceolata extract comparison with maceration. a - average of two 
runs, b - the resulting material following flash column chromatography was dark green 
and contained impurities. 
   
Figure 2.5 – CH2Cl2 maceration extract of T. lanceolata (left) and the resulting isolated 
polygodial sample (right). 
Entry EtOH %v/v Technique Crude mass, 
% yield w/w 
Purified 
polygodial,  
% yield w/w 
Table 2.1, 
Entry 4 
35 PHWE 586 mg, 
3.91 %a 
106 mg, 0.71 %a 
1 35 Reflux 
maceration, 1 h 
180 mg, 
1.20 % 
- 
2 35 rt maceration, 
24 h 
210 mg, 
1.40 % 
- 
3 CH2Cl2 rt maceration, 
24 h 
1100 mg, 
7.30 % 
165 mg, 1.10 %b 
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Figure 2.6 – T. lanceolata plant material after espresso machine PHWE (left) and CH2Cl2 
maceration (right). 
2.2.7 Temperature and Pressure Optimisation through Accelerated Solvent Extractor 
PHWE 
Following espresso machine PHWE method development, a study was undertaken using 
a Dionex ASE200 accelerated solvent extractor (ASE) system. As pressure and 
temperature cannot be programmed using the espresso machine, this system provided 
an alternative means of investigating these parameters. The accelerated solvent 
extractor is used for pressurised liquid extraction, and represented the closest available 
comparison to espresso machine PHWE to investigate extraction performance and yield. 
The lowest pressure the ASE can be set to is 500 psi (~35 bar), so values of 500 psi and 
1500 psi (~100 bar) were used to investigate if a higher pressure changed the efficiency 
of the extraction. Temperatures of 70, 90, 110 and 130 °C, and solvent concentrations of 
15, 25 and 35 % EtOH:H2O (v/v) were chosen. A single run was also undertaken with neat 
water as the extraction solvent at 150 °C to gauge the effect of increased temperature on 
the extraction. This instrument differs from the espresso machine in a few different 
ways. The espresso machine is a flow system, whereas the ASE uses static extraction. For 
these experiments, the system was set up to have 2 x 10 min static extractions, with 
solvent flushing in between. This lowers the overall extraction volume used, but 
increases the time of the extraction and therefore the amount of time the compounds in 
the extract are subjected to elevated temperature. The sample compartments of the 
instrument could each only contain about half the mass of T. lanceolata leaf material as 
the espresso machine (~7 g), but 24 samples could be set up and extracted automatically.  
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In preparation for the study, a method was developed for the quantitation of polygodial 
in an extract, without requiring isolation of the polygodial. This involved the use of a 
standard added to the crude extract, which could be compared to the amount of 
polygodial in the sample by integration of the relevant peaks in the 1H NMR spectrum. 
The standard chosen was 1,3,5-trimethoxybenzene (13) because it is a stable, non-
hygroscopic solid with a very simple 1H NMR spectrum. The 1H spectrum for this 
compound is simply a singlet integrating for the three aromatic protons at 6.08 ppm, and 
a singlet integrating for the nine methoxy protons at 3.76 ppm. The singlet at 6.08 was 
used as the signal for quantitation, compared with the integration of the aldehyde signals 
for polygodial. 
 
 
 
 
Figure 2.7 – The quantitation standard used, 1,3,5-trimethoxybenzene, polygodial, and 
the signals used for quantitative 1H NMR spectroscopic analysis of the crude extract. 
Initial investigation by 1H NMR spectroscopy of this standard in a sample of crude T. 
lanceolata extract showed that the default 1H NMR program on the 400 MHz instrument 
at the University of Tasmania was not quantitative. Quantitation relies on total relaxation 
of the protons after a pulse in the instrument, which occurs at different rates depending 
on the chemical environment of the proton.107,108 For these experiments to be 
quantitative a 1:1 integration of the aldehydes with respect to the alkene signal in 
polygodial, and a 3:9 integration of the aromatic protons to the methoxy protons within 
the standard is desired. Initial experiments showed that these integrations were not 
matching these expectations (Figure 2.8) and could not therefore be used in quantitative 
experiments.  
13 12 
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Figure 2.8 – 1H NMR spectrum of a crude T. lanceolata extract, containing 1,3,5-
trimethoxybenzene as the internal quantitation standard. Recorded using default 
acquisition parameters.  
Relaxation is influenced primarily by the angle of the pulse, and the relaxation delay. A 
lower angle pulse means that the protons relax and realign with the magnetic field more 
quickly, and a longer relaxation delay gives more time for this to occur.78,107 The default 
program on the Bruker 400MHz instrument has a 90 ° pulse angle and a 5 s relaxation 
delay. For quantitation, the pulse width was reduced to 30 °, and the relaxation delay 
increased to 10 s. Figure 2.9 shows a mixture of polygodial (12) and the NMR standard 13 
recorded using the default parameters. It can be seen that the integrations within each 
molecule are not quantitative. Figure 2.10 shows the result of changing the parameters 
to a 30 ° pulse width and a 10 s relaxation delay, where the protons within each molecule 
show the appropriate integration ratio required for a quantitative analysis. 
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Figure 2.9 – 1H NMR spectrum of polygodial with 1,3,5-trimethoxybenzene (~4:1 12:13 by 
mass). Recorded using default parameters.  
 
Figure 2.10 – 1H NMR spectrum of polygodial with 1,3,5-trimethoxybenzene (~4:1 12:13 
by mass). Recorded using default parameters with the pulse width reduced to 30 °, and 
the relaxation delay increased to 10 s.  
The results from the ASE optimisation study are reported in Figure 2.11 and Figure 2.12. 
It was observed that the highest percentage yield of polygodial was obtained at 90 °C and 
35 % EtOH, which is fortuitously the closest matching conditions to the espresso 
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machine. At temperatures above 90 °C, significant epimerisation of the aldehyde was 
observed, leading to a mixture of polygodial and 9-epipolygodial (14). Decomposition was 
also observed at higher temperatures, with the 1H NMR spectral data indicating more 
impurities. It was also observed that around the optimal conditions, the solvent 
composition has more influence on the extraction efficiency than the temperature. The 
highest yield recorded was 0.44 % w/w, which is significantly lower than the 0.7 % w/w 
achieved using the espresso machine PHWE method. The high temperature run with 100 
% H2O as the extraction solvent gave the lowest extraction yield of all the trials, and the 
high temperature caused significant decomposition.  
 
Figure 2.11 – Results obtained from the ASE200 PHWE optimisation study showing the 
yield of polygodial as a % (w/w) of the plant material extracted at 500 psi. 
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Figure 2.12 – Results obtained from the ASE200 PHWE optimisation study showing the 
yield of polygodial as a % (w/w) of the plant material extracted at 1500 psi. 
One of the previously mentioned contributing factors to a loss of polygodial yield at 
higher temperature was the epimerisation of polygodial. The appearance of 9-
epipolygodial was measured through the integration of the corresponding aldehyde 
peaks in the 1H NMR at 9.88 and 9.43 ppm, which are completely separate from the 
polygodial aldehyde peaks at 9.48 and 9.56 ppm (Figure 2.14).76,105 The epimerisation 
was calculated based on the ratio of polygodial to 9-epipolygodial observed, and shown 
in Figure 2.13 as a function of temperature.  
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Figure 2.13 – Epimerisation of polygodial during extraction with the Dionex ASE200 as a 
function of temperature. 
 
Figure 2.14 – Partial 1H NMR spectrum showing polygodial and 9-epipolygodial in a 
mixture following epimerisation at 150 °C.  
This epimerisation at 90 °C in the ASE extractions is at a much higher level than that 
observed for the espresso machine PHWE extraction, which is due to the much longer 
time at the extraction temperature (>20 mins vs ~2 min). The espresso machine 
extractions at 90 °C show negligible epimerisation, compared with nearly 10 % observed 
during ASE extraction. Even with epimerisation taken into account, the overall yield of 
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the extraction observed was highest at 90 °C and 35 % EtOH:H2O v/v, and represents a 
lower yield than PHWE extraction of the same plant material as shown in Figure 2.15.  
 
Figure 2.15 – Results obtained from the ASE200 PHWE optimisation study showing the 
combined yield of polygodial + 9-epipolygodial as a % (w/w) of the plant material 
extracted. 
The minimal epimerisation observed in the espresso machine PHWE extracts is significant 
as it suggests that the method is not only efficient, but also that compounds with limited 
thermal stability may be routinely extracted. Further, due to the easy accessibility of the 
collection vessel in the espresso machine, the extract may be collected into a vessel 
containing ice to allow cooling immediately upon extraction, further improving the ability 
of the espresso machine to extract thermolabile compounds. This is not something which 
can be done with the ASE without modification of the instrument. 
2.2.8 Isolation of Multi-Gram Scale Quantities of Polygodial, and Practical 
Considerations 
Following optimisation of the PHWE extraction parameters for T. lanceolata, the method 
was scaled up to demonstrate speed and efficiency for the extraction of larger amounts 
of plant material. T. lanceolata ground leaf material was extracted (12 x 15 g), with the 
entire process taking around 30 minutes. From this PHWE extract, 6.5 g of crude material 
was obtained (3.6 % crude yield w/w) which was purified to yield 1.24 g of polygodial, 
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(0.7 % isolated yield w/w). The entire process was completed over an 8-hour period, 
which speaks to the rapid and efficient nature of the method.  
Subsequently, samples of T. lanceolata were obtained that have specifically cultivated for 
their high polygodial content (variable, up to ~3.3 % w/w).* Applying the PHWE method 
to this material allowed the isolation of gram-scale quantities of polygodial efficiently 
within a matter of hours. The isolation of polygodial from this high yielding T. lanceolata 
crop was scaled up to the extraction of 120 g of leaf material, resulting in isolation of 2.44 
g of polygodial after chromatography. This represents a yield of 2.0 % w/w, which is 
lower than the highest percentage observed of 3.3 % w/w. However, this was attributed 
to observed variation in the high yielding T. lanceolata, and still represents rapid isolation 
of gram-scale quantities of valuable material. 
During these tests, after extraction with the espresso machine, the EtOH:H2O extract was 
concentrated under reduced pressure to remove EtOH prior to secondary extraction. This 
additional step of evaporating the EtOH had two advantages. The resulting extraction 
volume was reduced which led to a simplified secondary extraction with 
dichloromethane, and the build-up of emulsions in the separating funnel was reduced.  
Subsequently, ethyl acetate and heptane were trialled as less toxic alternatives for liquid-
liquid extraction of the PHWE extract. All of these solvents were efficient in extraction of 
the polygodial from the aqueous PHWE extract, with the heptane showing the greatest 
selectivity, as assessed qualitatively by analysis of the 1H NMR spectrum of the resulting 
extracts and by the colour of the resulting extract. A significant advantage of using 
heptane as the secondary extraction solvent is that during rotary evaporation, ~80–90% 
of the heptane can be readily recovered. Furthermore, when heptane was used as the 
extraction solvent, emulsions showed a much lower tendency to form during liquid-liquid 
extraction.  
The reduction of volume of the extract was of more significance during scale-up 
experiments, as solvent extraction was limited to a volume of 1.5 L for practical and 
safety reasons. Evaporation of the EtOH became standard practice for an extraction 
when the secondary extraction solvent was CH2Cl2 or EtOAc, or when large volumes of 
                                                          
* Material provided by Essential Oils of Tasmania, www.eotasmania.com 
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extract were generated. Initially there were concerns that the polygodial may undergo 
thermal degradation or epimerisation by being held at a higher temperature for a longer 
time, as the water bath on the rotary evaporator required a temperature of 50 °C to 
allow efficient removal of solvent. However, no decreases in yield were observed, and 
the 1H NMR spectrum of the extract obtained remained qualitatively unchanged 
following this process. 
2.2.9 Multi-Gram Isolation of Polygodial by Crystallisation 
It was subsequently discovered that from the high yielding crop of T. lanceolata, that 
polygodial could be isolated in gram-scale quantities rapidly without chromatography. 
The crude extract proved rich enough in polygodial when extracted with heptane that the 
compound could be readily obtained through crystallisation. When the material was 
crystallised without a chromatographic step, the crystals were typically of a small particle 
size and had an off–white/pale yellow appearance. In spite of the colour, the 1H NMR 
spectroscopic analysis showed no evidence of impurities and the material was 
determined to be sufficiently pure for synthetic applications (Chapter 4). This type of 
process has a potential greater relevance as an industrial process, based on the proof-of-
concept provided here. Pure white crystals were obtained if the material was subjected 
to silica flash column chromatography before crystallisation, with successive washing 
steps using ice-cold hexane. This resulted in a lower than optimal yield due to the 
solubility of the compound in hexane, but did provide polygodial of high purity in gram-
scale quantities.  
 
Figure 2.16 – Crystals of pure polygodial (12) obtained from chromatographed T. 
lanceolata heptane extract (left), off-white crystals of polygodial obtained through 
crystallisation of the crude heptane extract without a chromatographic separation (right).  
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2.2.10 Reactivity of Crude Polygodial Extract – Synthesis of Drimendiol 
Though this method has shown that polygodial is able to be isolated rapidly with minimal 
degradation, many syntheses involving polygodial involve reduction of the aldehydes to 
furnish the known natural product drimendiol (15). Drimendiol is another natural product 
isolated from plants of the Drimys (Winteraceae) genus,109 as well as some fungal 
species.110 To this end, drimendiol may be isolated from T. lanceolata through reduction 
of purified polygodial, or by reduction on the crude extract prior to purification. Reaction 
on the crude extract may be a more efficient route to obtain this compound, as only one 
chromatographic step is required. To demonstrate this, the crude organic extract from T. 
lanceolata extraction was treated with LiAlH4 in THF prior to purification. This process 
proceeded efficiently allowing expedited isolation of large quantities of drimendiol in up 
to 3.3 % yield (w/w).  
 
 
Scheme 2.1 – Reduction of polygodial (12) with LiAlH4 in the crude extract to form 
drimendiol (15). 
1H NMR spectroscopic analysis of the crude reaction product showed the loss of the 
aldehyde signals at 9.56 and 9.43 ppm, and the appearance of two sets of diastereotopic 
methylene signals at 4.30 ppm, 3.92 ppm, 3.85 ppm, and 3.61 ppm. This was indicative of 
the formation of hydroxymethyl groups in place of the aldehydes, indicating successful 
conversion to drimendiol. The material was purified by silica gel chromatography, 
resulting in drimendiol isolated in yields equivalent to the expected amount of polygodial 
in the extract. 
2.2.11 Summary 
Though PHWE would not typically be the first choice for the extraction of such a non-
polar substrate, the method developed has shown high efficiency in extraction of 
12 15 
crude extract 3.3 % yield w/w 
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polygodial (12) from T. lanceolata. The rapid nature of the method has allowed the 
isolation of this sensitive substrate with limited epimerisation or decomposition. This was 
evident through the degree of enrichment of polygodial evident in the spectroscopic 
analysis of the crude extracts compared with extracts produced through ASE extraction 
or maceration. Further, the ease of purification of polygodial by flash column 
chromatography or crystallisation further highlights the degree of enrichment of the 
PHWE extract and limited extraction of plant pigments and therefore the viability of this 
method for extraction of non-polar terpenoids. 
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2.3 Shikimic acid from Illicium verum 
2.3.1 Background 
Shikimic acid and derivatives continue to be of interest in synthetic chemistry for a 
number of biological applications.111-115 Indeed, in 2013 it was said of shikimate-derived 
natural products ‘…it is probably fair to say that terpenoid- and shikimate-derived natural 
products are now providing some of the most structurally interesting and biologically 
relevant target molecules of the 21st Century’.116  
 
Figure 2.17 – Shikimic acid (16), fluorinated derivatives (17), and Oseltamivir (18) (the 
phosphate salt is the antiviral drug Tamiflu®) 
Shikimic acid is a key intermediate in the shikimate pathway, used by plants and 
microbes to synthesize aromatic amino acids and other secondary metabolites.117 
Humans do not use this metabolic pathway,118 but it is key to the life of plants, bacteria 
and also protozoan parasites. A key example is Plasmodium falciparum, the parasite that 
causes malaria.119 Fluorinated shikimate derivatives (17) have been shown to be 
inhibitory to P. falciparum and have been tested as anti-malarial drugs.119 
Shikimic acid derivatives also have other functions such as the anti-viral drug Tamiflu® 
(oseltamivir (18) phosphate) which acts as a viral neuraminidase inhibitor and is used to 
treat seasonal influenza, and avian and swine influenza outbreaks.120 These properties 
make shikimic acid an attractive starting material for the synthesis of novel bioactive 
molecules. Further, due to the presence of the three contiguous stereocentres in the 
molecule, shikimic acid represents a versatile starting point in the asymmetric synthesis 
of synthetic targets. 
In 2009, the influenza pandemic led to a greater than ten-fold surge in shikimic acid 
pricing, and methods to improve the acquisition of this compound were sought. Much of 
the shikimic acid was extracted from Chinese star anise grown in China, where the 
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extraction process was noted to be expensive, and yields dependent on weather 
conditions during growth.121 At the time of this work being undertaken, the price of 
shikimic acid was relatively high. More recently, the price has decreased significantly due 
to industrial production of shikimic acid by microorganisms,122 but is still around 
AUD$200 per gram.* 
Shikimic acid is found in many plant species, but is noted to be in particularly high 
abundance in Chinese star anise (Illicium verum Hook. f.) fruit.115 Dried star anise pods 
are inexpensive, and readily available in kilogram quantities. The quantity of shikimic acid 
in star anise varies, but reports estimate an average of 3.3 % by mass.123,124 PHWE of 
shikimic acid has been previously undertaken, but on a custom built system for analysis 
of up to 0.5 g of sample at 150 °C at 150 bar pressure over 4 min.125 Exhaustive yields 
were reported based on HPLC analysis, but the method was not practical for semi-
preparative scale isolation. A method for larger scale isolation is therefore desirable. 
With this in mind, investigations into the efficient extraction and isolation of shikimic acid 
and various protected intermediates were undertaken as a complementary method to 
other ways of generating this substrate. Through extraction of this plant, PHWE was 
further investigated to isolate significant quantities of the polar, carboxylic acid-
containing compound shikimic acid from star anise. This represents an important 
expansion of the scope of the method, as initial method development was solely 
concerned with the extraction of polygodial, a C15 sesquiterpene.  
2.3.2 Extraction and Chromatography Free Isolation of Shikimic Acid 
For an initial test extraction, Chinese star anise was extracted with 30% v/v EtOH:H2O, 
and subsequently extracted with dichloromethane. Shikimic acid is water soluble, and 
therefore secondary extraction with an organic solvent does not extract the shikimic acid. 
It does, however, remove the essential oil component from the extract to simplify the 
isolation of the shikimic acid. The essential oils which are present in yields over 8% w/w, 
and consist mainly of anethole.126 The aqueous extract was subsequently evaporated, 
and analysis of the 1H NMR spectrum of the crude extract in D2O indicated that shikimic 
acid was the major organic component.  
                                                          
* As at 14/01/18 from Sigma Aldrich 
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Therefore, the extraction was repeated, silica gel and methanol were added, and the 
ensuing mixture was evaporated to dryness. The extract adsorbed onto silica was then 
loaded into a sintered glass funnel where different components of the extract could be 
successively eluted from the silica plug. The anethole and other essential oil components 
were removed by eluting with CH2Cl2 and EtOAc. Following this, the shikimic acid was 
eluted from the silica using 10% AcOH:EtOAc. This solvent system was of sufficient 
polarity to obtain the shikimic acid, while leaving behind many of the pigments and salts 
present in the extract. Upon evaporation of the solvent, an off-white solid was obtained 
which was further washed with a small quantity of CH2Cl2. 1H and 13C NMR spectroscopic 
analysis of the product obtained shows shikimic acid to be the major component, 
isolated in a 5.5% yield w/w in gram-scale quantities without chromatography. 
 
Figure 2.18 – 1H NMR spectrum (D2O) of shikimic acid isolated from I. verum without 
chromatography. (The unusual broad signal around 4.9 ppm represents a partially 
presaturated water signal.) 
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Figure 2.19 – Shikimic acid isolated from I. verum without chromatography. 
2.3.3 Isolation of Protected Shikimic Acid Derivatives 
While the isolation of shikimic acid directly provided material for synthesis, it was still 
impure (though this could be overcome with further purification by chromatography or 
recrystallisation). Additionally, synthetic work on this substrate often involves protection 
of the functional groups to form derivatives such as 19 and 20 as the first step.127-130 To 
this end, protection reactions were directly carried out on I. verum crude extracts to 
isolate protected derivatives of shikimic acid. 
 
Scheme 2.2 – Protected shikimic acid intermediate 19 in the synthesis of oseltamivir (18). 
As many components of plant extracts are very polar such as salts, sugars and glycosides, 
the reduction in polarity of the desired substrate may allow for simplified purification. 
The reaction to convert shikimic acid to the methyl ester, and the syn-hydroxy 
substituents to an acetonide to form protected shikimic acid derivative 20 is reported 
many times in the literature.130-134 A similar protected shikimic acid derivative (21) has 
been reported as an intermediate in the synthesis of marine natural product (–)-
pericosine E (22).135 
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Figure 2.20 – Acetonide derivative of methyl shikimate 
 
Scheme 2.3 – Protected shikimic acid derivative in the synthesis of (–)-pericosine E (22). 
To test the protection of shikimic acid in the crude extract, 90 g of the ground pods were 
extracted by PHWE in 6 portions of 15 g. The extract was reduced in volume before 
washing with CH2Cl2. The residual aqueous fraction was then evaporated to dryness, and 
the resulting crude dark material esterified with HCl in MeOH to form methyl shikimate 
23. After evaporation of the MeOH, this material was then dissolved in acetone and 2,2-
dimethoxypropane with Amberlyst® 15 acidic ion exchange resin added for the syn-diol 
protection of shikimic acid. Filtration and evaporation gave a black residue which was 
fractionated through a large silica plug, and subsequently purified by automated gradient 
flash chromatography to yield 4.76 g of protected shikimic acid derivative 20, 
representing a 4.0% w/w isolation of shikimic acid. Notably, the entire process (from the 
extraction of star anise, to the purified compound) was undertaken within 8 h. 
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Scheme 2.4 – Reaction sequence to form methyl protected shikimic acid derivative 20. 
Yield quoted represents equivalent weight of shikimic acid following extraction and 
protection followed by a single chromatographic step. 
This 2-step protection protocol was then scaled up, to target ethyl derivative 19, which is 
an intermediate in one of the syntheses of Tamiflu (Scheme 2.2, above).136 In this case, 
extraction of 200 g of star anise seed pods was undertaken (10 x 20 g). Following 
concentration by rotary evaporation, and washing with CH2Cl2, the crude aqueous extract 
was then evaporated to dryness, and esterified analogously as described before, instead 
using EtOH to form ethyl ester 24. Subsequent reaction with 3-pentanone and Amberlyst 
15 acidic ion exchange resin provided the crude material. Purification via silica plug 
yielded 13.15 g of a yellow/brown oil of sufficient purity as determined by 1H NMR 
spectroscopy, although an analytical sample could be provided by silica flash column 
chromatography. This mass represented a yield of 4.2 % w/w, and therefore a viable 
method to obtain protected shikimic acid derivatives for synthesis from an inexpensive 
source. 
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Figure 2.21 – 1H NMR spectrum of the ethyl-protected shikimic acid derivative 19. 
 
Scheme 2.5 – Reaction sequence to form ethyl protected shikimic acid derivative 19. 
Yield quoted represents equivalent weight of shikimic acid following extraction and 
protection followed by a single chromatographic step. 
Following the successful isolation of gram-scale quantities of material from these two 
model studies, protection of the syn-diol with benzaldehyde as previously reported by 
Payne and co-workers131 was undertaken. This yielded 3.7% (w/w) of the desired product 
as a mixture of diastereomers 25a and 25b (1:1.2 d.r.). Analysis of the 1H NMR spectrum 
for this material shows clearly the formation of two diastereomers, with the key signals 
being the pair of singlets at 5.97 and 5.94 ppm representing the methine proton of the 
acetal adjacent the aromatic ring.  
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Scheme 2.6 – Synthesis of acetal diastereomers 25a and 25b with benzaldehyde. Yield 
quoted represents equivalent weight of shikimic acid following extraction and protection 
followed by a single chromatographic step. 
 
Figure 2.22 – 1H NMR spectrum of the mixture of diastereomers 25a + 25b 
2.3.4 Unsuccessful Protection Reactions 
Protection of the hydroxy substituents at the 3- and 5- positions was attempted, which 
would leave a free hydroxy at the 4- position. This was based on a reported protection 
using TBDMS chloride which was shown to selectively protect these groups when only 2 
equivalents of TBDMS chloride are added,130 presumably due to steric influence. The 
problem with applying this method to the crude I. verum extract is that the amount of 
starting material, and the amount of other material in the crude mixture that could react 
with TBDMS chloride, is unknown. Excess TBDMS chloride could not be used however 
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due to the possibility of converting all three hydroxy substituents to the corresponding 
silyl ether. Unsurprisingly, this reaction afforded a mixture of unidentified products in 
negligible yield. 
Protection of the anti-diol is also possible as reported by Armesto137 using 2,3-
butanedione as a protecting reagent in methanol under acidic conditions to form 
shikimate derivative 27. The reported method uses camphorsulfonic acid in a sealed tube 
to go above the boiling point of methanol. A test was undertaken to determine whether 
this method could be made more facile by using Amberlyst® 15 resin and simple reflux in 
methanol, but no product was observed. 
  
Scheme 2.7 – Protection of the anti-diol of a shikimate derivative reported by Armesto. 
These more selective alcohol protection reactions are more sensitive to the conditions 
used, so it would be more practical to isolate esters 23 and 24 prior to protection of the 
hydroxy substituents.  
2.3.5 Isolation of Shikimic Acid Esters 
The methyl and ethyl esters were prepared analogously to above, and were found to be 
readily isolable. The methyl and ethyl ester were isolated successfully by automated 
gradient flash column chromatography eluting with MeOH:EtOAc in 4.7 % w/w (2.03 g 
from 40 g of Chinese star anise) and 5.4 % w/w (2.49 g from 40 g of Chinese star anise) 
yield respectively.  
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Scheme 2.8 – Esterification of the crude extract of shikimic acid to form esters 23 and 24. 
Yields quoted represents equivalent weight of shikimic acid following extraction and 
protection, and a single chromatographic step. 
2.3.6 Summary 
Extraction of shikimic acid (16) from I. verum highlighted the viability of the method for 
the extraction of more polar compounds. In the same way as for for T. lanceolata, the 
enrichment of the extracts obtained by PHWE allowed for simple purification. Shikimic 
acid was isolated in gram-scale quantities without chromatography via fractionation by 
ion-exchange resin, Further, derivatisation of the shikimic acid to form less-polar 
substrates was efficiently achieved. 
2.4 Coumarins from Correa Species 
2.4.1 Background 
As a result of a bioprospecting survey completed by the research group,* rapid and 
efficient isolation of milligram- to gram-scale quantities of coumarins from three species 
of Correa (Rutaceae) which are endemic to Australia – Correa reflexa ((Labill.) Vent.), C. 
alba (Andrews), and C. backhouseana (Hook.) was achieved. The aim of the survey was to 
investigate native or endemic Tasmanian plants, which had not been previously 
investigated, for natural product scaffolds. In this survey, each plant was extracted using 
the in-house developed PHWE method and there were two criteria that had to be 
satisfied in order for further investigation to be undertaken on the given plant. Given that 
the aim of the survey was to identify plant sources of organic scaffolds for potential 
synthesis applications, the criteria for further study for a given plant were major 
components identifiable in the 1H NMR spectrum and TLC analysis of the crude extract, 
                                                          
* Bianca Deans, Honours Thesis, University of Tasmania 2014 
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and sufficient crude yield (≥1% w/w from 15 g of dried plant) following PHWE with 35% 
EtOH:H2O, and subsequent liquid-liquid extraction with CH2Cl2. The chemistry of these 
Correa species has not been previously reported.46 Following from this initial result from 
the survey, optimisation of the extraction yield was undertaken.  
Coumarin compounds (2H-chromen-2-ones) are an important class of naturally occurring 
biologically active molecules extracted from a variety of plant species.138-142 Owing to the 
diverse range of observed biological activities, coumarins are an attractive target for 
isolation from plant species, as well as being useful starting materials for synthesis of 
analogues.  
 
Figure 2.23 – The simplest coumarin compound, coumarin (28, numbered). 
C. reflexa was found to contain significant amounts of seselin (29) and (+)-
epoxysuberosin (30). C. alba and C. backhouseana were both found to contain significant 
quantities of the coumarins alosin (31) and (–)-meranzin (32). C. backhouseana was also 
found to contain heraclenin (33). The similarity between C. alba and C. backhouseana 
compared with C. reflexa is consistent with the morphological similarity of the two, and 
also their relationship genetically, with C. alba and C. backhouseana being more closely 
related to each other than they are to C. reflexa.143 All isolated coumarins in this study 
have an oxygen atom connected at the 7-position, and are further substituted at the 6- 
and/or 8- position. The isolated compounds are all known, and have previously reported 
biological activity. 
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Figure 2.24 – Compounds isolated from Correa spp. 
Seselin (29) has been shown to disrupt the development of blowfly larvae,140 as well as 
showing antifungal144,145 and anti-inflammatory activity.146 (+)-Epoxysuberosin (30) has 
shown mild anti-tumor activity,147 as well as being investigated for antioxidant activity, a 
trait many coumarins are known to possess.148 Alosin (31) has shown antifungal,149 anti-
leishmanial150 activity, as well as anti-proliferative activity towards human cancer cell 
lines.151 The majority of reports of the bioactivity of (–)-meranzin (32) are concerned with 
that of the compound (–)-meranzin hydrate, in which the epoxide functionality has been 
ring-opened with water. Such activity includes anti-depressive152 and anti-proliferative 
towards human prostate cancer cells.153 This compound exists as a natural product154 but 
may also be an artefact of isolation. Heraclenin (33) has shown phytotoxic,141 
antiplasmodial,155 anti-bacterial,156 nematocidal,157 mutagenic,158 and anticoagulant159 
activity. In addition, heraclenin has been studied as a potentially useful material in 
organic electronics due to its optical properties.160  
Most of these compounds are available commercially, but their use in synthesis and 
biological applications is inhibited by a price range of $60–180 per mg.46 Following the 
survey and identification of the major components, the method was further developed 
for this specific application and the yields of the compounds isolated increased 
significantly upon optimization. The main focus of the extraction of these compounds 
was to maximise the yield obtained from the extraction.  
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2.4.2 Liquid-liquid Extraction Solvent Optimisation for C. reflexa 
C. reflexa was extracted by PHWE (35% EtOH:H2O), and various parameters were 
investigated similar to the optimisation of the extraction of T. lanceolata described 
previously. It was determined for the Correa spp., that the maximum amount of plant 
material that would fit into the sample compartment  of the espresso machine was 10 g, 
in comparison to 15 g for the T. lanceolata, and 20 g for I. verum. This was simply due to 
the physical nature of the leaves.  
An extraction of C. reflexa (10 g) was undertaken, and the resulting PHWE extract then 
extracted successively with CH2Cl2 and EtOAc. Both organic extracts contained 2 major 
identifiable components, seselin (29) and (+)-epoxysuberosin (30). The combined yield of 
366 mg represented a yield of 3.7 % w/w from dry plant material, compared with 2.6 % 
w/w when using CH2Cl2 extraction alone. As these extracts contained the same 
components, this suggested that CH2Cl2 was not an appropriate extraction solvent for the 
efficient exhaustive extraction of the coumarin compounds from the PHWE extract. An 
important feature of the 1H NMR spectra for C. reflexa is the lack of impurities. Indeed, 
for this extract, a single chromatographic separation was required to isolate the two 
major components.  
 
Figure 2.25 – 1H NMR spectrum of the CH2Cl2 extract (above) and the subsequent EtOAc 
extract (below) of C. reflexa (contains residual EtOAc)  
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2.4.3 PHWE Solvent Volume Optimisation for C. reflexa 
A sample of C. reflexa was then extracted by PHWE (3 x 100 mL, 35% EtOH:H2O) to 
determine if the PHWE extraction is exhaustive for the compounds. Each fraction was 
then extracted with EtOAc, and following removal of solvent, fraction 1 contained 266 
mg, fraction 2 contained 103 mg, and fraction 3 contained 16 mg. A qualitative 
assessment of the 1H NMR spectrum of these extracts also determined that the last 
fraction was the least enriched in the coumarin compounds. This was consistent with the 
result observed for T. lanceolata, showing that 200 mL of extraction solvent from the 
espresso machine is sufficient for extraction of the desired material from the plant, and 
that a higher volume increases the levels of undesired components being extracted. 
2.4.4 Scaled-Up Extraction of Correa Species 
Following the optimisation of key parameters, it was determined that EtOAc should be 
used for liquid-liquid extraction of the PHWE extract, instead of CH2Cl2. Subsequently, 
large-scale extractions were carried out on all species, and the components isolated to 
purity. The results are summarised in Table 2.3, with comparison to the yields previously 
obtained by Deans.* 
 C. reflexa C. alba C. backhouseana 
 % of dry 
plant 
weight  
Mass 
isolated 
(g) 
% of dry 
plant 
weight 
Mass 
isolated 
(g) 
% of dry 
plant 
weight 
Mass 
isolated 
(g) 
seselin 29 1.00 
(0.14) 
1.00 - - - - 
(+)-epoxysuberosin 30 1.15 
(0.25) 
1.15 - - - - 
alosin 31 - - 0.89 
(0.37) 
.268 0.065 
(0.079) 
0.065 
(–)-meranzin 32  - - 0.31 
(0.19) 
.094 0.050 
(0.051) 
0.050 
heraclenin 33 - - - - 0.041 
(0.029) 
0.041 
 
Table 2.3 – Compounds isolated from Correa spp. with % yield w/w. Numbers in 
parentheses represent the initial yields reported from the bioprospecting survey by 
Deans.* The primary difference in the method was use of EtOAc instead of CH2Cl2. 
                                                          
* Bianca Deans, Honours Thesis, University of Tasmania 2014 
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For C. reflexa, extraction of 100 g of material (10 x 10 g) was undertaken. After 
concentration by rotary evaporation, subsequent EtOAc extraction provided an extract in 
3.9 % w/w yield. Purification by automated flash column chromatography yielded the 
compounds seselin (29) and (+)-epoxysuberosin (30) in 1.0 and 1.15 % yield (w/w) 
respectively. C. alba (3 x 10 g) was extracted, yielding alosin (31) in 0.89% yield w/w and 
(–)-meranzin (32) in 0.31 yield w/w. C. backhouseana (10 x 10 g) also contained the major 
components, alosin (31) (0.065 % yield w/w) and (–)-meranzin (32) (0.050 % yield w/w) 
as well as an additional component, heraclenin (33), isolated in 0.041% yield (w/w). For 
all of these extractions, no ring-opening of the epoxide moieties was observed, again 
demonstrating the mild nature of this extraction method. 
These experiments show the difference in extraction yield, influenced by a combination 
of factors. Level of experience with the technique, optimisation of pressure based on 
flow rate, and secondary extraction solvent have all played a part in increasing the yield 
of the coumarin compounds isolated from these Correa species. The increase in the yield 
obtained increased up to ~7x greater in the case of seselin, isolated from C. reflexa. The 
above table summarises in full the compounds isolated from the scaled up and optimised 
extraction of the 3 Correa species. The isolation of compounds from C. backhouseana did 
not show an increase in yield, however, C. reflexa and C. alba gave a significant increase 
in yield following the optimisation. 
2.4.5 Summary 
The extraction of gram-scale quantities of valuable coumarins (29–33) from three Correa 
species further highlights the application of this method for the extraction of sensitive 
non-polar substrates. These compounds were potentially unstable to the extraction 
conditions due to their epoxide moieties. However, as for polygodial, the reaction or 
degradation of these substrates was not observed. The NMR spectroscopic analysis of 
the extracts of these plants showed a high concentration of the targeted coumarin 
compounds, resulting in simple purification of these compounds by flash column 
chromatography. These results support the use of the PHWE method for screening plants 
for natural products, as degradation of sensitive substrates is limited. 
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2.5 Conclusion 
Through the rapid extraction of the three plants described, the viability of an unmodified 
espresso machine for PHWE has been conclusively demonstrated. The extract for T. 
lanceolata was demonstrated to be more enriched in the desired compound, and 
therefore more facile to purify compared with maceration extracts. For all the given 
compounds, Soxhlet extraction would require specialised glassware, and is noted to take 
a significantly longer time compared to this PHWE method. In addition, the isolated 
compounds would not be viably extracted through hydrodistillation due to their high 
boiling points. Modern techniques such as supercritical fluid extraction may prove to be 
efficient ways to extract some of these compounds, however, the apparatus is 
specialised and expensive and therefore would not be compatible with the aims of this 
project.  
Though this method is not always going to be the optimal choice for all natural product 
extractions, it has proven to be faster and more cost effective than the methods 
described in the introductory chapter of this thesis for the examples given. This new 
method represents an efficient, rapid and cost-effective complementary technique for 
the isolation of gram-scale quantities of valuable and sensitive organic compounds. 
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Chapter 3: Applications of the PHWE Method 
3.1 Overview 
In this chapter, the PHWE method was further investigated though the extraction of 
various plant species ranging from invasive plants, commercial crops and common herbs. 
These species were chosen for a variety of reasons to demonstrate the broad 
applications of this new method.  
Thirteen different plant species were investigated to provide a broad range of examples, 
each increasing the understanding of the scope and utility of this method. Eupatorium 
adenophorum, Chrysanthemum cinerariaefolium, and Momordia charantia were 
extracted to rapidly generate extracts for biological applications. Castanospermum 
australe and Marrubium vulgare were extracted as they are known to contain valuable 
natural products that are used extensively for biological studies, or further synthetic 
studies. Extraction of Drimys winteri, and a survey of Tasmannia lanceolata were 
undertaken to further investigate the viability of the method as a rapid screening and 
bioprospecting tool. Finally, extraction of the essential oils from 6 common culinary 
plants were undertaken to investigate the potential of the method as an alternative to 
distillation, and as part of efforts to translate the method into an undergraduate 
laboratory natural products extraction technique. 
3.2 Rapid Generation of Bioactive Extracts 
3.2.1 Terpenes and Glycosides from Crofton Weed (Eupatorium adenophorum) 
3.2.1.1 Background 
Eupatorium adenophorum (Spreng.) (Crofton weed) is an invasive plant species, which 
contains several cadinane type sesquiterpenes. The basic structure of many of these 
compounds was reported in the late 70’s161 and early 80’s.162 However, subsequent 
analysis and X-ray studies on this class of molecules led to the revision of the absolute 
stereochemistry.163,164  
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Figure 3.1 – Representative example of cadinane sesquiterpene 34, showing numbering 
system  
In spite of the correction of the absolute stereochemical assignment of the cadinane 
backbone in E. adenophorum, the incorrect absolute stereochemistry is shown in more 
recent reports.165,166 Further, in a number of instances the stereochemical information 
has been omitted entirely.167,168 Historically, study of Crofton weed became important in 
part due to the toxicity of the plant to horses. Horses were noted to go into respiratory 
distress and develop lung damage if allowed to continually consume the plant, indicating 
that metabolites of this plant possessed interesting biological properties.169,170 
Additionally, Crofton weed extracts have been extensively studied for their allelopathic 
(seed germination and growth inhibition) effects against various plant species.171-178 
The original report of the cadinane components, reported by Bohlmann and Gupta, 
describes the isolation of six cadinene terpenes. The structures are shown in Figure 3.2, 
below. The structures provided in the original paper are of the opposite absolute 
stereochemistry, which was revised after publication as described above. In this report, 
320 g of plant material was extracted to yield 160 mg combined cadinanes, representing 
a total yield of ~0.05% w/w cadinanes.162 
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Figure 3.2 – Originally reported cadinanes by Bohlmann and Gupta. The original report 
showed the enantiomers, which were subsequently revised.  
Many reports of the isolation of cadinane compounds form E. adenophorum have shown 
inefficient extraction and featured labour- and time-intensive procedures requiring large 
volumes of solvents, and multiple chromatographic procedures, yielding compounds in 
yields as low as 0.00002 % w/w. For example, He and co-workers report the extraction of 
31 kg of E. adenophorum plant material using an unspecified volume of methanol. The 
resulting extract was subsequently fractionated by suspension in water, and extraction 
with petroleum ether, chloroform, and EtOAc. Multiple flash column chromatographic 
steps and recrystallization were required to isolate the cadinane components of this 
extract. In this way, four cadinane derivatives (509 mg total mass) were isolated (Figure 
3.3), representing a yield of 0.0016% w/w.179 
34 35 36 
37 38 39 
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Figure 3.3 – Cadinane terpenes isolated by He and co-workers. 
In another example, Li and co-workers report the extraction of 10 kg of E. adenophorum 
plant material, using 75 L of petroleum ether, followed by multiple column 
chromatography steps requiring litres of chloroform/petroleum ether mixtures to isolate 
five known and four previously unreported cadinane derivatives (Figure 3.4) in a yield of 
0.0017% w/w (170 mg total mass).172  
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Figure 3.4 – Cadinane terpenes isolated by Li and co-workers. 
Other examples of cadinanes isolated in low yields from this plant include Shi and co-
workers report of the isolation of cadinane terpene 48, in a 4 mg yield from 1 kg of 
leaves, after 4 flash column chromatographic steps. This represents a yield of 0.0004 % 
w/w.180 Additionally, a separate report from He and co-workers describes the isolation of 
cadinane 49 from 1 kg of leaf material (21 mg, 0.002% yield w/w). The dried plant was 
extracted with methanol for 6 days, suspended in water, and fractionated into petroleum 
ether, chloroform, ethyl acetate and n-butanol. The chloroform fraction was subjected to 
multiple flash chromatographic steps and recrystallization to yield this compound.181 
  
Figure 3.5 – Cadinane terpenes 48 and 49. 
A review of all compounds isolated from E. adenophorum was completed in 2015, 
containing all reports up to 2013, including those discussed above.182 The revision of 
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stereochemistry for these compounds was not mentioned in the review, with the 
incorrect stereochemistry for these compounds reported therein.  
Collaborators at the School of Biological Sciences at the University of Tasmania were 
interested in investigating the allelopathic effects previously discussed. Therefore, PHWE 
was investigated as a tool to extract compounds from this plant. Given the 
inconsistencies in previous reports, and the large number of compounds that have been 
reported, the aim of this extraction of this plant was to extract, isolate, and quantify 
where possible the major cadinane sesquiterpenoids. Subsequently, our collaborators 
used these compounds in their biological studies.  
3.2.1.2 Extraction and Isolation of Heptane Soluble Components 
The plant was extracted by PHWE with 35% EtOH:H2O, and the resulting crude aqueous 
extract was extracted with heptane to yield a fraction composed primarily of terpene-
type compounds. The 1H NMR spectrum of the heptane extract is shown below In Figure 
3.6. A number of major components are evident in the spectrum. 
 
Figure 3.6 – 1H NMR spectrum of the heptane extract of E. adenophorum 
Purification of the heptane extract by automated flash gradient chromatography 
provided the chromatogram shown in Figure 3.7. The peaks between 8 and 20 minutes in 
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the separation profile were analysed, and it was found that some of these peaks 
contained multiple compounds. This was not an unexpected result, as there are many 
compounds previously reported within this plant which are very similar in structure and 
polarity. The peaks are labelled 1 through 7 for the purposes of discussion.  
 
Figure 3.7 – Separation profile of the E. adenophorum heptane extract, major peaks are 
numbered 1 through 7. 
As some of the peaks in the chromatogram contained multiple components, some 
compounds required multiple chromatographic steps to obtain pure material for 
characterisation. Other peaks contained pure fractions which could be directly identified 
without further chromatography. With the exception of compound 50, all the 
compounds isolated and identified from this extract were cadinane type 
sesquiterpenoids. Of these compounds, seven were known and three were previously 
unreported. A summary of the compounds isolated from this heptane extract from E. 
adenophorum is provided in Figure 3.8 and Table 3.1, below. 
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Structure Yield 
(mass, 
% w/w) 
Ref Structure Yield 
(mass, 
% w/w) 
Ref 
 
4 mg, 
0.02 % 
183 
 
9 mg, 
0.05 % 
168 
 
5 mg, 
0.03 % 
165 
 
30 mg, 
0.15 % 
164 
 
3 mg, 
0.02 % 
168 
 
12 mg, 
0.06 % 
- 
 
63 mg, 
0.32 % 
164 
 
5 mg, 
0.03 % 
- 
 
56 mg, 
0.28 % 
164 
 
Crystal 
only 
isolated 
- 
 
Table 3.1 – Compounds isolated from the heptane extract of E. adenophorum 
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Figure 3.8 – Chromatogram showing the separation profile for the compounds isolated 
and identified from E. adenophorum heptane extract.  
NMR spectroscopic analysis of peak 1 provided a spectrum that was not consistent with a 
cadinane sesquiterpene, and the compound was subsequently identified as compound 
50 through comparison with literature data.183 This compound has been previously 
reported as isolated from E. adenophorum,184 and has been also been found in other 
plant species such as Tithonia diversifolia183 (Mexican sunflower). Key features of the 1H 
NMR spectrum differentiating this compound from the cadinane terpenes were the 
aromatic singlets at 7.53 and 6.38 ppm, and the singlet corresponding to the gem-
dimethyl groups in the pyran ring at 1.44 ppm. Singlets integrating for 3 protons at 3.9 
and 2.56 ppm were consistent with the methoxy and acetoxy functionalities of the 
molecule, and the alkene signals at 6.30 and 5.52 ppm had a coupling constant of 9.9 Hz, 
consistent with a cis-configuration. 
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Figure 3.9 – 1H NMR spectrum of compound 50. 
Peak 2 required a second flash chromatographic step to isolate known compounds 34165 
and 46.168 The difference between these two compounds was the nature of the bond 
between C-6 and C-11. In compound 34 this was a single bond, and in compound 46 this 
was a double bond. The key differentiating signals between these two compounds were 
the signals for the methyl groups at the C-12 and C-13 positions. For compound 34, these 
signals were doublets around 1 ppm, which were split by the adjacent methylene proton 
attached to C-11. In compound 46, these signals were singlets closer to 2 ppm, which is 
consistent with attachment to an sp2 hybridised carbon atom of an alkene. The shift of 
the methine proton signal from 2.72 ppm in compound 34 to 3.57 ppm in compound 46 
supports the position of the alkene. 
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Figure 3.10 – 1H spectrum of compound 34 (below) and 46 (above). 
Peak 3 contained a single major component, known compound 37,164 which was isolated 
from the initial flash chromatographic run. NMR spectroscopic analysis of this compound 
showed a similar structure to compound 34, with evidence that the acetoxy group was 
absent, replaced by a ketone. The 13C NMR showed carbonyl signals at 210.8 and 198.2 
ppm, consistent with the assignment of a two ketone functionalities, compared to the 
carbonyl signals at 214.4 and 170.9 ppm for compound 34. The 1H NMR spectrum 
showed three doublets at ~1 ppm consistent with the methyl groups at C-12, C-13 and C-
14 all having a single adjacent proton. 
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Figure 3.11 – 1H NMR spectrum of compound 37. 
Peak 4, overwhelmingly the largest peak by area in the chromatogram, contained two 
known compounds 51164 and 35,168 which required further purification for the isolation of 
the components. The early eluting side of the peak contained compound 51, which was 
followed by compound 35. These compounds share the same relationships as acetoxy 
compounds 34 and 46, in that they differ only by the bond order between C-6 and C-11, 
with compound 51 containing a single bond, and compound 35 containing a double bond 
in this position.  
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Figure 3.12 – 1H spectrum of compounds 51 (below) and 35 (above). 
Peak 5 contained a single major component, known compound 38,164 isolated in the 
initial flash chromatographic run. The key aspects of the NMR spectroscopic analysis for 
this compound were the methine signal in the 1H NMR spectrum at 4.14 ppm, and the 
signal in the 13C NMR spectrum at 67.4 ppm. These signals are consistent with the 
addition of a hydroxyl group at the 7-position on the ring. The single carbonyl signal at 
199.6 ppm in the 13C NMR spectrum is also consistent with one of the ketones being 
reduced to an alcohol. 
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Figure 3.13 – 1H spectrum of compound 38. 
Peak 6 of the separation contained a complex mixture, with a major component which 
required further flash chromatography for purification. The spectral data for this 
compound did not match with any compound identified in the literature. This compound 
was subsequently identified as hydroperoxide derivative 52, primarily through reaction 
with PPh3 to form known alcohol 55, discussed below. The 1H NMR spectrum showed an 
exchangeable singlet at 8.18 ppm, consistent with a more acidic hydroperoxide moiety 
being present. The terminal methylene group is supported by the signals at 5.52 and 5.61 
ppm, which correlate to the same alkenyl carbon signal in the HSQCme spectrum. 
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Figure 3.14 – 1H NMR spectrum of compound 52. 
Another minor component was isolated during chromatographic purification of the 
hydroperoxide species 52. This compound is significantly less polar than the 
hydroperoxide, and eluted very early in the purification. This suggests that this 
compound is formed as a degradation product of the hydroperoxide, rather than being 
part of the initial extract. The compound was identified as epoxide species 53, which is 
plausibly formed from the hydroperoxide through intramolecular epoxidation of enol 
tautomer 54. 
 
52 
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Scheme 3.1 – Formation of epoxide 53 from peroxide 52  
The 1H NMR spectrum for this compound shows the loss of the hydroperoxide signal at 
8.18 ppm, as well as the loss of the methine signal at 3.38 ppm, which corresponded to 
the proton at C-5 in the hydroperoxide compound. The alkene signal at 6.01 ppm and the 
terminal methylene signals at 5.26 and 5.12 ppm provide evidence that these alkenes are 
intact in the epoxide product. The 13C NMR spectrum shows signals at 70.3 and 71.8 ppm, 
which is consistent with the C–O bonds of the epoxide. 
 
Figure 3.15 – 1H NMR spectrum of compound 53. 
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A chromatographic fraction from within peak 6 was observed to partially solidify. A 
crystal was taken and subjected to single crystal X-ray diffraction analysis and was shown 
to be compound 54. This compound is particularly distinct from the major terpene 
derivatives, as it lacks oxygenation at the C-2 and C-7 position which is seen in all other 
derivatives isolated. Analysis of the 1H and 13C NMR spectra for the fraction that the 
crystal was isolated from suggest that this is only a very minor component, and was not 
isolated except for the single crystal. 
 
 
 
 
 
 
 
Figure 3.16 – Novel peroxide species 54 (left) and X-ray crystal structure (right) 
Peak 7 appeared to contain a major component by 1H NMR spectroscopic analysis, 
however, attempts to isolate any components by flash chromatography resulted in 
compound decomposition and complex mixtures of compounds obtained.  
3.2.1.3 Autoxidation Studies 
The isolation of hydroperoxide type compounds led to the hypothesis that the 
compounds isolated from E. adenophorum may be prone to autoxidation. To test this 
hypothesis, a neat sample of compound 35 was placed in a NMR sample tube in air. After 
1 week, the 1H NMR analysis indicated that 50% of compound 35 had been converted to 
hydroperoxide species 52. This provides evidence that compound 52, as well as other 
previously reported molecules may result from post-extraction autoxidation, rather than 
by enzymatic control of the plant. The transformation that converts compound 35 to 52 
presumably occurs via an ‘ene’ reaction. 
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Figure 3.17 – 1H NMR spectrum of compound 35 (bottom), 1H NMR spectrum after 1 
week in CDCl3 (middle), and 1H NMR spectrum of the resulting purified hydroperoxide 
species 52 (top).  
 
Scheme 3.2 – Hydroperoxide 52 formation from 35 upon exposure to oxygen. 
Hydroperoxide 52 has not been previously reported in the literature but corresponding 
alcohol 55 is known.180 Therefore, this compound was subjected to reaction with 
triphenylphosphine to convert the hydroperoxide to the alcohol 55 (Scheme 3.2). The 1H 
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and 13C NMR spectroscopic data for compound 55 were consistent with those previously 
reported.180 
 
Scheme 3.3 – Conversion of peroxide 52 to alcohol 55 through reaction with PPh3. 
This result provides compelling evidence that these cadinane compounds are prone to 
autoxidation, and will undergo transformations to form different components such as 
peroxides and epoxides. This suggests that some of the previous reports of compounds 
discussed in the beginning of the chapter may be describing compounds which are 
artefacts of isolation rather than true natural products. This is a reasonable conclusion, 
based on the reactivity observed directly for compound 35, and given that many of the 
previously discussed isolation procedures involved laborious extraction methodologies 
and multiple flash chromatographic steps therefore increasing exposure to molecular 
oxygen. 
3.2.1.4 Extraction for Quantitation and Generation of Bioactive Extracts for Testing 
Based on this observed reactivity, a subsequent extraction and isolation where the 
extract was treated more carefully was undertaken. The sample was chilled immediately 
after the extraction and was stored in the fridge, away from light, and under a nitrogen 
atmosphere where possible. The chromatographic parameters were kept constant 
between the two runs, and this can be seen in the similarities between the two 
extraction profiles. This second chromatogram shows much smaller peaks after peak 5. 
Specifically, compounds 52–54 from peak 6, and peak 7 from the first extraction were not 
present. This result provides further evidence that this PHWE method provides a means 
of efficiently extracting sensitive compounds due to the short extraction times, and in 
this instance, limiting exposure to molecular oxygen. 
 
52 55 
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Figure 3.18 – Separation profile of fresh E. adenophorum heptane extract, major peaks 
are numbered 1 through 5. 
The following chromatogram, zoomed in from Figure 3.18 above, shows which 
compounds were isolated from which sections of the separation profile. These samples 
were quantified as individual compounds or mixtures as appropriate to get a more 
accurate picture of the yield of each compound from the plant. 
 
Figure 3.19 – Expansion of chromatogram (Figure 3.18) of E. adenophorum heptane 
extract without oxidation products present. 
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Table 3.2 – Compounds and mixtures isolated from E. adenophorum. Compound 50 was 
excluded from the total yield, as the cadinane terpenes were the compounds of interest. 
The results obtained for the extraction of this plant suggest that the extraction method, 
and subsequent handling and purification of the extract is of critical importance. The 
combined yield of compounds 37, 51 and 35 was nearly double (1.14 % vs 0.65 % w/w) in 
the second extraction, due to these factors. The demonstration that compound 35 can be 
converted to a hydroperoxide, and subsequently into an epoxide species through 
reaction with molecular oxygen suggests these compounds must be stored carefully. This 
result also provides further evidence that many of the minor compounds previously 
reported may be artefacts of the extraction and isolation of the plant, and not true 
natural products. Of course, these oxidation products may be the source of the 
allelopathic effects shown by E. adenophorum, but further study is required to determine 
this as previous studies of this activity have primarily focussed on the more abundant 
metabolites such as 37, 35 and 51. 
3.2.1.5 Extraction and Isolation of Ethyl Acetate Soluble Components 
The residual aqueous extract was further extracted with EtOAc, which showed a 
distinctly different 1H NMR spectral profile compared with the heptane extract, which 
suggested a different class of compounds was being extracted with the EtOAc, with no 
cadinane terpenes observed. Of note was the appearance of a number of signals above 
6.5 ppm, which were absent in the heptane extract.  
Compound Yield (mg) Yield (% w/w) 
50 4 0.01 
34, 46 77 0.21 
37, 51, 35 428 1.14 
38 43 0.11 
Total (excl 50) 548 1.46 
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Figure 3.20 – 1H NMR spectrum of the EtOAc extract of E. adenophorum 
The 1H NMR spectrum and TLC analysis of this extract provided evidence of two major 
components. Normal phase silica gel column chromatography yielded co-elution of the 
two compounds, however, they were able to be separated successfully using reversed-
phase flash column chromatography to provide compounds 56 and 57 in 0.18 % and 0.22 
% yield w/w respectively. The 1H and 13C NMR spectroscopic data for these compounds 
was consistent with a report by He and co-workers in 2016.185 
 
Figure 3.21 – Glycosides 56 and 57 isolated from E. adenophorum EtOAc extract. 
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3.2.2 Pyrethrins from Dalmatian Chrysanthemum (Chrysanthemum cinerariaefolium) 
3.2.2.1 Background 
Chrysanthemum cinerariaefolium (L.) (Dalmatian chrysanthemum, Pyrethrum) is a 
member of the daisy (Asteraceae) family and contains a mixture of six insecticidal 
compounds, collectively known as the pyrethrins. These are separated into classes I and II 
as shown in Figure 3.22. The focus of the extraction of the pyrethrins was to test PHWE 
for extraction of thermally sensitive molecules, as pyrethrins are known to be thermally 
labile. If successful, the subsequent goal was to develop a method for the selective 
hydrogenation of pyrethrin I and pyrethrin II to convert them selectively into lesser 
abundant jasmolin I and jasmolin II. 
 
Figure 3.22 – The major components of pyrethrin extract 
The structure of pyrethrin I was initially reported by Staudinger in 1924186 as compound 
64, and methods for the quantitative isolation of the primary active components were 
published in the late 1920’s.187 In Staudinger’s initial report, the terminal double bond of 
the side chain was incorrectly placed in the adjacent position, forming an allene, and 
lacked a double bond in the cyclopentenone ring. Further, the minor components, cinerin 
I and II and jasmolin I and II were not isolated and unambiguously identified until 
1944/45188,189 and 1966190 respectively. 
 
58 60 62 
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Figure 3.23 – 1924 proposed structure of pyrethrin I 
The quantity of the pyrethrins within the plants is highest in the flowers, and continues 
to increase in concentration as the flowers mature. Specifically, the achene (small fruit 
containing the seed) of the flower contains ~90% of the pyrethrins, but only accounts for 
~30% of the weight of the flower. Subsequently, it was found that the pyrethrins are 
found in oily deposits on the surface of the achenes. For practical reasons it is most 
convenient to take the whole flowers for isolation of these compounds.191 
Pyrethrin I and II are the most abundant and most active components of this mixture in 
the toxicity towards insects.192,193 They are, however, also the least stable and will rapidly 
undergo degradation due to oxygen and light when used as an insecticide.194 This is a 
desirable property for many applications because it means that they do not linger in the 
environment and contaminate food crops. However, due to this instability, it may be 
beneficial to take crude pyrethrum extract and convert the pyrethrin I and II selectively 
into jasmolin I and II to create an insecticidally active but more stable extract.  
 
Scheme 3.4 – Formation of jasmolin I (60) and II (61) from pyrethrin I (58) and II (59). 
There are currently no reports of this transformation, as previous attempts proved 
unsuccessful. Traditional metal catalyst based hydrogenation were inappropriate due to 
the lack of selectivity in hydrogenation of the molecule, and indeed cleavage of ester 
linkage, presumably by formation of a π-allyl cation.186,195 A report of the hydrogenation 
using PtO2 as the metal catalyst on pyrethrin II with a short reaction time was found to 
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yield dihydrojasmolin II (66), where the side chain was fully saturated.196 A longer 
reaction time resulted in cleavage of the ester portion. Formation of the dihydro 
derivatives is not desirable for insecticidal applications as they are not insecticidally 
active.197  
 
Scheme 3.5 – Hydrogenation of pyrethrin II with PtO2 
For the development of a method for the selective hydrogenation of pyrethrin I and II to 
form jasmolin I and II, it was chosen to investigate using diimide as the reducing agent. 
Diimide (H2N2) is a mild hydrogenation reagent,198 which is ideal for the selective 
hydrogenation. Diimide reductions were observed as early as 1905 when glyceryl oleate 
was converted to stearic hydrazide199 which was published alongside the conversion of 
oleic acid to stearic acid in the presence of hydrazine in 1929.200 Diimide was not 
implicated in the process until the 1960’s.199 Previous reports have shown that diimide 
reductions proceed most efficiently for lesser substituted alkenes, and do not proceed 
for tri or tetra-substituted alkenes.199 These reductions are also known to proceed faster 
for symmetrical multiple bonds (C=C, N=N) than for polarised multiple bonds such as C=O 
or C=N.198  
Pyrethrin I and II are a great model for testing development of a selective hydrogenation 
method as they contain mono, di, tri, and tetrasubstituted C=C double bonds. Given the 
previously reported lack of reactivity towards highly substituted alkenes, the proposed 
major products of the reaction of pyrethrin I and II with diimide would be jasmolin I and II 
following hydrogenation of the terminal alkene. Pyrethrin I and II are the only 
components of the mixture with a mono-substituted alkene, so the reaction should 
proceed most rapidly for these components. The competing reaction, where 
hydrogenation occurs on the disubstituted alkene present in the jasmolins and cinerins 
would form dihydrojasmolin I and II, and dihydrocinerin I and II (65–68). 
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Figure 3.24 – Substitution pattern of the alkenes in pyrethrin I (58) 
 
Scheme 3.6 – Competing reaction to form dihydro derivatives 65–68. 
Though the approximate amount of pyrethrins in the crude extracts can be determined, 
there is an added complication of using diimide. Diimide must be generated in situ as it is 
prone to disproportionation to form nitrogen gas and hydrazine, as well as 
decomposition to nitrogen and hydrogen gas during the reaction. This makes the 
addition of a stoichiometric amount of reagent difficult to achieve full conversion.199 
There are numerous reported methods for the in situ generation of diimide, however, 
many of these involve the use of molecular oxygen as a reagent.199 A method based on 
ease of operation as well as a method that did not rely on molecular oxygen was chosen, 
as pyrethrin degrades in air.194  
A report from 2002 details the first use of NBSH (2-nitrobenzenesulfonyl hydrazide, 70) 
to generate diimide for the reduction of alkenes201, which employs a modification of a 
preparation of the compound reported by Myers and co-workers in 1997.202 A more 
recent report by Marsh and co-workers again demonstrates the use of NBSH as a reagent 
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for the efficient generation of diimide under mild conditions with the reduction of a 
number of alkenyl substrates.203  
 
Scheme 3.7 – Synthesis of o-nitrobenzenesulfonylhydrazide (NBSH) 
3.2.2.2 Extraction and Analysis of the Crude Extract 
Pyrethrum flower obtained from Botanical Resources Australia contained BHT to supress 
oxidative decomposition of pyrethrins 58 and 59. For reaction experiments, plant 
material was extracted in 15 g batches using 200 mL 35% v/v EtOH:H2O. Subsequent 
extraction with heptane yielded the crude pyrethrin extract. The extraction was found to 
be highly reproducible, with the process repeated multiple times with very similar results 
for the mass of the crude extract (~1.6% w/w) and components observed by 1H NMR 
spectroscopic analysis. NMR spectra for these extracts showed the primary identifiable 
components as the pyrethrins 58–63, as well as the compound sesamin (71). The key 
signals in the 1H NMR spectrum of the crude extract are 3 of the alkene signals for 
pyrethrin I and II, shown in Figure 3.26. Enrichment in pyrethrin I and II supports the mild 
nature of the method, and demonstrates again the viability of the method for the 
extraction of sensitive substrates. 
 
Figure 3.25 – Sesamin 
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Figure 3.26 – 1H NMR spectrum of the heptane extract of C. cinerariaefolium. 
NMR spectroscopic analysis alone is insufficient for determination of the relative 
proportions of the compounds in the extract due to their structural similarities and 
therefore overlapping signals in the analysis. For this reason, NMR spectroscopic analysis 
was used in combination with GC-MS for the analysis of extracts and reaction mixtures. 
LC-MS would be preferable, however an appropriate instrument was unavailable at the 
time. Pyrethrin I and II are not stable to GC-MS injection conditions, as they undergo 
thermal isomerisation to form isopyrethrin I and II.204,205  
 
Scheme 3.8 – Thermal isomerisation of pyrethrin I (58) to give isopyrethrin I (72) 
In the GC-MS trace of the crude extract, there were two peaks with mass of pyrethrin I, 
which have mass spectra consistent with pyrethrin I (58) and isopyrethrin I (72). The 
jasmolins 60 and 61 and cinerins 62 and 63 are not susceptible to this degradation and 
are unchanged in the GC-MS analysis. The ratio of jasmolins to cinerins is ~0.6:1, showing 
that the jasmolins are the least abundant component of the crude extract. The 
combination of pyrethrin I and II can be measured in the 1H NMR spectrum due to the 
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unique alkene signals shown in Figure 3.26. Therefore, given that the primary goal was to 
react the majority of the pyrethrin I and II to form jasmolin I and II, it is valid to first take 
an NMR spectrum of the sample to determine residual pyrethrin I and II levels, and 
subsequently subject the sample to GC-MS analysis to determine the ratios of the 
jasmolins and cinerins. Hence, GC is not the most appropriate method to quantify 
pyrethrin I and II. However, as the interest was in relative ratios, and conversion to 
jasmolin I and II, it was the most convenient method. 
 
Figure 3.27 – Partial GC chromatogram of crude pyrethrin heptane extract. 
3.2.2.3 Synthesis and Testing of NBSH 
For reaction with pyrethin extract, NBSH (70) was synthesised through further 
modification of the reported method. Following reaction by the conditions of Marsh and 
co-workers, the compound was precipitated through addition of water, and collected by 
filtration, which resulted in the rapid generation of gram-scale quantities of this reagent. 
Following the synthesis of this reagent, 2 concurrent test reactions were performed to 
investigate the differences in reactivity of 2 simple alkenes. Conditions were based on the 
method of Marsh.203 Eugenol isolated from cloves (S. aromaticum), and anethole isolated 
from Chinese star anise (I. verum) were used as test substrates for confirming the 
reactivity of the reagent. These were chosen because they are both phenylpropenes 
which differ in the position and substitution of the alkene. 
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Scheme 3.9 – Reaction of eugenol (above) and anethole (below) with NBSH 
Eugenol and anethole were separately reacted with 1 equivalent of NBSH in acetonitrile. 
An aliquot of each reaction was taken at 1 h and the ratio of starting material to product 
determined by integration ratio of the appropriate signals in the 1H NMR spectra. The 
eugenol reaction had proceeded to ~20 % completion, whereas the anethole reaction, 
which was expected to be much slower as it contains di-substituted alkene had only 
proceeded ~5%. This provided evidence that the reagent can reduce C=C bonds under 
the given conditions, and that the reaction with a mono-substituted alkene proceeds 
more rapidly. The reactions were worked up after a further 19 h of stirring. At this point, 
the progress of each reaction had increased to ~60 % for the eugenol reaction and ~51 % 
for the anethole reaction. This result showed that the reagent behaves as expected and 
the generated diimide undergoes other reactions such as disproportionation, meaning 
the reaction does not proceed to completion with 1 equivalent of NBSH, and provided 
information for how much reagent may be required for a selective alkene reduction. The 
1H NMR spectroscopic data obtained for this reaction is shown in the 1H NMR spectrum 
below of the 1 h aliquot taken of the reaction with eugenol (73). The appearance of the 
signals for the saturated side chain is clear as shown on the spectrum. 
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Figure 3.28 – 1H NMR spectrum of the reaction of eugenol with NBSH after 1 h. 
3.2.2.4 Hydrogenation of Pyrethrin Extract with NBSH 
The primary goal of the diimide reduction reactions was to form an extract that was 
enriched with jasmolin I and II, where there was negligible pyrethrin I and II and minimal 
formation of dihydrojasmolin I and II. A separate experiment was also conducted, 
specifically targeting the dihydro derivatives. The degree of enrichment was determined 
by the ratio of jasmolins to cinerins compared with the crude extract. An optimisation 
study was carried out due to the previously discussed difficulties in performing this 
reaction stoichiometrically. The results from the optimisation of conditions for diimide 
reduction of the pyrethrins are summarised in Table 3.3. 
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Entry Crude 
pyrethrins 
(mg) from 
45 g plant 
NBSH 
(mg) 
Time 
(h) 
Ratio 
Jasmolins 
to 
Cinerins 
Ratio 
natural to 
dihydro 
derivatives 
Crude 
yield 
(mg) 
Isolated 
Yield  
(mg, %w/w) 
Crude 
extract 
- - - 0.6:1 - - -  
1 590 659 21 4:1 1:1 500 297 (60–63) 
0.66% 
2a 722 400a 18 1.6:1 - - -b 
   76 5.2:1 2.3:1 546 - 
3 721 250 42 4.0:1 10.4:1 564 309 (60–63) 
0.69% 
4 700 800 72 - - 429 170 (65–68) 
0.38% 
 
Table 3.3 - Results from diimide reduction tests. a - 250 mg of NBSH was added at t = 0, 
followed by an extra 150 mg after 18 h. b - As the reaction had proceeded further than 
desired, the mixture of products (60–63, 65–68) were not chromatographed in this case. 
  
Scheme 3.10 – Diimide mediated selective hydrogenation of pyrethrins to jasmolins 
The initial attempt at the selective hydrogenation (Table 3.3, Entry 1) indicated by GC-MS 
and 1H NMR spectroscopic analysis that all the pyrethrins had been either reacted or 
degraded, and that there was a significant enrichment of the jasmolins in the sample. The 
1H NMR spectrum clearly shows the loss of the alkene signals which are distinct for 
pyrethrin I and II (see Figure 3.26). 
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Figure 3.29 – 1H NMR spectrum of initial diimide reduction of pyrethrin extract (below) 
vs. the crude pyrethrin extract (above). 
The reaction was subsequently fractionated by automated flash column chromatography 
into 2 separate fractions, one containing the I series and the second containing the II 
series. GC-MS analysis of these fractions showed each contained 4 major components. 
The ratio of total jasmolins to total cinerins was ~4:1 and the ratio of the desired product 
to the dihydro products was ~1:1. This shows significant enrichment of jasmolin content 
which provides evidence that the hydrogenation protocol was proceeding as intended. 
The yields of this reaction were 114 mg I series and 183mg II series from 45g of 
pyrethrum crop representing a yield of 0.66% w/w pyrethrins. 
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Figure 3.30 – GC chromatogram of diimide reduction Table 3.3, entry 1, I series 
 
Figure 3.31 – GC chromatogram of diimide reduction Table 3.3, entry 1, II series 
Entry 2 shows a reduction protocol which initially showed enrichment of jasmolins 60 
and 61 with significant quantities of the pyrethrins 58 and 59 still present, which upon 
further reaction showed complete reaction of pyrethrins, but with significant levels of 
the undesired dihydro products 65–69. Entry 3 shows formation of an extract enriched in 
the jasmolins and with minimal amounts of the over hydrogenated jasmolins and cinerins 
present, which fulfils the goal of achieving an extract which is enriched in the jasmolin 
components, with minimal formation of the dihydro derivatives.  
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Figure 3.32 – GC chromatogram of diimide reaction Table 3.3, Entry 2, t = 18 h. 
 
Figure 3.33 – GC chromatogram of diimide reaction Table 3.3, Entry 2, t = 76 h. 
 
Figure 3.34 – GC chromatogram of diimide reaction Table 3.3, Entry 3. 
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From Entry 2 and Entry 3 in Table 3.3, it can be seen that the reaction of pyrethrin I and II 
takes around 42 hours to proceed to near completion. As discussed previously, diimide is 
not a long-lived molecule in solution, which suggests that the rate-limiting step in this 
process is the formation of diimide from NBSH. This study has shown proof of concept 
that the pyrethrin I and II may be hydrogenated with diimide with high selectivity, 
however, this is not a feasible process for industrial scale conversion. A more efficient 
method of generating diimide for this reaction would be the logical next step for this 
work. Myers and co-workers note that the formation of diimide from NBSH proceeds 
more rapidly in polar protic solvents such as water and methanol.202 Therefore, a solvent 
screen for this reaction maybe appropriate. 
The ‘over-hydrogenated’ dihydrojasmolin and dihydrocinerin products 65–68 have not 
been fully characterised in the literature. A protocol employing a high excess of NBSH 
over 72 h was undertaken so that the reaction would proceed completely to these 
compounds. The results from this experiment are shown in Table 3.3, Entry 4. This 
reaction was fractionated by flash chromatography to fractions containing the I series 
and II series of compounds. While the compounds were not isolated to purity and fully 
characterised as these derivatives have a similar polarity and co-elute in flash column 
chromatography, HRMS analysis of fractions containing these compounds provided 
strong evidence for their identity. In the 1H NMR analysis, the lack of alkenyl signals is the 
key evidence for the formation of the fully saturated side chain. Further, the key signal 
indicating the presence of the cinerin components of the mixture is the small triplet at 1 
ppm, which represents the terminal methyl group on the side chain of the molecule 
which is 1 carbon shorter in the cinerin derivatives 67 and 68 than in the jasmolin 
derivatives 65 and 66. 
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Scheme 3.11 – Hydrogenation of jasmolin and cinerin to give dihydrojasmolin and 
dihydrocinerin 
 
Figure 3.35 – 1H NMR spectrum of the dihydrojasmolin I and dihydrocinerin I, bottom, 
and dihydrojasmolin II and dihydrocinerin II, top.  
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3.2.3 Crude Extract from Bitter Melon (Momordia charantia) 
3.2.3.1 Background 
Collaborators at the University of Tasmania’s School of Medicine were interested in the 
studying biological properties of the extract from M. charantia (L.). Bitter melon is used 
frequently in Asian cooking, and has been used as a traditional medicine in Chinese and 
Indian culture.206,207 Bitter melon has been shown to contain a wealth of biologically 
interesting molecules including cucurbitane triterpenoids such as 77.208-212 A wealth of 
other compounds have been isolated from this plant, reviewed in 2016.213 The extract 
has shown a range of biological activities including anti-diabetic,214 antioxidant,215 and 
anti-cancer activity.216,217 
 
 
 
 
 
Figure 3.36 – Cucurbitane type triterpene from M. charantia. 
3.2.3.2 Extraction 
Through the PHWE method, an extract was rapidly produced for testing. However, this 
particular plant provided some challenges in developing the method for extraction, 
particularly due to the significantly high water content of the material. Upon drying, the 
mass of material obtained indicated that the bitter melon fruits are approximately 92% 
w/w water. When exposed to the solvent inside the espresso machine, the plant material 
showed a high tendency to swell and cause blockages. Therefore, the method used for 
the preparation of the extract of bitter melon was 4 g of powdered bitter melon fruit, 
with 12 g of sand. The sample was extracted with 100% water, as a test extraction using 
and EtOH:H2O mixture, followed by an extraction with an organic solvent did not yield 
any appreciable quantity of material.  
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Following the PHWE, the resulting aqueous extract was evaporated to dryness on the 
rotary evaporator and evaluated for biological activity without further purification. 
Ultimately, a multi-gram-scale bitter melon extract was produced in a yield of 25% w/w. 
The results of a subsequent study by collaborators into the anti-inflammatory activity of 
the bitter melon extract produced through PHWE are published.218 In this study, the 
extract was tested against a human colonic adenocarcinoma cell line (LS174T). The 
extract showed no toxicity towards the cells, and showed a reduction in markers of 
endoplasmic reticulum (ER) stress. Therefore, this extract has the potential to be used as 
a treatment in inflammatory disorders such as inflammatory bowel disease (IBD). Future 
work in this project within the research group will be the isolation of compounds from 
the extract, in order to determine the bioactive metabolites. 
3.2.4 Summary 
Through the extraction of E. adenophorum, C. cinerariaefolium and M. charantia, the use 
of the PHWE method for the rapid generation of bioactive extracts was demonstrated. As 
for the extraction of T. lanceolata and Correa spp. (Chapter 1), the efficient extraction of 
somewhat sensitive substrates was achieved.  
The extraction of sensitive terpene components from E. adenophorum convincingly 
demonstrated that this method is compatible with mildly air-sensitive compounds, 
provided that the resulting extract is treated appropriately. These compounds require 
minimal purification steps and handling time, therefore a rapid and simple purification is 
desired for optimal isolated yield. The combination of rapid PHWE extraction, and 
subsequent liquid-liquid extraction with heptane provided a crude extract highly 
enriched in the desired class of compounds leading to efficient purification, with each 
component requiring a maximum of two short flash chromatographic steps. These results 
also suggest that many of the compounds previously reported are artefacts of isolation 
through exposure to molecular oxygen by long extraction times and repeated 
chromatography. 
Extraction of C. cinerariaefolium and subsequent liquid-liquid extraction with heptane 
rapidly provided an extract significantly enriched in pyrethrins. This extract showed very 
little evidence of other significant components aside from sesamin through GC-MS and 
NMR spectroscopic analysis, and was pale-green in colour. This suggested only trace 
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amounts of plant pigments and other coloured compounds, which is consistent with the 
other plants extracted. The ready ability to perform a selective diimide-mediated 
hydrogenation on the pyrethrin molecules within this extract further highlights the 
viability of this method for the rapid generation of enriched plant extracts. 
3.3 Extraction of Known Valuable Natural Products 
3.3.1 Marrubiin from White Horehound (Marrubium vulgare) 
3.3.1.1 Background 
M. vulgare (L.) is known to yield the compound marrubiin (78), which is known as a 
component of traditional medicine and shows analgesic properties. Studies into the 
structure of this compound were undertaken as early as the 1900’s,219,220 but the 
structure was not completely determined until 1953.221 An X-ray study in 1983 provided 
conclusive evidence of the structure including stereochemistry of the product, which 
aligned with previous determination through synthetic studies.222 Since then it has been 
extensively studied and shown that this compound and simple derivatives thereof have a 
number of different biological activities.223-225 Numerous publications into the synthesis 
of this compound exist, including a total synthesis paper published in 2016.226 This 
compound is not thought to be the true natural product, but an artefact of isolation. 
Premarrubiin (78b) is the true natural product which readily converts to marrubiin (78) 
on exposure to water and heat.227 
  
Figure 3.37 – Marrubiin (78) and premarrubiin (78b) 
3.3.1.2 Extraction and Isolation 
The extraction of this plant material with this PHWE method, and subsequent heptane 
extraction gave an extract enriched in the compound marrubiin (78). A fraction from the 
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chromatographic separation was taken which contained a high proportion of the 
compound, but was still not pure. However, trituration with hexane resulted in the 
isolation of marrubiin (78) as an amorphous solid. The spectral data obtained was 
consistent with that reported in the literature.226 
 
Figure 3.38 – 1H NMR spectrum of the crude extract from M. vulgare (below) and the 
purified compound (above). 
In spite of the low isolated yield (0.06 % w/w, much lower than a reported yield of 0.4 % 
w/w)228, analysis of the 1H NMR spectrum of the crude extract (862 mg from 15 g of M. 
vulgare, 5.75 % w/w) indicated a much higher content of 78, which appears to 
decompose. This is demonstrated by significant reduction in the intensity of the furan 
resonances in the 1H NMR spectrum at 6.27, 7.24 and 7.36 ppm (Figure 3.39). This 
reflects the importance of a method such as this novel PHWE method which is rapid, and 
has been shown to require less chromatography compared with other extraction 
methods for isolation of the compounds within the extract. 
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Figure 3.39 – 1H NMR spectrum flash chromatographic fractions containing marrubiin, 
showing significant decomposition had occurred during purification. 
In spite of these low yields, this material is of interest for synthetic applications within 
the research group, targeting natural products and analogues based on this scaffold. 
Commercial sourcing of the compound is not feasible, as with many of the examples 
detailed in this thesis.* Investigations are continuing into the improved isolation of this 
compound. 
3.3.2 Castanospermine from Moreton Bay Chestnuts (Castanospermum australe) 
3.3.2.1 Background 
The toxic seeds of C. australe (A.Cunn & C.Fraser ex Hook.), also known as Moreton Bay 
Chestnuts, are known to contain the neurotoxic alkaloid castanospermine (79), which 
was first identified in 1981.229 It has been extensively studied since then and shown 
diverse biological activity, including anti-HIV activity, anti-diabetic activity, and inhibition 
of various enzymes.230-236 
 
Figure 3.40 – Castanospermine, isolated from C. australe 
                                                          
* ~USD$100 per 10 mg from Carbosynth, UK 14/11/17 
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The initial report details a procedure where 3 kg of the seeds are extracted with litres of 
75% EtOH:H2O, and separated by means of multiple ion exchange resin columns, and 
multiple crystallisation steps. The final yield of crystalline compound was 1.69 g, for an 
overall yield of 0.056% w/w. The X-ray analysis of the compound only gave relative 
stereochemistry, and the absolute stereochemistry was determined upon total synthesis 
of the compound from glucose, reported in 1984.237 
Subsequently, the extraction and isolation of this compound was patented, with an 
improvement on the reported yield of 1.2 % w/w, representing the isolation of 3.5 g of 
crystals from 100 g of the fresh seeds. 238 A summary of the procedure from the patent is 
as follows: 
“(a) extracting the ground seeds with a mixture of water and 2-propanol; 
(b) washing the extract with petroleum ether; 
(c) chromatographing the solution on an acid resin with elution with ammonium 
hydroxide; 
(d) rechromatographing the eluate on a basic resin with elution with water; and 
(e) concentration of the aqueous eluate followed by trituration with acetone to 
give castanospermine.” 
Therefore, it was investigated if PHWE could be applied to this important compound. 
3.3.2.2 Extraction and Isolation 
For extraction of castanospermine (79) by espresso machine PHWE, the fresh seeds were 
grated before extraction of the wet material. It was observed that the seeds were unable 
to be extracted if allowed to dry out as they went very hard and could not be ground up. 
Amberlyst® 15 acidic ion exchange resin was added to bind to the castanospermine, and 
the supernatant was then filtered away from the resin. The resin was then eluted with a 
methanol:ammonia solution, to provide an extract enriched in castanospermine. 
Purification by automated gradient flash chromatography yielded the compound as a 
white amorphous solid, in a yield of 0.56 % w/w (565 mg). This is 10x higher than the 
initially reported yield of the compound but around half that achieved and reported in 
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the patent, though in much less time (which may be due to variation of concentration of 
the compound within the seeds).229,238 This is another valuable natural product, and 
therefore this represents another example of viable extraction of compounds that are 
expensive to source commercially. * 
 
Figure 3.41 – 1H NMR spectrum of castanospermine in D2O. 
3.3.3 Summary 
The extraction of marrubiin (78) and castanospermine (79) demonstrate the application 
of the method for rapid extraction of known valuable natural products which may be 
used as starting materials for synthesis. The extraction of marrubiin from M. vulgare 
showed that in spite of the sensitive nature of the target compound, the PHWE extract 
contained a high proportion of this valuable natural product. Purification of this 
compound proved problematic, with significant decomposition observed, highlighting the 
viability of the extraction method for extraction of sensitive compounds. 
The extraction of castanospermine from C. australe provided quantities of this material 
sufficient for small-scale synthetic studies. However, this method may not be as efficient 
as other methods for extracting this compound, particularly on a larger scale. This further 
                                                          
*AUD$281 for 10 mg of material from Sigma–Aldrich, 01/11/17 
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demonstrated that traditional natural product extraction techniques are still important 
for various plants, and that the PHWE method is a complementary extraction technique 
that like all extraction methods has its limitations. 
3.4 Bioprospecting/Chemotaxonomic Applications 
3.4.1 Drimanes from Wielangta Forest Tasmanian Native Pepper (Tasmannia 
lanceolata) 
3.4.1.1 Background 
A specimen of T. lanceolata from Wielangta Forest in Tasmania which contained a 
previously unreported derivative of polygodial (12), 1β-acetoxypolygodial105 (80) as well 
as the known lower oxidation state 1β-acetoxyisodrimeninol (81), was discovered and 
reported by the Smith group.105 
 
Figure 3.42 – 1β-acetoxypolygodial (80) and 1β-acetoxyisodrimeninol (81). 
This was a serendipitous discovery during an undergraduate field-trip to collect samples 
for natural product laboratory classes in 2012. All previously investigated T. lanceolata 
samples including those received from Essential Oils of Tasmania and Diemen Pepper 
showed no evidence of containing 1β-acetoxypolygodial. In this original report, 
traditional extraction methods were used. The purification of 80 required multiple 
chromatographic separations, and the isolated crystals were still green due to the 
presence of plant-based chlorophylls.105 Based on this different metabolite, it was 
hypothesised that this specimen may be a new genetically different subspecies of T. 
lanceolata. Therefore, to investigate this further, samples of T. lanceolata from the 
surrounding area were collected to demonstrate the viability of this new PHWE method 
for a rapid pilot chemotaxonomic study of Wielangta Forest T. lanceolata specimens. 
Initially, it was hypothesised that there would be trees which exclusively contained either 
polygodial (12), or 1β-acetoxypolygodial (80).  
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3.4.1.2 Initial Extraction 
A second sample from the original specimen was extracted, and following subsequent 
liquid-liquid extraction with heptane, the following 1H NMR spectrum was obtained. 
 
Figure 3.43 – 1H NMR spectrum of the extract from Wielangta forest T. lanceolata 
containing 1β-acetoxypolygodial (80). 
Key signals in the 1H NMR spectrum are the aldehyde signals at 9.72 and 9.35, which 
differ significantly in chemical shift from the aldehyde signals for polygodial (12), and the 
doublet of doublets at 4.72, which represents the proton attached to the carbon at the C-
1 position where the acetoxy functionality is attached.  
3.4.1.3 Survey of a Population of T. lanceolata from Wielangta Forest 
In 2017, a further ten samples of T. lanceolata were taken from the surrounding area in 
Wielangta Forest. GPS locations for all the trees that were sampled in this experiment 
were taken, and are shown on the following map (Figure 3.44). This sample of trees 
covered only a very small area of the forest, but was deemed sufficient for a preliminary 
chemotaxonomic survey. 
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Figure 3.44 – Map showing the locations of the T. lanceolata specimens sampled in the 
survey. 
Each sample was extracted and the ratio of the products was determined by 1H NMR 
spectroscopic analysis. Each sample was also purified to isolate the individual 
components. The initial results showed that each sample contained a varying amount of 
each substance. This result was contrary to the original hypothesis that each sample may 
contain either polygodial (12) or 1β-acetoxypolygodial (80), but not both. Additionally, all 
trees that contained 1β-acetoxypolygodial, also contained the corresponding hemiacetal 
derivative 1β-acetoxyisodrimeninol (81) which is consistent with the original sample. 
Some samples contained a majority of one or the other compound, and others had a 
more even mixture. Compounds 12, 80 and 81 showed good separation by TLC analysis 
as shown in Figure 3.45, and baseline separation by automated gradient flash column 
chromatography as shown in Figure 3.46. 
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Figure 3.45 – TLC analysis of Wielangta Forest T. lanceolata samples 2, 6 and 9. 
 
Figure 3.46 – Chromatogram of the separation of T. lanceolata sample 6, showing 
separation of the 3 major components. 
Table 3.4 and Figure 3.47 summarise the results. Notably, Sample 2 showed polygodial 
(12) as overwhelmingly the major component with none of the 1β-acetoxy derivatives 
(80 + 81) observed, and sample 9 showed the major components being 1β-acetoxy 
derivative (80). Other samples showed a much more balanced level of the major 
components. The yield of each of the compounds within the plant varied widely (~0.1 % – 
~1.4 % for 12, 0 % – ~1.2 % for 80, and 0 % – ~1.0 % for 81), as did the ratio between 
them, as well as the overall yield of drimanes from each sample (0.48–2.93 % w/w). 
There also did not appear to be any correlation between the relative levels of the 1β-
acetoxy derivatives (80 + 81). This survey was not of a sample size large enough to draw 
definitive conclusions about the distribution of specimens vs. the compounds isolated. 
Polygodial 
1β-acetoxypolygodial 
1β-acetoxyisodrimeninol 
80 
81 
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12 80 81 
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However, these results did indicate that the population of trees surveyed in Wielangta 
Forest contained varying amounts of these compounds, and did not exclusively contain 
1β-acetoxy derivatives 80 and 81 as originally hypothesised.  
 
 
 
 
 
 
 
 
Table 3.4 – Summary of the extraction yields from each of the samples, and the total 
amount of each compound obtained.  
 
Figure 3.47 – Yield of compounds isolated from Wielangta Forest T. lanceolata. 
Overall, 1.656 g of 1β-acetoxypolygodial (80), 1.200 g of 1β-acetoxyisodrimeninol (81), 
and 1.203 g of polygodial (12) were isolated, representing an overall yield of 0.47 %, 0.34 
%, and 0.34 % w/w respectively, and therefore a total overall yield of 1.15 % w/w of total 
drimanes from all the samples combined. Typically, these plant samples may be 
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T. lanceolata sample
Sample Plant 
mass 
(g, dry) 
12  
mass, g 
80  
mass, g 
81 
mass, g 
Total yield, g, 
(% w/w) 
1 60.0 0.113 0.405 0.266 0.784 (1.31 %) 
2 31.5 0.459 0.000 0.000 0.459 (1.46 %) 
3 44.1 0.050 0.207 0.266 0.523 (1.19 %) 
4 6.8 0.032 0.013 0.072 0.117 (1.72 %) 
5 47.1 0.071 0.106 0.058 0.235 (0.50 %) 
6 31.2 0.079 0.075 0.090 0.244 (0.78 %) 
7 25.7 0.111 0.193 0.104 0.408 (1.59 %) 
8 40.0 0.056 0.142 0.118 0.316 (0.79 %) 
9 32.6 0.034 0.111 0.012 0.157 (0.48 %) 
10 32.0 0.198 0.404 0.336 0.938 (2.93 %) 
Total g,  
% w/w 
351.0 1.203 g, 
0.34 % 
1.656 g, 
0.47 % 
1.200 g, 
0.34 % 
4.059 g, 
1.15 % 
H
O H
O
H
H
O H
O
H
O
O
H
O
O
O
HO
12 
80 
81 
Chapter 3: Applications and Scope 
 105 
combined and extracted as a bulk homogenous sample. However, the rapid nature of the 
PHWE extraction method allowed the efficient extraction of each sample individually to 
build a chemotaxonomic profile of the area surveyed. 
It is not currently understood why these specific trees produce 1β-acetoxypolygodial (80) 
when it has never been reported previously in the literature, and has only been found in 
one location in Tasmania despite the extensive literature on this species. In addition, no 
conclusions were made as to why the level and ratio of the compounds varies to such an 
extent in this population of trees. Secondary metabolites may vary within individuals of a 
species for a variety of complex reasons, highlighted in a 2014 review by Moore and co-
workers.238a Further investigations would be necessary to determine the reason for this 
unusual metabolite occurring in this population of specimens. 
3.4.2 Extraction of Winter’s Bark (Drimys winteri) 
3.4.2.1 Background 
Drimys winteri (J.R. Forst. & G. Forst.) is related to T. lanceolata, and is known to contain 
polygodial (12).239 This plant was extracted to investigate polygodial content, as well as to 
identify other major components. D. winteri has also been previously found to contain 9-
epipolygodial (14) and (–)-drimenol (118).240,241 Flavonoid compounds taxifolin and 
astilbin (82) have also been isolated from the bark of this plant.239 
3.4.2.2 Extraction and Isolation 
The leaves were extracted using the PHWE method, and the resulting extract 
fractionated through extraction with heptane, followed by EtOAc. The residual aqueous 
extract was subsequently evaporated to dryness, and the 1H NMR spectra of these 
extracts showed a high degree of selectivity in the of fractionation of components, as 
shown above for E. adenophorum.  
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Figure 3.48 – 1H NMR spectra of Drimys winteri fractions (from top) aqueous extract in 
D2O, EtOAc extract in MeOD, heptane extract in CDCl3. 
The 1H NMR spectrum of the heptane extract clearly showed polygodial (12) as the major 
component, with the diagnostic aldehyde signals at 9.53 and 9.46 ppm, the alkene at 
7.12 ppm, and the three characteristic methyl singlets of the drimane skeleton around 1 
ppm. The mass of the crude heptane had a yield of 2.1 % w/w, indicating that this sample 
of D. winteri does not contain a level of polygodial equivalent to the high content T. 
lanceolata, so extraction of this plant for the polygodial content was not pursued. The 
EtOAc extract, however, had a much higher crude mass, with a crude yield of 12.1 % 
w/w. In addition, 1H NMR spectroscopy and TLC analysis indicated two major 
components. These compounds proved difficult to separate by normal phase column 
chromatography, with co-elution yielding 1.44 g (8.4 % w/w) of a fine yellow powder. 
These compounds were readily separable in reversed-phase mode, and after isolation 
were identified as astilbin (82) and quercitrin (83) by comparison with NMR data with 
that previously reported.242,243 These two compounds differ only in the degree of 
saturation in the heterocyclic ring. Only a small sample of the two compounds were 
separated into their individual components due to the size of the reversed-phase column 
used, but the ratio of the compounds gives the overall yield of the two compounds. The 
1H NMR spectrum shows a ratio astilbin:quercitrin 1:0.44, which gives approximate yields 
Heptane extract 
EtOAc extract 
Residual aqueous extract 
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of these compounds of 5.8 % and 2.6 % w/w respectively, indicating that these 
compounds may be readily obtained in high yields from this plant. 
  
Figure 3.49 – Astilbin and quercitrin isolated from D. winteri 
Astilbin has been previously isolated from D. winteri in a 0.20 % yield w/w.239 Quercitrin 
has been isolated from the closely related D. brasiliensis.89 These compounds have 
known biological activity, being actively studied in 2017,244-247 and are relatively 
expensive to source commercially.*  
3.4.3 Summary 
The extraction of the T. lanceolata from Wielangta Forest demonstrates the utility of the 
method for rapid extraction of individual samples for rapid bioprospecting and 
chemotaxonomic analysis. The extraction of multiple samples for comparison of the 
relative levels of major components was simplified as the enrichment of the extract 
allowed baseline separation of the major components in a single flash chromatographic 
run, and therefore an accurate quantitative assessment of each sample. Not only did this 
method provide a rapid method for comparison, but also allowed isolation of gram-scale 
quantities of the three major components. 
The extraction D. winteri again demonstrates the flexibility of the method for the 
extraction of compounds of a wide range of polarity, which in turn further highlights the 
validity of PHWE as a bioprospecting method. The initial target from extraction of this 
plant was the non-polar terpene polygodial. However, the most significant result was the 
very high quantities of valuable glycosides, which were obtained during the extraction. 
                                                          
* Astilbin – USD$252 for 25 mg from AK Scientific, Quercitrin – USD$130 for 20 mg from Arctom Chemicals USA 
14/11/17 
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The significantly higher yield of astilbin from D. winteri also demonstrates the advantage 
of the PHWE method, where a single chromatographic step is required for isolation of 
components, which leads to less losses through sample handling and decomposition.  
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3.5 Extraction of Essential Oils from Common Culinary Plants 
3.5.1 Overview 
Due to the utilitarian nature of this method, it was anticipated that it could be readily 
integrated into the undergraduate laboratory program at the University of Tasmania as a 
replacement/alternative to traditional hydrodistillation. To this end, a number of 
common culinary plants were extracted, targeting the essential oil components. 
Combined, these demonstrate the ease of generation of extracts enriched in essential 
oils. Cloves, star anise, caraway seeds, thyme, oregano and lemon myrtle were all 
extracted to provide extracts enriched in the major components. 
3.5.2 PHWE in the Undergraduate Laboratory  
Natural Products extraction in the undergraduate teaching laboratory often involves 
hydrodistillation of essential oils from plants. Indeed, as recently as 2015, undergraduate 
experiments pertaining to the extraction of monoterpenoid natural products from 
common culinary plants using this method have been reported.248 As discussed through 
this thesis, PHWE is an increasingly popular method of extracting organic components 
from various complex matrices including plant materials. Providing students with hands-
on experience at an undergraduate level, however, can be expensive/impractical due to 
the costly nature of the equipment involved. To that end, the espresso machine PHWE 
has been incorporated into the undergraduate laboratory at second- and third-year 
levels as an inexpensive option to custom-made instruments.75  
Implementation of this work into the undergraduate laboratories serves many purposes. 
In incorporating work from research groups within the building into the curriculum, the 
students are able to more clearly see the applications of the topics taught during their 
undergraduate education. Additionally, this experiment replaced a traditional 
hydrodistillation, so the students are exposed to a broader range of techniques. The 
hydrodistillation required an expensive set of glassware for every student, and the 
distillation takes a substantial amount of the laboratory time to complete. In contrast, 
two espresso machines are sufficient for a laboratory of ~16 students, who can quickly 
complete the extractions one after another and therefore accomplish more within the 
laboratory session. 
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This section describes the extraction and isolation of major components from common 
culinary plants. Such plants are often used, due to being available, and the simplicity of 
the resulting extraction and analysis of the major components.249 The degree of 
enrichment of the 1H NMR spectra for the resulting extracts for these plants makes these 
excellent examples for undergraduate natural products chemistry. 
3.5.2 Cloves (Syzygium aromaticum) 
The hydrodistillation of eugenol (73) and acetyleugenol (84) from cloves, the flower buds 
of S. aromaticum ((L.) Merrill & Perry), was an experiment already performed by second 
year undergraduate students at the University of Tasmania up until 2014. Investigations 
into the efficacy of the PHWE method for the extraction of these compounds were 
undertaken. This method was subsequently incorporated into the undergraduate 
laboratories and supplanted the traditional steam distillation experiment. 
 
Figure 3.50 – Eugenol and acetyleugenol 
Espresso machine PHWE extraction with 25% EtOH:H2O (200 mL) provided a brown crude 
extract. CH2Cl2 has been typically used as the extraction solvent but limiting the use of 
toxic halogenated solvents by undergraduate students is desirable. Therefore, heptane 
was trialled as an alternative solvent. This is preferable to the more common 
hydrocarbon solvent, hexane, which is a potential neurotoxin.250-252 To compare the 
extraction yield for these two solvents, cloves (15 g) were ground and extracted by 
PHWE. The resulting extract was extracted with heptane to generate a crude essential oil 
extract. Following acid–base extraction to separate the acidic eugenol (73) from the non-
acidic acetyleugenol (84) The resulting extract containing eugenol (73) was split into two 
portions before one fraction was extracted with heptane and the other with CH2Cl2. 
Upon isolation of the product, the respective masses of the resulting pale-yellow oils 
were 636 mg and 646 mg which were shown by GC-MS and 1H NMR spectroscopic 
analysis to be one major component, providing evidence that heptane is an efficient 
solvent for the extraction of eugenol from an aqueous mixture. The overall yield of the 
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extraction was 8.5 % w/w. Acetyleugenol (1.2% w/w) was the primary component of the 
neutral fraction. These results are comparable with traditional hydrodistillation, which 
demonstrates that PHWE is a viable alternative, and offers the benefit of a more rapid 
extraction, and low cost per student to implement into the laboratories. 
 
Figure 3.51 – GC analysis of the resulting eugenol from PHWE and acid–base extraction. 
 
Figure 3.52 – 1H NMR spectrum of the resulting eugenol from PHWE and acid–base 
extraction. 
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3.5.3 Chinese star anise (Illicium verum) 
Aside from being a rich source of shikimic acid (see Chapter 2), star anise also contains a 
large essential oil fraction, with two major components, anethole (75) and p-
anisaldehyde (85). Ground star anise seeds and seed pods were extracted by PHWE (25% 
EtOH:H2O), followed by extraction with CH2Cl2 provided a crude green extract (3.8 % yield 
w/w). The resulting pale yellow/green oil showed the two major components identifiable 
in the 1H NMR spectrum, in a ratio of approximately 13:1 anethole:p-anisaldehyde 75:85. 
 
Figure 3.53 – Anethole and p-anisaldehyde 
 
Figure 3.54 – 1H NMR spectrum of the CH2Cl2 extract from Chinese star anise showing the 
major components and their ratios. 
3.5.4 Caraway seeds (Carum carvi) 
Caraway seeds (Carum carvi L.) contain the fragrant flavour compound S-(+)-carvone 
(86), which is enantiomeric with R-(–)-carvone which is the spearmint flavour from the 
spearmint plant (Mentha spicata). Ground caraway seeds were extracted by PHWE (30% 
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EtOH:H2O), followed by extraction with CH2Cl2. The resulting yellow oil (127 mg, 0.85 % 
w/w from 15.0 g of seeds) showed clearly the major component in the 1H NMR spectrum. 
The difference in smell of these enantiomers is a classic demonstration of the importance 
of stereochemistry, so extraction of spearmint could be undertaken to obtain the 
enantiomer. 
  
Figure 3.55 - Enantiomers of carvone. 
 
Figure 3.56 – 1H NMR spectrum of the CH2Cl2 extract from caraway seeds. 
3.5.5 Oregano (Origanum vulgare) 
Oregano (Origanum vulgare L.) contains a complex mixture of compounds in its essential 
oil fraction. The major components are regioisomers thymol (88) and carvacrol (89). 
These compounds can exist in varied ratios in the plant.253 Two different brands of 
oregano (15.0 g and 12.5 g) were extracted by PHWE (25% or 30% EtOH:H2O), which had 
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very different 1H NMR spectral profiles. The yields for these extractions were 1.46 % (204 
mg) and 0.41 % (61 mg) (w/w) respectively. 
 
Figure 3.57 - Regioisomers thymol and carvacrol 
 
Figure 3.58 – Partial 1H NMR spectra of the two different oregano extracts showing a 
difference in their chemical composition. 
It can be seen that the bottom NMR spectrum (zoomed in on the aromatic region) shows 
1 major compound, and the top NMR spectrum shows a mixture of compounds. The 
bottom fraction contains only carvacrol (89), whereas the top spectrum contains thymol 
(88) and carvacrol (89) in a ratio of ~2:1. This example further highlights how this method 
could be applied as an analytical tool due to the rapid preparation of the extracts, as was 
demonstrated for 1β-acetoxypolygodial (80) previously (Section 3.4.1). 
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3.5.6 Thyme (Thymus vulgaris) 
The essential oil of thyme (Thymus vulgaris L.) also contains thymol as a major 
component, but lacks the carvacrol that oregano contains.254 Extraction of ground thyme 
leaves by PHWE (30% EtOH:H2O), followed by extraction with CH2Cl2 provided a crude 
green extract (1.46 % yield w/w). This extract was primarily composed of thymol (88), 
determined by analysis of the 1H NMR of the crude extract. 
 
Figure 3.59 – 1H NMR spectrum of the CH2Cl2 extract of thyme 
3.5.7 Lemon Myrtle (Backhousia citriodora) 
Lemon myrtle (Backhousia citriodora F.Muell.) is known to contain a mixture of 
compounds known as citral (90 + 91). Citral is a mixture of double bond isomers, geranial 
(90) and neral (91), which possess a strong but pleasant citrusy odour. These compounds 
make excellent candidates for study by undergraduate students as they are highly 
abundant in readily available plants, and can undergo simple chemoselective reactions 
due to the different functional groups they possess.255 The two compounds are difficult 
to separate by standard flash column chromatography but they can be selectively 
hydrogenated to form a single compound, citronellal.255 
OH
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Figure 3.60 – Stereoisomeric components of citral 
 
Figure 3.61 - Citronellal 
Dried lemon myrtle (Backhousia citriodora) leaves were ground and extracted using the 
PHWE method (35% EtOH:H2O). Subsequent extraction with CH2Cl2 provided a pale 
yellow oil in a yield of 8.1% w/w. The resulting 1H NMR spectrum showed an extract that 
is relatively clean and contains primarily 90 and 91. The most distinct peaks are those of 
the aldehydes, which can be used directly on the crude extract to determine the ratio of 
geranial to neral in the extract. The observed ratio of 2:1 is consistent with previous 
findings.256 This extract can be used for subsequent chemical modification without 
purification due to the lack of significant impurities.  
 
 
Figure 3.60 – 1H NMR spectrum of the crude extract CH2Cl2 extract of lemon myrtle, 
showing the ratio of the two aldehydes present. 
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3.5.8 Summary 
These extractions have demonstrated the ease with which extracts enriched in essential 
oils may be obtained through the PHWE method. This showed that the PHWE method 
may be used as an alternative to hydrodistillation, further highlighting the flexibility and 
application of this method to a broad range of substrates. 
The implementation of the method in the undergraduate laboratories also represents a 
significant achievement. Substituting the PHWE technique removed a distillation, which 
was a previously learned technique for most of the students, and this new method allows 
students to be exposed to current research developments. Extracts such as those 
considered make excellent teaching examples for students, as they can see major 
components in the 1H NMR spectra of the crude material. Further, by adding TLC analysis 
and chromatography, developing undergraduate experiments at varying levels is 
possible. Student feedback is generally positive about the use of this method, with many 
expressing surprise that the method is so effective, and commenting that it is a unique 
and interesting idea which hopefully will aid in students thinking outside the box in 
future academic pursuits. 
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3.6 Subsequent Espresso Machine PHWE Applications 
Other members of the research group at the University of Tasmania have undertaken 
further research exploiting the rapid and efficient nature of this novel method for 
extraction of interesting molecules. This includes large scale extraction of the important 
bioactive molecule asperuloside,257 and the discovery of new diterpene carboxylic acid 
natural products from Dodonaea viscosa.88 A significant synthesis project was also 
undertaken on the synthesis of pyrrolic derivatives of polygodial targeting other families 
of natural products.258 There are other current projects underway in the research group, 
focussing on the extraction of metabolites from endemic Tasmanian plant species for 
bioprospecting and chemotaxonomic applications. 
National and international collaborations have been established through this work, with 
gram–scale quantities of polygodial sent to the USA, as well as Belgium. The research 
groups in these countries had a need for this compound for their research but were 
unable to source it efficiently.  
Since this research was undertaken, another research group has explored espresso 
machine extraction. A research group in Spain are employing a different type of espresso 
machine for their own research.259-262 The group uses a hard cap espresso machine, more 
commonly known as a ‘pod’ espresso machine, so named because instead of using a 
sample basket for the plant material, the material is packed into disposable pods. This 
research group are using these machines for analytical applications, which shows another 
application not currently exploited by the research group at the University of Tasmania. 
The ability to use an espresso machine for quantitative extraction as required for 
analytical applications, further highlights the viability of espresso machines as high-
performance laboratory equipment. 
3.7 Conclusion 
The examples provided highlight the significance and scope of the espresso machine 
PHWE method. The rapid extraction of bioactive extracts such as the pyrethrins from C. 
cinerariaefolium and terpenoids from E. adenophorum has provided further collaboration 
for the research group and therefore expansion of the projects undertaken. Rapid 
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isolation of valuable natural products from a variety of plant materials was further 
highlighted through isolation of castanospermine and marrubiin. 
The simplicity of the method for bioprospecting/chemotaxonomic profiling in 
combination with near exhaustive product isolation was also further supported through 
the survey of T. lanceolata from Wielangta Forest and the rapid identification of major 
components from D. winteri. The rapid extraction, combined with the simplicity of the 
subsequent flash column chromatography (as demonstrated for polygodial from T. 
lanceolata in Chapter 2) allowed this project to be conducted in a more efficient manner 
than if a different extraction methodology were undertaken. 
Finally, the use of the method as an alternative to hydrodistillation for the rapid 
generation of extracts rich in essential oils further highlights the flexibility and application 
of the method. 
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Chapter 4: Polygodial as a Scaffold for Synthesis 
4.1 Overview 
In this chapter, the reactivity of polygodial and derivatives was explored to investigate 
the potential utility of this molecule as a complex scaffold for organic synthesis. The 
fundamental reactivity of this compound was explored through various classical synthetic 
transformations. Subsequently, the development of a reactant for the divergent 
synthesis of known natural products and analogues based on polygodial was explored. 
4.2 Background  
4.2.1 Stereoselective and Stereospecific Synthesis 
Stereoselective synthesis is of incredible importance in synthetic chemistry.263 There are 
many examples of biologically active compounds that have only one active stereoisomer, 
which can mean a single enantiomer out of many possible stereoisomers.264 For 
paclitaxel (7), described in Chapter 1, the 11 stereocentres result in a total of 211 = 2048 
possible stereoisomers. Stereoselective synthesis also leads to efficiency, as undesired 
by-products of differing stereochemistry are minimised or eliminated altogether.265 
Stereoselective synthesis can be achieved in a number of ways, but may suffer some 
drawbacks such as increased number of steps, low yield, low stereoselectivity, and/or 
expensive and sensitive catalysts and ligands.266 
The use of natural products in synthesis can mitigate some of the problems of 
stereoselective synthesis. Many natural products contain a significant number of 
stereocentres within the molecule, and often exist as a single enantiomer from the 
natural source. This is certainly true of the examples of diosgenin (3) and paclitaxel (7) 
discussed in Chapter 1. Stereocontrolled synthesis in biological systems is typically 
achieved through enzymatic control of the biochemical pathways. Indeed, such is the 
power of enzymes, that they are being increasingly exploited for chemical synthesis, both 
by using microorganisms to effect chemical transformations,267 and by purifying enzymes 
and using these instead of more traditional catalysts and reagents to facilitate synthetic 
transformations.268  
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If a stereochemically pure complex scaffold is used as a starting point in a synthesis, this 
can avoid some of the problems associated with stereoselective synthesis. Complex 
scaffolds with fixed absolute stereochemistry can lead to stereospecific synthesis by 
imparting stereocontrol on subsequent transformations, as the steric bulk and set 
conformation of the molecule can force reactions to occur only in a specific orientation 
leading to a single stereoisomer being formed. The complex scaffold may be an intrinsic 
part of the desired molecule, or alternatively a bulky chiral fragment may be attached to 
an achiral molecule, and subsequently removed from the substrate after the reaction. In 
the case where the chiral portion is removed, it is known as a chiral auxiliary. Of course, 
this specificity can also be a disadvantage as the enantiomeric series may not be able to 
be accessed when only a single enantiomer of a natural product is available. Two 
examples of natural products and derivatives used as chiral auxiliaries are 
pseudoephedrine (94) in the stereospecific synthesis of various carbonyl derivatives 
(97)269 and carbohydrate derivatives (98) in the stereospecific synthesis of pyrrolidines 
(101).270 
 
Scheme 4.1 – Asymmetric synthesis of carbonyl derivatives employing pseudoephedrine 
as a chiral auxiliary. 
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Scheme 4.2 – Asymmetric synthesis of pyrrolidines exploiting a carbohydrate derivative 
as a chiral auxiliary. 
4.2.2 Drimane-Based Natural Products 
This chapter is focused around the reactivity of polygodial, and the use of polygodial as a 
reactant for divergent synthesis of molecules containing the drimane skeleton. Drimane 
is a C15 terpene (sesquiterpene) found ubiquitously in nature as the core of many 
biologically active secondary metabolites.271 Drimane (102) has the fixed absolute 
stereochemistry and numbering system shown in Figure 4.1.  
 
Figure 4.1 – Drimane skeleton with numbering system. 
In 2012, work reported by Baran and co-workers highlighted the use of a similar complex 
organic scaffold, based on the drimane skeleton, which was used as a divergent 
precursor for the stereospecific synthesis of a suite of meroterpenoid natural products. 
The absolute stereochemistry of the drimane system allowed stereospecific reactions 
due to the bulk and rigid conformation of the scaffold. An inexpensive and readily 
available natural product, sclareolide (103), was used as a complex organic scaffold, and 
through a 5–step process generated borono-sclareolide (107a) as a key intermediate, 
that facilitated the divergent synthesis of numerous meroterpenoids.272 This synthesis 
over 5 steps gave a 60 % yield of borono-sclareolide (107a), in a 3:1 ratio of 
diastereomers. From this intermediate, natural products such as (–)-isozonarol (108), (–)-
isozonarone (109) and (–)-pelorol (110) were able to be efficiently synthesized. 
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Scheme 4.3 – Baran and co-workers’ 5-step synthesis of borono-sclareolide 
 
 
Figure 4.2 – (–)-isozonarol, (–)-isozonarone and (–)-pelorol synthesized from sclareolide. 
Inspired by the work of Baran, efforts were made towards the synthesis of natural and 
non-natural compounds, starting from polygodial. The reactivity of polygodial and 
derivatives was explored through classical chemical transformations. Subsequently, the 
ultimate goal was to convert this valuable material into a substrate from which divergent 
synthesis of terpenoid natural products could be achieved. 
4.3 Reactivity Studies on Polygodial and Derivatives 
Currently, there is limited literature on the synthetic transformations of polygodial (12). 
Previously, there have been a number of reports of hydride reduction to form drimendiol 
(15),76,241,273,274 and a report of the oxidation to the di-carboxylic acid (111).275 In 
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addition, Kornienko and co-workers have reported a number of reactions of this scaffold 
including acetal formation (112) through reaction with various alcohols, hydrogenation 
with a nickel catalyst (114 and 115), epimerisation of the C-9 position to form 9-
epipolygodial (14) and selective Wittig derivatisation of the conjugated carbonyl (113). 
Kornienko’s work was reported while the current project was being undertaken.276,277  
 
Scheme 4.4 – Previously reported transformations on polygodial. 
Polygodial (12) contains 3 contiguous stereocentres, and 2 distinct aldehydes. The carbon 
at C-9 adjacent the aldehyde at C-11 is epimerisable, and due to the steric and electronic 
difference, the aldehydes are able to be selectively functionalised. This makes polygodial 
an excellent candidate as a synthetic scaffold towards natural products and analogues. 
Polygodial is expensive to source commercially, which limits its feasibility as a precursor 
for synthetic transformations if an alternative source is not available.* However, as 
described in Chapter 2, gram-scale quantities of pure polygodial can be isolated without 
                                                          
* AUD$162 for 10 mg as at 29/10/17 from Sigma–Aldrich 
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chromatography within a day from T. lanceolata by the PHWE method, thus allowing 
polygodial to be a viable scaffold for synthesis. 
4.3.1 Reduction of Drimendiol 
Following the near quantitative conversion of polygodial (12) to drimendiol (15) (Chapter 
2), further synthetic manipulations were performed to allow a greater understanding of 
the reactivity of this diol. A previous report on synthetic manipulation of the C-9 epimer 
of drimendiol (116) showed that when subjected to a hydrogen atmosphere with 
catalytic Pd/C, the resulting product was not the predicted hydrogenation product, but 
instead hydrogenolysis of the allylic alcohol occurred to form 9-epidrimenol (117).273 
 
 
Scheme 4.5 – Hydrogenolysis of 9-epidrimendiol to form 9-epidrimenol 
This reaction was explored on drimendiol, with the synthesis of (–)-drimenol (118) in 
mind. Upon reaction with hydrogen gas and Pd/C in EtOH for 1.25 h, (–)-drimenol was 
isolated in a reproducible 64 % yield. Key signals in the 1H NMR spectrum for this 
compound were the diastereotopic methylene signals at 3.85 and 3.73 ppm, which 
indicated that the compound contained only one -CH2-OH group. Further, the signal at 
5.54 ppm indicated that the alkene was still intact. The spectral data were consistent 
with the formation of (–)-drimenol,278 showing that the reaction proceeded in the same 
fashion as for the C-9 epimer previously reported. As (–)-drimenol is formed as the only 
product of the reaction, this indicates that the hydrogenolysis of the allyl alcohol occurs 
exclusively before any subsequent hydrogenation of the alkene. A possible mechanism is 
that this process occurs through the formation of a π-allyl cation. 
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Figure 4.3 – 1H NMR spectrum of (–)-drimenol (118). 
 
Scheme 4.6 – Two-step synthesis of (–)-drimenol from polygodial. 
(–)-Drimenol (118) is a bench-stable compound, which has been used as a scaffold in 
synthesis of numerous natural products. To source (–)-drimenol commercially for 
synthesis is not viable due to it being prohibitively expensive,* so this method for 
obtaining the material provides a significant advantage. Gram-scale quantities of (–)-
drimenol are obtained by this method in a reproducible yield of ~64 % over 2 steps, 
which represents the most efficient means of obtaining this compound to the author’s 
knowledge. A review of the synthesis of (–)-drimenol, and its use as a scaffold for 
synthesis of natural products and derivatives was published in 2011.279  
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When the reaction time was increased to 5 h, 2 major products were observed, neither 
of which were (–)-drimenol (118). In the 1H NMR spectra for these two products 
(separable by flash chromatography), the appearance of methyl signals split into doublets 
indicated that the hydrogenation of the double bond was occurring, forming the two 
epimeric saturated drimanols 119 and 120, whose NMR spectroscopic data matched 
literature reports.280,281 The low yield (~30 % combined) was consistently observed with 
this particular reaction, indicating that the compound degrades over time under these 
conditions, forming unknown by-products that were not isolated or identified. This 
reaction showed a 1.5:1 ratio of 119 to 120, suggesting some stereocontrol for this 
reaction imparted by the configuration of the drimane backbone.  
 
Scheme 4.7 – Hydrogenolysis and hydrogenation of drimendiol 15. 
Surprisingly, reduction of crude drimendiol following reduction of polygodial with NaBH4 
resulted in the isolation of the two isomers of drimandiol 121 and 122. The only 
difference to previous reactions was that the drimendiol 15 was the crude reaction 
product, and not purified by column chromatography. This reproducible observation 
indicated that the crude NaBH4 reaction product contained a contaminant that was 
hindering the hydrogenolysis step. 
As boron is oxophillic it was hypothesised that residual boric acid may be preventing 
formation of a π-allyl cation and therefore preventing hydrogenolysis. To test this, the 
same reduction conditions were attempted on the pure diol with the addition of 
trimethylborate. However, this reaction proceeded to form the two saturated drimanol 
isomers 119 and 120. Therefore, it is not clear why there is a stark contrast between 
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using the crude and pure drimendiol. This was not explored further, but is potentially 
useful to target the dihydroxy derivatives 121 and 122. 
 
Scheme 4.8 – Hydrogenation of crude drimendiol. 
Drimendiol was also reacted with Adam’s catalyst (platinum oxide, PtO2) under 1 atm of 
hydrogen in EtOAc for 3 h. Following flash chromatography, 3 compounds were isolated - 
syn-drimanol 120 and drimandiol isomers 121 and 122. This reaction shows that under 
these reduction conditions, there is competition between hydrogenation and 
hydrogenolysis, which resulted in an almost 1:1 mixture of the drimanol isomer 120, with 
the drimandiol isomers 121 and 122. syn-Isomer 121 has been previously reported in the 
literature,282 however, anti-isomer 122 has not previously been fully characterised. The 
key features in the NMR spectra for diol isomers 121 and 122 are the loss of any alkene 
signal, and the two sets of diastereotopic methylene signals observed between 3.5 and 4 
ppm.  
 
Scheme 4.9 - Reduction of drimendiol with H2/PtO2 in EtOAc 
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Figure 4.4 – 1H NMR spectrum of the products from reduction of drimendiol with H2/PtO2 
in EtOAc 
To support the stereochemical assignment, diols 121 and 122 were crystallised, and 
analysed by single crystal X-ray diffraction. The difference in the stereochemistry at the 
C-8 position was supported through this analysis and matches with the stereochemistry 
previously reported for the syn-isomer 121.282 The bias towards isomer 121 is supported 
by the X-ray crystal structure 3D conformation of the starting material drimendiol, as the 
-CH2OH at C-9, and the methyl group at C-10 provide steric bulk near C-8, which favours 
delivery of hydrogen by the catalyst on the opposite face. 
 
Figure 4.5 – X-ray crystal structure of drimendiol 15. 
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Figure 4.6 – X-ray crystal structures for the saturated diols 121 (left) and 122 (right). 
4.3.2 Hydrogenation of Polygodial 
In continuing work on the reactivity of polygodial (12), reduction under various 
conditions with hydrogen was attempted. Polygodial was subjected to a hydrogen 
atmosphere with catalytic Pd/C in both EtOH and EtOAc. 1H NMR spectroscopic analysis 
of the crude material obtained from the reactions indicated a complicated mixture of 
products in each case. The 1H NMR spectrum of the reaction in EtOAc shows a significant 
number of aldehyde signals, showing at least 3 major products in this reaction. 
Additionally, the signals around 4 ppm are consistent with formation of various acetal 
type derivatives. This is consistent with the result seen by Kornienko and co-workers 
using a nickel catalyst.276 As a major compound was not observed, no further reactions 
were attempted. 
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Figure 4.7 – 1H NMR spectrum of hydrogenation of polygodial in EtOAc. 
4.3.3 Olefination of Polygodial 
Reaction of polygodial (12) with the Wittig reagent, ethyl 
(triphenylphosphoranylidene)acetate (123), resulted in regioselective reaction of the α,β-
unsaturated aldehyde at C-12 to form compound 124 in good yield (79 %). Surprisingly, 
with an excess of the Wittig reagent, the aldehyde at C-11 aldehyde showed no tendency 
to react. This was postulated to be due to the steric hindrance of the neo-pentyl 
aldehyde. This result was independently observed by Kornienko and co-workers, detailed 
in a report published around the same time as this work.76 The 1H NMR spectrum of the 
purified material clearly shows the remaining aldehyde with a doublet at 9.46 ppm, 
supporting the selectivity of the reaction for the C-12 aldehyde of polygodial. The 
expected formation of the (E)–alkene was supported in the 1H NMR spectrum by the 16.2 
Hz coupling constant between the signals of the newly formed alkene protons at 7.30 
and 5.48 ppm.  
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Scheme 4.10 – Wittig reaction of polygodial (12) 
 
Figure 4.8 – 1H NMR spectrum of the purified Wittig product 124. 
A Horner–Wadsworth–Emmons olefination was attempted, where polygodial was 
reacted with triethyl phosphonoacetate (126) and sodium hydride in THF. This reaction 
resulted in a mixture of products with analysis of the 1H NMR spectral data indicating an 
inseparable mixture of the expected acrylate product with the C-9 epimer 125 indicated 
by a second doublet at 9.53 ppm in the 1H NMR spectrum, as well as further by-products.  
 
Scheme 4.11 – Horner–Wadsworth–Emmons Reaction of polygodial. 
H
O H
O
H
O H
H
O
OEt
O
OEt
Ph3P
CH2Cl2
79 % yield
H
O H
O
H
O H
H
O
OEt
O
OEt
NaH
P
O
EtO
EtO
THF
O Ha
H
O
OEt
Hb
Hd
Hc
Ha 
Hb 
Hc Hd 
124 + 125 12 
12 
123 
124 
124 
126 
Chapter 4: Polygodial as a Scaffold for Synthesis 
 133 
4.3.4 Reactivity of the Wittig Adduct 
This Wittig product 124 compound contains a diene moiety, which may undergo Diels–
Alder type chemistry. Therefore, this reactivity was explored to demonstrate the facile 
synthesis of enantiopure polycyclic systems. To this end, a model reaction using N-
phenylmaleimide (127) was undertaken in an attempt to form a tricyclic carbon skeleton. 
This reaction proceeded to yield a single enantiomerically pure compound (128) in 
moderate yield (55 %). In spite of the moderate yield, no evidence for other 
stereoisomers was observed in the 1H NMR spectral data. The structure was supported 
through spectroscopic analysis, including HRMS consistent with the predicted structure. 
In the 1H NMR spectrum, the resonance at 9.58 ppm showed that the aldehyde remained 
intact in the reaction, and the incorporation of a phenyl moiety was indicated by signals 
integrating for a total of 5 protons between 7 and 7.5 ppm. The presence of the nitrogen 
containing heterocycle was supported through the carbonyl signals at 176.6 and 175.7 in 
the 13C NMR spectrum. The stereochemical assignment was supported through the NOE 
correlations shown in Figure 4.9, below, and is consistent with the expected outcome of 
a Diels–Alder reaction through an endo-transition state.   
 
Figure 4.9 – Partial NOE Spectrum of compound 128. 
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The Wittig adduct 124 was also subjected to reaction with LiAlH4 to reduce the aldehyde 
and the ester functionalities, setting up for subsequent reaction to form a different diene 
substrate for synthesis of novel tricyclic compound 131. This reaction proceeded to give a 
complicated mixture of products, from which an impure fraction containing the diol 129 
was obtained in low yield. As the desired product was obtained in sufficient yield for 
further reaction, no optimisation was undertaken to improve the yield or purity of 
compound 129. This fraction was then subjected to Pb(OAc)4, which proceeded as 
expected based on analogous reactivity observed in similar systems by Preite and 
Cuellar283 to form 130 in moderate yield, which contained a rearranged diene system 
which could undergo Diels–Alder chemistry. Diels–Alder reaction with 127 proceeded to 
yield polycyclic product 131 as a single diastereomer in 7 % yield over 3 steps. This 
reaction proceeded as expected with HRMS consistent with the expected product from a 
Diels–Alder reaction, and the NMR spectra again supporting the inclusion of the 
maleimide as discussed for compound 128. In addition, a carbonyl signal at 170.6 ppm in 
the 13C NMR spectrum, and a methyl singlet at 2.15 ppm (overlapped signal) in the 1H 
NMR spectrum indicated the acetoxy functionality. This reaction leaves another synthetic 
handle in the form of an allylic acetoxy group at the C-7 position. This could be exploited 
in cross-coupling reactions with Pd,284 or hydrolysed to yield an allylic alcohol which may 
also undergo a number of reactions including Pd-mediated dehydrative cross-coupling 
with alkenes.285 
 
Scheme 4.12 – Synthesis of enantiopure polycyclic systems 128 and 131. 
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4.3.5 Synthesis of (+)-Euryfuran 
The reduction of polygodial with NaBH4 in EtOH was investigated in more detail to 
determine if the compound isodrimeninol 132 could be formed through selective 
reduction of the α,β-unsaturated aldehyde. This would allow the synthesis of (+)-
euryfuran (133), a marine natural product found in nudibranchs and sponges.286,287 It was 
thought that the cyclic intermediate formed in the reduction would efficiently eliminate 
water in the presence of acid, followed by rearrangement of the alkene to aromatise the 
system, forming the furan. Initially, polygodial was reacted with 1.1eq of NaBH4 at rt for 4 
h. 1H NMR spectroscopic analysis indicated the exclusive formation of drimendiol in this 
reaction. Performing the reaction at 0°C for 20 min gave the desired isodrimeninol (132) 
in 78% yield (containing some residual impurity). With this in hand it was treated with 
HCl to provide (+)-euryfuran (133) in a 13 % yield over 2 steps. The formation of 
isodrimeninol by oxidation of drimendiol (15) with Dess–Martin periodinane was also 
attempted as an alternative pathway to this natural product, however these reactions 
produced a complex mixture of products. 
 
Scheme 4.13 – Synthesis of the natural product (+)-euryfuran via isodrimeninol. 
The 1H NMR spectrum of the intermediate, isodrimeninol (132), shows the C-7 – C-8 
alkene of polygodial still in place with a signal at 5.54 ppm. The other key peaks for this 
intermediate are the diastereotopic methylene peaks for C-12 at 4.25 and 4.47 ppm. The 
C-11 acetal is also evident through the resonance at 5.25 ppm. Upon treatment with HCl, 
the resulting 1H NMR spectrum for (+)-euryfuran showed the formation of the furan 
through the proton signals at 7.08 and 7.05 ppm, and loss of the C-7 – C-8 alkene signal. 
The appearance of diastereotopic methylene peaks at 2.77 and 2.50 ppm is consistent 
with the formation of the CH2 at the C-7 position after the alkene shift. These data were 
consistent with literature reports.288 
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Figure 4.10 – 1H NMR spectrum of impure isodrimeninol (132) (below) and (+)-euryfuran 
(133) (above). 
4.3.6 Euryfuran Derivatives Synthesis 
A hindrance in the aforementioned synthesis of (+)-euryfuran was the difficulty in 
obtaining the hemiacetal, isodrimeninol (132). In the previous report of the extraction 
and isolation of 1β-acetoxypolygodial (80) from a select group of T. lanceolata trees 
(Chapter 3), all of the specimens contained the corresponding 1β-acetoxyisodrimeninol 
(81). Treatment of 81 with HCl under analogous conditions to above yielded the 
corresponding furan analogue 135. During this synthesis, intermediate 134 in which the 
alkene has not shifted into conjugation was also obtained and fully characterised. The 1H 
NMR spectrum for 134 showed alkenyl peaks at 5.60 and 5.54 ppm, whereas the 1H NMR 
spectrum for product 135 showed the formation of the furan through signals at 7.09 and 
7.07 ppm and loss of the alkene signals.  This reaction proceeded in low yield (21 %) with 
significant decomposition observed.  
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Scheme 4.14 – Synthesis of 1β-acetoxyeuryfuran (135) and an intermediate (134) from 
the natural product 1β-acetoxyisodrimeninol (81). 
Reaction of 135 with LiAlH4 yielded the derivative 1β-hydroxyeuryfuran (136) in 50 % 
yield. This compound contains a hydroxyl group at C-1 as an extra synthetic handle to 
allow further modification of the compound.  
 
 
Scheme 4.15 – Reduction of 1β-acetoxyeuryfuran. 
4.3.7 Pyridazine Synthesis 
Continuing with studies on the reactivity of polygodial (12), a reaction with hydrazine 
hydrate was undertaken to observe whether the dialdehyde would undergo a double 
imine condensation to form a pyridazine. It was hypothesised for this reaction the alkene 
of the scaffold could shift into the newly formed ring to form the pyridazine system. As 
the C-11 aldehyde showed previously a lower reactivity than the C-12 aldehyde, it was 
not known whether this reaction would proceed on both aldehydes. However, as the 
second imine condensation would be intramolecular, this may increase the likelihood of 
the reaction occurring as anticipated. Polygodial (12) was reacted with 1.1eq of hydrazine 
hydrate in ethanol at rt for 3 h, resulting in a complex mixture of products, which 
indicated partial reaction. 
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Therefore, the reaction with excess hydrazine hydrate in refluxing ethanol for 1.5 h was 
attempted, which gave the desired pyridazine 137 in >99 % yield. The characteristic 
peaks in the 1H NMR spectrum for the product are the singlets at 8.80 and 8.91 ppm 
corresponding to the two protons in the pyridazine ring. Recrystallisation of the 
compound provided crystals suitable for single crystal X-ray diffraction, which provided 
further supporting data for the assigned structure.  
 
Scheme 4.16 – Pyridazine synthesis from polygodial. 
 
 
Figure 4.11 - 1H NMR spectrum of the crude reaction mixtures of polygodial with 
hydrazine at rt (below) and reflux (above). 
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Figure 4.12 – X-ray crystal structure diagram of pyridazine 137. 
4.3.8 Epimerisation 
9-Epipolygodial (14) has been reported to have interesting biological activity, however, 
the previously reported transformation was inefficient, with acid-catalysed epimerisation 
in toluene over 40 h providing the compound in 40 % yield.276 Therefore, efforts were 
made to improve on the conditions and yield of the reaction. Given the previously 
observed epimerisation of polygodial at high temperature during PHWE extraction,76 an 
attempt was made to effect the epimerisation through high temperature microwave 
conditions in a solution of 20 % EtOH:H2O. The reaction was maintained at 110 °C for 20 
min, but analysis of the 1H NMR spectrum showed that the reaction had not proceeded, 
and the starting material (12) was recovered. Subsequently, addition of K2CO3 to the 
reaction showed that epimerization will proceed under microwave conditions in aqueous 
EtOH with the addition of base. Ultimately, the reaction proceeded in a reproducible 37 
% yield after 50 min, with the recovery of 23 % starting material. 
It was determined that the reaction reaches an equilibrium, which slightly favours the 
formation of 9-epipolygodial (14) under these conditions. Reaction times longer than 50 
min decreased the overall yield presumably through decomposition and did not improve 
the ratio of the products. This reaction does not provide a higher yield than the 
previously reported synthesis, but does significantly decrease the reaction time. Crystals 
of 9-epipolygodial were formed, which were analysed by single crystal X-ray diffraction, 
and show clearly the change in position of the C-9 aldehyde to the opposite face of the 
ring, now in a pseudo–axial position, in contrast with the pseudo–equatorial position 
seen in the X-ray crystal structure of polygodial. 
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Scheme 4.23 – Reversible epimerisation of polygodial 
 
Figure 4.13 – X-ray crystal structure for 9-epipolygodial (left) vs polygodial (right) 
The corresponding 9-epidrimendiol (116) and 9-epidrimenol (117) were synthesised from 
9-epipolygodial (14) in yields almost identical to those seen for drimendiol (15) and (–)-
drimenol (118), discussed previously. 9-Epidrimendiol (116) was crystallised and analysed 
by single crystal X-ray diffraction, providing further supporting evidence for the 
successful epimerisation and assignment of absolute stereochemistry. 
 
Scheme 4.24 – Synthesis of 9-epidrimeniol (116) and 9-epidrimenol (117) from 9-
epipolygodial (14). 
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Figure 4.14 – X-ray crystal structure of 9-epidrimendiol 116. 
4.3.9 Polygodial Vinyl Grignard Reaction 
Due to the observed lack of reactivity of the C-11 aldehyde of polygodial (12) towards the 
Wittig reagent 123, a stronger nucleophile was employed to further investigate the 
different reactivity of the two aldehydes. Polygodial was reacted with excess 
vinylmagnesium bromide to yield two diastereomers 138 and 139, which were separable 
by flash column chromatography. The saturated aldehyde at the C-11 position reacts 
with a high level of stereocontrol upon reaction with Grignard reagents (discussed in 
section 4.4.4) whereas the aldehyde at the C-12 position does not show the same level of 
control. Recrystallisation of diastereomer 139 provided crystals appropriate for single 
crystal X-ray diffraction, which provided supporting evidence for the assignment of 
stereochemistry. The ratio of the products was 1:1.6, shown by integration of the 1H 
NMR resonances at 4.94 and 4.84 ppm, with an overall yield of 74 %. 
 
Scheme 4.17 – Grignard reaction of polygodial with vinylmagnesium bromide 
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Figure 4.15 – X-ray crystal structure of the divinyl product 139 
 
 
Figure 4.16 – 1H NMR spectrum of the polygodial vinylMgBr reaction crude mixture 
(below) and the two isolated diastereomers 138 and 139 (above). 
4.3.10 Ring-Closing Metathesis and Oxidation 
Following the vinyl Grignard addition reaction, the resulting dienes 138 and 139 were 
subjected to ring-closing metathesis conditions to form tricyclic products 140 and 141. 
Both of the stereoisomers proceeded efficiently in this reaction, with full conversion of 
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the starting material evident by TLC analysis after < 10 min with Grubbs 2nd generation 
catalyst C848 (10% catalyst loading), in CH2Cl2 at room temperature.  
 
 
Scheme 4.18 – Ring-closing metathesis of divinyl drimane derivatives 138 and 139. 
In the 1H spectra NMR for these compounds, the loss of the terminal alkene signals of the 
vinyl groups were indicative of a successful reaction. The 13C NMR spectra also showed 
only 4 alkenyl signals for the products 140 and 141, compared with 6 for the starting 
materials 138 and 139.  
Following successful RCM, oxidation with Dess–Martin periodinane was attempted to 
form a quinone, which ultimately resulted in the isolation and identification of quinone 
143. It was hypothesised that upon oxidation, the alkene from the drimane skeleton may 
shift into conjugation as was seen previously in the synthesis of (+)-euryfuran 133, and 
pyridazine derivative 137. An initial attempt at oxidation of tricyclic diols 140 and 141 
with Dess-Martin periodinane gave a mixture of products, and subsequent flash column 
chromatography gave 3 impure fractions. The 1H NMR spectroscopic analysis suggested 
that a quinone product had been formed, with the key piece of evidence being the 
formation of two very close doublets at 6.59 ppm and 6.55 ppm (10.0 Hz coupling). This 
was also supported by the appearance of 2 carbonyl signals at 189.5 ppm and 187.7 ppm 
in the 13C NMR spectrum. Other chromatographic fractions appeared to have 
intermediates where the alkene had not shifted, which were complex mixtures of 
products. The HSQCme spectrum for the quinone fraction was analysed, and was found 
to only contain 4 methylene signals as opposed to the expected 5. There was also a 
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carbon resonance at 62.7 ppm in the 13C NMR spectrum which was unexpected based on 
the proposed structure of the product, but is consistent with a >CH-OH in the ring. This 
led to the tentative identification of the quinone product as having an extra hydroxyl 
functionality (142).  
 
Figure 4.17 – 1H NMR spectrum of the impure quinone fraction (above) and the purified 
compound after further oxidation (below)  
This fraction was subjected to further reaction with Dess-Martin periodinane, and upon 
purification the 1H NMR spectral data still showed evidence for a quinone, but the signals 
had shifted slightly to 6.71 ppm and 6.66 ppm. In addition, the 13C NMR spectrum 
showed an extra carbonyl functionality at 197.0 ppm consistent with oxidation of the 
suggested alcohol to a ketone. This product was isolated and fully characterised as 
compound 143. This shows that the reaction was able to form a quinone product, but 
suggests that under the given conditions this only proceeds upon nucleophilic attack of 
water onto the α,β-unsaturated carbonyl of the intermediate 141a with subsequent 
tautomerisation and further oxidation to yield the α-keto quinone 143. Understanding 
this process may allow optomisation to maximise the yield of the product, but this was 
not undertaken. 
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Scheme 4.19 – Quinone synthesis with an unexpected extra oxidation 
Oxidation of the system may also take place prior to the RCM reaction. To this end, 
oxidation of a mixture of the stereoisomers of the divinylpolygodial substrates 138 and 
139 was undertaken and proceeded in 50 % yield to yield the diketone 144. Subsequent 
attempts at RCM, however, in the manner described above provided complex mixtures. 
 
 
Scheme 4.20 – Oxidation of divinylpolygodial 138 and 139 before ring-closing metathesis. 
4.3.11 Proposed Future Work from RCM Reactions 
As the reactivity of the two aldehydes of polygodial differ, as seen previously in Wittig 
type chemistry, this suggests that careful reaction control could allow for a first Grignard 
reaction to selectively functionalise the aldehyde at the C-8 position, followed by 
subsequent Grignard reaction to functionalise the aldehyde at the C-9 position. This, 
combined with the interesting result for the quinone synthesis above, could be used for 
the synthesis of the natural product cryptoquinone (145), an anti-fungal and cytotoxic 
diterpene,289 as well as similar abietane diterpenes such as royleanone (146) and 
horminone (147) which have reported biological activity.290-293 
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Scheme 4.21 – Abietane natural products cryptoquinone, royleanone and horminone 
 
Scheme 4.22 – Proposed 4-step synthesis of cryptoquinone (145) from polygodial (12). 
4.4 Towards a Reactant for Divergent Natural Product Synthesis from (–)-
Drimenol 
Inspired by Baran’s work, development of a reactant based on polygodial for the 
divergent synthesis of natural products was investigated. The synthesis of various 
electrophilic and nucleophilic reactants was attempted. Initial work focussed on the 
halogenation of (–)-drimenol (118), and the saturated drimanol derivatives 119 and 120. 
These can serve as electrophilic reactants in various coupling reactions, or be readily 
converted into a Grignard reagent through reaction with Mg metal to then subsequently 
react as a nucleophile with carbonyl or nitrile substrates. Following this, investigations 
towards development of a potassium alkyltrifluoroborate (R–BF3K) salt (153) from 
polygodial (12) via (–)-drimenol (118) were undertaken. R–BF3K salts are typically bench 
stable reagents which make excellent coupling partners for difficult alkyl transfers in 
Suzuki–Miyaura reactions.294,295 Finally, investigations into electrophilic reactants in the 
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form of aldehydes and nitriles were conducted, which may react with Grignard or aryl 
lithium reagents. Ultimately, facile synthesis of the aldehyde (155) and subsequent 
Grignard reactions to form 156 proved the best route towards various natural product 
targets. 
 
Scheme 4.25 – Proposed synthetic routes towards meroterpenoid natural products. 
4.4.1 Functionalisation of (–)-drimenol 
The reactivity of (–)-drimenol (118) towards forming these coupling partners was 
investigated. Whilst being a useful scaffold for synthesis as has been published 
previously,279 (–)-drimenol provided some unanticipated challenges in attempts to 
functionalise it that have not been reported in the literature.  
Halogenation of (–)-drimenol (118) for use as a coupling partner showed that the 
molecule is prone to elimination to form a conjugated diene derivative, drimendiene 
(157). In early tests, (–)-drimenol was halogenated with Br2 and PPh3, as well as N-
bromosuccinimide and PPh3. 1H NMR spectroscopic analysis of the crude material 
showed a nearly identical composition of products. The 2 major products were diene 157 
118 
151 152 
153 154 
155 156 
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formed through elimination, mentioned above, as well as the desired halogenation 
product 158. In both cases these were formed in an ~1:1 ratio, with other minor products 
evident in the 1H NMR spectra. Separation of these two products by column 
chromatography proved challenging due to their similar polarity, and only a portion of 
the compound was isolated to purity. The low yield, difficulty purifying, and sensitivity to 
elimination of the halide meant that transformation of this substrate was not pursued 
further. 
  
Scheme 4.26 – Bromination and elimination of (–)-drimenol. 
  
Figure 4.18 – 1H NMR spectrum of the crude mixture from bromination of (–)-drimenol. 
An Appel reaction was carried out, reacting (–)-drimenol with CCl4 and PPh3 to 
investigate the possibility of forming the corresponding chloride 159 without the 
elimination taking place. This reaction led to a similar result observed, with the 1H NMR 
spectrum of the crude material showing a 1:1.3 ratio of the diene to the chloride. The 
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chloride was isolated from the reaction in 41 % yield, which represents a greater yield 
than the bromination, but was still an inefficient synthesis. 
 
Scheme 4.27 – Appel reaction of (–)-drimenol. 
Following the facile formation of diene 157, investigations turned to exploring the 
elimination reaction. Despite the loss of a stereogenic centre from the elimination, it was 
thought that stereochemical control in subsequent reactions may still be achieved due to 
the fixed absolute stereochemistry of the drimane skeleton. The first attempt to 
synthesise the diene selectively was through acid-catalysed elimination. Unfortunately, 
treatment of (–)-drimenol with H2SO4 in THF resulted in a complicated mixture of 
products and no spectroscopic evidence of the methylene signals expected for the 
terminal alkene in the 1H NMR spectrum was observed. A subsequent attempt using PPh3 
and I2 in CH2Cl2 gave a clear colourless oil, which showed in the 1H NMR spectrum ~90% 
pure diene 157 product without purification. In this case, elimination is favoured over 
substitution as the I- is too large to act as an effective nucleophile in this reaction. This 
was a promising result, however, attempts to repeat and scale up this experiment 
resulted in formation of the product with much higher levels of undesired and 
inseparable by-products.  
 
Scheme 4.28 – Dehydration of (–)-drimenol. 
An analysis of the X-ray crystal structure of (–)-drimenol provides some evidence towards 
this by showing the steric bulk around the C-9 position. The reaction is also favoured by 
the formation of a conjugated diene system. The crystal structure for (–)-drimenol has 
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been reported previously and showed an unusual Z’ value of 3, i.e. 3 molecules in the 
asymmetric unit of the crystal lattice. The results obtained here are in agreement with 
those previously published.296 
 
Figure 4.19 – X-ray crystal structure of (–)-drimenol (118) showing steric influences 
around the hydroxymethyl substituent. 
A different leaving group was investigated to attempt to find a substrate that undergoes 
elimination without significant formation of by-products. (–)-Drimenol was mesylated 
through reaction with methanesulfonyl chloride. This reaction proceeded within minutes, 
with high conversion to compound 160. The mesylate was eliminated without the 
formation of by-products by the action of potassium t-butoxide in THF at 50 °C. In 
contrast, attempts to form the corresponding tosylate of (–)-drimenol (118) were 
unsuccessful. 
 
Scheme 4.29 – Two–step synthesis of drimendiene 157. 
With drimendiene 157 in hand, the synthesis of a borylated derivative was attempted, 
with the synthesis of a BF3K salt 153 in mind. Hydroboration of drimendiene was 
attempted with pinacolborane (165) following conditions published by Reichle and 
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Breit.297 However, this reaction gave a complicated mixture of products. A second 
reaction using conditions reported by Tsuji298 with B2pin2 (164) as the boron reagent was 
attempted, and in this case no reaction occurred. Hydroborations were also attempted 
with 9-BBN (166) at high and low temperature, with a complicated mixture of products 
evident in each case. 
 
Scheme 4.30 – Attempted borylation of drimendiene 
4.4.2 Functionalisation of drimanols 
Due to the problems with reactivity of drimenol forming a diene system, reactions with 
the fully saturated analogues were also attempted as model systems where the substrate 
was not quite so sensitive. Reaction of anti–drimanol 119 with PPh3 and Br2 resulted in 
full recovery of starting material, which is an unexpected result for a primary alcohol.  
 
 
Scheme 4.31 – Attempted bromination of drimanol 119. 
H
pinacol borane
(PPh3)2RhCOCl
CH2Cl2 
reflux
9-BBN
THF
0 °C or reflux
CuCl
NaOtBu
Xantphos
B2pin2
MeOH
Toluene
20 h 28 °C
O
BH
O
O
B
O
2
B
H
B2pin2
pinacol borane
9-BBN
H
Bpin
H
Bpin
H
BR2
X
X
X
H
OH
Br2
PPh3
CH2Cl2
no reaction
157 
161 
162 
163 
164 
165 
166 
Chapter 4: Polygodial as a Scaffold for Synthesis 
 152 
This suggests steric hindrance around the hydroxymethyl centre causing unexpectedly 
low reactivity. Further evidence for the low reactivity and steric influence of the molecule 
was observed upon the reaction of the saturated alcohols 119 and 120 with SOCl2 in 
CH2Cl2. These reactions were intended to form the chloro derivative of the alcohol, but 
these were not observed. Analysis of the reaction by 1H NMR spectroscopy showed that 
the reaction is complete almost as soon as the reagents are mixed at room temperature 
to form two products, which initially were difficult to identify. The 1H NMR spectra of the 
reaction mixture prior to purification showed a complex mixture of what appeared to be 
around 4 different products based on the number of resonances observed between 3.5 
and 5 ppm, the region where -CH2-OH signals are expected. These chemical shifts are 
higher than the expected shifts for -CH2-Cl suggesting a lack of chloride incorporation into 
the molecule. 
 
Figure 4.20 – 1H NMR spectrum of the crude reaction mixture of alcohol 120 with SOCl2. 
Purification of the mixture on silica gel gave 2 major fractions. One of these contained 
the starting material, which was not observed in the 1H NMR spectrum of the crude 
reaction mixture. This provided evidence that one of the compounds formed in the 
reaction was unstable to silica gel chromatography and converted back to the starting 
material. The other fraction initially appeared to be a mixture of products, as indicated by 
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a doubling of many of the signals observed in the 1H NMR spectrum. This was also clear 
in the 13C NMR spectrum which showed most signals either being in pairs, or overlapping 
causing the signal to be of a greater intensity. Fortuitously, the product readily formed 
crystals, and the structure of the compound was determined through X-ray 
crystallography.  
 
Figure 4.21 – 1H NMR spectrum of the isolated sulfur bridged dimer 168. 
 
Figure 4.22 – X-ray crystal structure of the sulfur bridged dimer 168. 
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Instead of halogenation occurring, the compound was undergoing dimerization through a 
S=O bridge. This occurs by a stepwise process, where intermediate 167 is formed through 
nucleophilic attack of the alcohol to the sulphur atom of thionyl chloride. For 
halogenation, the next step would be the nucleophilic attack of the resulting chloride 
anion, causing loss of the OSOCl- group to form the alkyl chloride. In this case, however, 
the subsequent reaction is a second nucleophilic substitution of the alcohol onto the 
sulphur, eliminating a second chloride anion and resulting in the dimerised product. This 
is likely occurring due to the steric hindrance of the drimane skeleton hindering the 
attack of the chloride anion. This provides further support for the lack of reactivity of this 
neo-pentyl carbon. 
 
Scheme 4.32 – Stepwise reaction to form the S=O bridged dimer 168. 
This suggested mechanism explains why the reaction is complete immediately upon 
addition of the alcohol to the SOCl2:CH2Cl2 mixture. As the alcohol is added, initially it will 
react with SOCl2 to form the intermediate. As subsequent alcohol is added, it can either 
react with SOCl2 or the already formed intermediate to form the dimer. Under these 
conditions, no reversibility of the intermediate formation is observed which would allow 
the reaction to proceed to full formation of the dimer. The yield could therefore be 
optimised if desired by the slow addition of thionyl chloride to a concentrated solution of 
the alcohol. This unexpected reactivity has been previously observed in the reaction of 
10-hydroxycamphor with thionyl chloride.299 
Other reactions were attempted to halogenate these compounds which were ultimately 
unsuccessful. anti-Drimanol (119) was mesylated and subsequently refluxed in acetone 
with NaI to attempt to install an iodine atom but ultimately only the mesylate was 
recovered. Reaction with PBr3 and PCl5 also yielded complicated mixtures of products. 
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Chlorination was eventually successful in good yield (72 %) through use of the Appel 
reaction, refluxing alcohol 119 in CCl4 with excess PPh3. The use of CCl4 is undesirable due 
to the significant toxicity of this solvent and the expense and difficulty of obtaining it. 
 
Scheme 4.33 – Halogenation of alcohol 119 through the Appel reaction. 
4.4.3 Nitrile Derivatives 
Nitrile substitution was attempted on saturated chloride 169 as well as unsaturated 
mesylate 160 to test if a stronger nucleophile could affect substitution at neopentyl 
carbon C-12. These reactions allow the extension of the carbon chain by 1 carbon atom, 
and attach a new functional group, which can undergo reaction with reagents such as 
Grignard reagents, organolithiums, and cuprates. Nitrile derivatives 170 and 171 were 
successfully formed through these reactions, in low yields (26 % and 17 %). Analysis of 
the 13C NMR spectra for these compounds showed the appearance of signals around 
120.6 (170) and 121.0 ppm (171), consistent with the formation of a nitrile derivative. In 
addition, the IR spectrum for 170 showed a characteristic signal at 2422 cm-1, consistent 
with the formation of a nitrile. 
 
Scheme 4.34 – Formation of nitrile derivatives 170 and 171. 
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The substitution of these reagents with -CN was slow and required elevated temperature, 
and resulted in the formation of some of the diene product in the case of drimenyl 
mesylate (160) which is consistent with results from previous reactions. These reactions 
proceeded in low yields, and were deemed inadequate for larger scale preparation 
without significant reaction optimisation. Subsequently, unsaturated nitrile derivative 
171 was reacted with BuLi in Et2O to give butyl ketone 172 which was supported by 1H 
and 13C NMR spectroscopic data of the crude reaction mixture. However, the compound 
was unstable to chromatographic purification. 
 
 
Scheme 4.35 – Proposed product of reaction of nitrile 171 with BuLi. 
4.4.4 Drimenal Reactivity 
Following on from the observed reaction of polygodial towards Grignard reagents, the 
corresponding aldehyde from (–)-drimenol (118), drimenal (155), was synthesised for 
testing with various Grignard reagents. This compound was readily synthesised in good 
yield (93 %) using Dess-Martin periodinane. This reaction proceeded efficiently at room 
temperature to furnish the aldehyde 155. This aldehyde was noted to be unstable in air 
at ambient temperature, and so was always made immediately prior to reaction or 
stored at –18 °C under N2.  
The instability of the aldehyde limited the scope of reactivity. Examples of this were the 
attempted Wadsworth–Emmons olefination with triethyl phosphonoacetate and Wittig 
reaction with ethyl (triphenylphosphoranylidene)acetate, which yielded no reaction at 
room temperature, and subsequent heating of the reactions led to the decomposition of 
the aldehyde. 
Drimenal (155) was reacted with an excess of benzylmagnesium chloride, which 
proceeded to furnish formate ester 174 in 36 % yield rather than the secondary alcohol, 
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which was not the expected product from Grignard addition to aldehyde 155. The 1H 
NMR spectrum of the isolated product showed a singlet at 8.02 ppm, and the 13C NMR 
spectrum showed an extra carbon resonance than expected at 160 ppm. Fortuitously, 
the product was observed to crystallise in the NMR sample tube, and subsequent analysis 
by single crystal X-ray diffraction showed that a formate ester had been formed, which 
was consistent with the aforementioned resonances in the NMR spectra. The NMR 
spectral data were consistent with the formation of a single diastereomer, and this 
crystal structure analysis allowed the determination of the absolute stereochemistry for 
the isomer formed. The source of formate is unknown, but may have been from an 
incorrectly labelled or contaminated reagent bottle used during workup, or have been 
the result of an unexpected reaction with CH2Cl2. 
 
Scheme 4.36 – Unexpected result from Grignard reaction, formation of formate ester 
174. 
 
Figure 4.23 – X-ray crystal structure of the formate ester 174 showing absolute 
stereochemical outcome of the Grignard reaction. 
A subsequent repeat of this reaction proceeded to give the expected product 178 in good 
yield (71 %), supporting that the formate arose from contamination (but was still useful 
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for determining the absolute stereochemistry). Drimenal (155) was then reacted with 
two further Grignard reagents (175 and 176) to confirm the reactivity with a variety of 
substrates. The reactions proceeded in good yields in each case to form 177 and 179 with 
high stereospecificity, therefore indicating control of facial addition to this substrate by 
the axial methyl group (C-15) which can be seen in the X-ray crystal structure of the 
product in Figure 4.23. This shows that the aldehyde 155 is a potentially useful 
intermediate for synthesis. 
  
Scheme 4.37 – Synthesis of drimenal 155 followed by Grignard reaction. 
The C-8 epimer of drimenal (180) was synthesised, and also showed reactivity towards 
Grignard reagents to form a single diastereomer. This reaction proceeded in a low yield 
(22 %) but conditions were not optimised. The stereochemistry of the resulting alcohol 
was not determined for this reaction. 
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Scheme 4.38 – 9-epidrimenal (180) synthesis and subsequent Grignard reaction with 
vinylMgBr to form 181. Note - the stereochemistry was not determined for this reaction 
product. 
4.4.5 Future Work from Grignard Reactions 
The reaction of drimenal with 2,5-dimethoxyphenylmagnesium bromide to form 177 is of 
particular significance as it forms a potential intermediate for the synthesis of some 
meroterpenoid natural products targets such as  (–)-isozonarol (108) and (–)-isozonarone 
(109). Deoxygenation of the benzylic alcohol, and subsequent ether deprotection would 
yield (–)-isozonarol (108), followed by oxidation to give (–)-isozonarone (109). Therefore, 
compound (108) has the potential to be synthesised from polygodial (12) in 5 steps. 
 
 
 
Scheme 4.39 – Natural product targets from the Grignard product 177, (–)-isozonarol 108 
and (–)-isozonarone 109. 
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4.4.6 Towards Mycoleptodiscin A 
The natural product mycoleptodiscin A (182) was discovered and reported in 2013.300 
Subsequently, a 25 step total synthesis with an overall yield of <1 % was published in 
2015.301 This natural product was the target for synthesis from a drimane coupling 
partner, with an indole derivative as the other half of the molecule in a divergent 
synthesis. The most promising drimane derivative was the aldehyde drimenal (155) as 
demonstrated through stereospecific reactions with various Grignard reagents. 
Aldehydes are able to be coupled directly to the 3-position of an indole, catalysed by 
various Lewis and Brønsted acids.302-304 These reactions can result in the indole adding 
twice to the aldehyde, however, it was anticipated that the bulk of the drimane based 
aldehyde, and control of the amounts of the reagents mono-addition would be favoured.  
 
Figure 4.24 – Mycoleptodiscin A 
 
 
Scheme 4.40 – Proposed synthesis of mycoleptodiscin A (182) from polygodial (12). 
Scheme 4.40 (above) shows the planned route towards 182, which involves initial 
addition of indole 183 to aldehyde 155, followed by intramolecular Heck coupling of the 
aryl halide to the alkene. Subsequent hydrogenation, deoxygenation, ether deprotection, 
and aerobic oxidation301 would form the natural product.  
Indole 183 was synthesised in 10.4 % yield over 6 steps, starting from 3,4-
dimethoxybenzaldehyde (184, veratraldehyde) via a modified literature procedure which 
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was used for a similar indole derivative.305 The bromination reaction of 184 proceeded 
smoothly, with a slight excess of Br2 in MeOH furnishing the product as a white fluffy 
solid, which did not require purification. The following step required the synthesis of 
methyl 2-azidoacetate (187) prior to the reaction. Methyl 2-azidoacetate (187) was 
formed quantitatively by reaction of excess sodium azide with methyl 2-bromoacetate 
(186) in a water:acetone mixture and did not require purification. Condensation of 
methyl 2-azidoacetate (187) with 6-bromoveratraldehyde (185) proceeded in good yield 
to give azido ester (188). Indole aldehyde 189 was synthesised directly from this 
substrate through reflux in xylene causing a cyclisation of the azide onto the aromatic 
ring, with elimination of N2. This reaction proceeded in moderate yield. The resulting 
indole 189 then underwent a series of transformations to remove the ester. Reduction to 
the alcohol with LiAlH4 furnished the alcohol 190 in excellent yield, but this compound 
was noted to be unstable and required careful handling. The subsequent Dess–Martin 
periodinane-mediated oxidation required the addition of a base to keep the pH high and 
avoid acid mediated degradation of the alcohol. This is a divergence from the literature 
method, which employed MnO2 for the oxidation.305 The reaction was carried out at 0 °C 
to limit thermal degradation, and proceeded in excellent yield to form aldehyde 191. The 
final step involved a rhodium catalysed decarbonylation reaction published by Meyer and 
Kruse.306 The precatalyst 192 was synthesised from RhCl3 following a literature 
method.307 Due to the anhydrous RhCl3 being used, the reaction required a much longer 
time than reported in combination with sonication to overcome the low solubility of the 
RhCl3, but this reaction did proceed to give the desired product. The subsequent 
decarbonylation reaction then required the in situ formation of the catalyst from 
RhCl(CO)(PPH3)2, with 1,3-bis(diphenylphosphino)propane (dppp), followed by addition 
of the aldehyde 191.306 Overnight reflux, and subsequent work-up and purification 
afforded indole 183 in moderate yield. 
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Scheme 4.41 – Synthesis of indole 183. 
With indole 183 in hand, attempts were made towards the coupling reaction between 
the aldehyde 155 and indole. Unfortunately, these reactions yielded complicated 
mixtures of products, presumably due to the instability and limited reactivity of the 
aldehyde. Due to time constraints within the project, the synthesis of mycoleptodiscin A 
(182) was not pursued further. 
4.4.7 Future Work Towards Mycoleptodiscin A 
Since this work was undertaken, two more efficient total syntheses have been 
reported.308,309 Chandrasikar and co-workers published a synthesis starting from (+)-
sclareolide in which they synthesised the product over merely 9 steps in a 19 % overall 
yield. This synthesis is scalable, providing opportunities for preparation of large 
quantities of the material, and efficient synthesis of analogues.308 
Dethe and co-workers reported a total synthesis using a biomimetic approach. This 
synthesis makes use of an isomer of (–)-drimenol (194) for the drimane portion of the 
molecule, which was synthesised in 7 steps and 47 % overall yield from the Wieland-
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Miescher ketone 193.309 This particular route is 13 steps, with a lower overall yield and is 
therefore not as efficient as Chandrasikar’s method. However, due to some of the 
intermediates, it provides potential opportunity for a formal synthesis of the material 
efficiently from polygodial (12). 
 
Scheme 4.42 – Drimane derivative 194 in Dethe’s total synthesis of mycoleptodiscin A. 
Instead of using 194 as the drimane source for this synthesis, it is hypothesised that a 
formal total synthesis of mycoleptodiscin A from (–)-drimenol (118) could be achieved, 
significantly shortening their method. From (–)-drimenol (118), common intermediate 
196 in their synthesis may be formed through coupling to an indole derivative to form 
197, and subsequent nitrogen protection. If this isomer reacts analogously in the 
subsequent cyclisation step to form 196, this would give a total synthesis of 
mycoleptodiscin A in 6 steps from (–)-drimenol (118). The primary difference between 
these two substrates is that 194 is an allylic alcohol, whereas 118 is not.  
 
Scheme 4.43 – Proposed synthesis of Mycoleptodiscin A (182) from (–)-drimenol (118). 
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4.5 Conclusion 
Through the investigation of the reactivity of polygodial and related derivatives, a 
number of natural products and novel non-natural derivatives were synthesised. These 
include the natural products (+)-euryfuran, drimendiol and (–)-drimenol, as well as non-
naturally occurring compounds such as a pyridazine derivative, Wittig adducts, as well as 
some larger polycyclic systems. 
Investigation of various (–)-drimenol derivatives through substitution to form halogen 
and nitrile derivatives, provided some unexpected difficulties in functionalisation due to 
the steric hindrance of the neopentyl carbon. However, oxidation to the aldehyde (155) 
provided a scaffold for the synthesis of natural products and derivatives.  
Investigation of the Grignard chemistry of drimenal (155) provided the most promising 
results towards the reliable and efficient coupling of the drimane skeleton to various aryl 
systems in the synthesis of meroterpenoid natural products. Efforts towards the 
synthesis of mycoleptodiscin A, combined with subsequent literature results have 
provided a potential synthesis of an interesting natural product in just 6 steps from (–)-
drimenol, supporting polygodial as a potentially important scaffold for synthesis. 
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Chapter 5: Experimental Details 
5.1 General Experimental Details 
Plant material was ground using a Sunbeam spice/coffee bean grinder. Pressurised hot 
water extraction (PHWE) was undertaken employing a Breville Espresso Machine Model 
800ES and using a Dionex ASE200 Accelerated Solvent Extractor.  
Unless otherwise specified, reactions were conducted with magnetic stirring in oven-
dried glassware under nitrogen.  
Automated gradient flash chromatography was carried out using a Reveleris® X2 Flash 
Chromatography System using silica gel cartridges. Flash column chromatography was 
performed using Merck flash grade silica (32-63 μm) according to the general method of 
Still et al.310 
NMR spectra were recorded on a Bruker NMR spectrometer operating at 400 or 600 MHz 
(1H) and 100 or 150 MHz (13C). Unless otherwise specified, 1H and 13C NMR spectra were 
referenced to the solvent signals. The following abbreviations were used to 
describe 1H, and 13C splitting patterns: s = singlet, bs = broad singlet, d = doublet, t = 
triplet, dd = doublet of doublets (etc.), q = quartet, quin = quintet, m = multiplet, complex 
m = complex multiplet where multiple signals overlap. 
IR spectra were recorded using a Shimadzu FTIR 8400s instrument on NaCl plates as thin 
films for all solid and liquid samples. 
Microwave irradiation experiments were carried out in a CEM Discover System 
microwave apparatus (model # 908010). 
Mass spectrometry and high-resolution mass spectrometry were performed on a Kratos 
Concept ISQ mass instrument using electron impact mass spectrometry or by 
electrospray ionization by direct infusion into an LTQ-Orbitrap XL mass spectrometer 
using a syringe pump. Accurate mass was measured by “peak matching” at 10000 
resolution against perfluorokerosene. Analyses were performed by The Central Science 
Laboratory at the University of Tasmania.  
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Optical Rotations were recorded using a Rudolph research analytical Autopol III 
automatic polarimeter. 
Merck silica gel 60 F254 aluminium backed sheets were used for analytical thin layer 
chromatography. TLC plates were visualised under a 254 nm UV lamp and or by 
treatment with a phosphomolybdic acid (37.5 g), ceric sulfate (7.5 g), sulfuric acid (37.5 
mL), water (720 mL) dip or a potassium permanganate dip (3 g KMnO4, 20 g K2CO3, 5 mL 
5 % aqueous NaOH, 300 mL water), followed by heating. 
Pyrethrin samples were analysed using a GC-MS/MS system consisting of a Varian 3800 
GC and Bruker 300-MS MS/MS instruments. An Agilent VF-5MS 30 m x 0.25 mm x 0.25 
µm capillary column was used with helium as the carrier gas at 1.2 ml/min.  Injection 
volume was 1 µl with split/splitless injector temperature maintained at 290 oC, transfer 
line at 280 oC and source temperature 220 oC.  Oven temperature began at 67 oC for 2.5 
min, then ramped to 130 oC at 40 oC/min, then to 150 oC at 12 oC/min, 250 oC at 5.5 
oC/min, 270 oC at 15 oC/min and finally to 305 oC at 40 oC/min, which was maintained for 
1.5min. Data was acquired in full scan mode utilising electron impact ionisation over the 
mass range (m/z) 50 to 500 and processed using Star software (Bruker Star MS 
Workstation Version 7.0, 2010).  
All solvents and reagents were either purchased at high purity suitable for immediate 
use, or when necessary purified by standard laboratory procedures. 
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5.2 Chapter 2 Experimental 
Polygodial and derivatives 
Tasmannia lanceolata leaf material was provided as a finely ground and dried sample by 
Diemen Pepper (http://www.diemenpepper.com). T. lanceolata containing higher 
polygodial content was provided as fresh leaf material from Essential Oils of Tasmania 
(http://www.eotasmania.com.au) and dried at 35 °C for 18 h prior to use.  
Polygodial – extraction of T. lanceolata leaf material from Diemen Pepper (15 g)  
 
Dried, ground T. lanceolata leaves (15 g) were mixed with sand (2 g), placed into the 
portafilter (sample compartment) of an espresso machine and extracted with 35% 
EtOH/H2O (200 mL of a hot solution). The extract was concentrated to a volume of ∼100 
mL under reduced pressure in order to remove EtOH (50 °C water bath temperature). 
The ensuing mixture was extracted with CH2Cl2 (3 × 50 mL). The organic fractions were 
then combined, dried (MgSO4), filtered, and the solvent removed under reduced 
pressure to provide a viscous, green oil (602 mg). Purification via automated gradient 
flash chromatography (silica; 0 → 25% EtOAc/hexane) provided the title compound as an 
off-white solid (130 mg, 0.8% yield w/w). The spectroscopic data obtained was consistent 
with data reported in the literature.240  
1H NMR (400 MHz, CDCl3): δ  9.53 (d, J = 4.4 Hz, 1H), 9.46 (s, 1H), 7.12 (m, 1H), 
2.83 (m, 1H), 2.51 (m, 1H), 2.31 (m, 1H), 1.84 (m, 
1H), 1.59–1.45 (complex m, 3H), 1.38 (td, J = 12.9, 
4.5 Hz, 1H), 1.30–1.19 (complex m, 2H), 0.96 (s, 3H), 
0.94 (s, 3H), 0.92 (s, 3H).  
13C NMR (100 MHz, CDCl3): δ  202.1, 193.4, 154.4, 138.5, 60.5, 49.2, 41.9, 39.8, 
37.1, 33.31, 33.30, 25.4, 22.1, 18.2, 15.5.  
H
O H
O
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Polygodial – extraction of T. lanceolata leaf material from Diemen Pepper (180 g)  
 
Dried, ground T. lanceolata leaves (15 g) were mixed with sand (2 g), placed into the 
portafilter of an espresso machine and extracted with 35% EtOH/H2O (200 mL of a hot 
solution). This was repeated with a further 11 samples of T. lanceolata (15 g). The 
extracts were combined and concentrated to a volume of ∼1.2 L under reduced pressure 
in order to remove EtOH (50 °C water bath temperature). The ensuing mixture was then 
divided into portions of equal volume (2 × ∼600 mL) and each portion was then extracted 
with CH2Cl2 (4 × 100 mL). The organic fractions were then combined, dried (MgSO4), 
filtered, and the solvent removed under reduced pressure to provide a viscous, green oil 
(6.50 g). Purification via automated gradient flash chromatography (silica; 0 → 25% 
EtOAc/hexane) provided the title compound as an off-white solid (1.24 g, 0.7% yield 
w/w)  
Polygodial – extraction of T. lanceolata leaf material from Essential Oils of Tasmania (30 g)  
 
Dried T. lanceolata leaves (15 g) were finely ground using a coffee bean grinder. This 
material was mixed with sand (2 g), placed into the portafilter of an espresso machine 
and extracted with 35% EtOH/H2O (250 mL of a hot solution). This was repeated with 
another sample of T. lanceolata (15 g). The extracts were combined and concentrated to 
a volume of ∼250 mL under reduced pressure in order to remove EtOH (50 °C water bath 
temperature). The ensuing mixture was extracted with CH2Cl2 (5 × 50 mL). The organic 
fractions were then combined, dried (MgSO4), filtered, and the solvent removed under 
reduced pressure to provide a viscous green oil (1.84 g). Purification via automated 
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gradient flash chromatography (silica; 0 → 25% EtOAc/hexane) provided the title 
compound as an off-white solid (1.00 g, 3.3% yield w/w).  
Polygodial (chromatography-free isolation) 
 
Dried, ground Tasmannia lanceolata leaves (15 g) were mixed with sand (2 g) placed into 
the portafilter (sample compartment) of an espresso machine and extracted with 35% 
EtOH/H2O (200 mL of a hot solution). This was repeated with a further eight samples of T. 
lanceolata to yield 1.80 L of combined extract. This green mixture was extracted with 
heptane (4 x 200 mL), and the combined organic fractions dried over MgSO4, filtered and 
evaporated to dryness to yield a crude green oil (4.6 g). Hexane (30 mL) was added to 
dissolve the extract, which was cooled to 0 °C and seed crystals of polygodial were 
added. The mixture was allowed to crystallise before being filtered and washed with ice-
cold hexane to yield a pale yellow fluffy solid (1.4 g). The filtrate was evaporated to 
dryness and the crystallisation process repeated to yield further polygodial (1.0 g). 
Combined yield: 2.4 g, 1.8% w/w (note: the mother liquor contains more polygodial 
which can be purified by chromatography).  
Drimendiol 
 
Extraction of T. lanceolata leaf material from Diemen Pepper (15 g) was performed as 
described above to yield 661 mg of the crude extract containing polygodial (12). A 
mixture of this residue in THF (10 mL) was slowly added to a suspension of LiAlH4 (200 
mg) in THF (10 mL) maintained at 0 °C. The reaction mixture was then warmed to r.t. and, 
after 1 h, THF and EtOH were added (5 mL of a 1:1 solution). The insoluble salts were 
H
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dissolved by the addition of KHSO4 (80 mL, 2 M aq.). The ensuing mixture was then 
extracted with CH2Cl2 (3 × 50 mL), dried (MgSO4), filtered, and evaporated to dryness 
under reduced pressure to provide a dark red oil (632 mg). Purification via flash 
chromatography (silica; 40 → 50% EtOAc/hexane) provided the title compound as a light-
yellow oil (129 mg, 0.8% yield w/w). The spectroscopic data obtained was consistent with 
data reported in the literature.-240 
1H NMR (400 MHz, CDCl3): δ  5.75 (m, 1H), 4.30 (d, J = 12.3 Hz, 1H), 3.92 (d, J = 
12.3 Hz, 1H), 3.85 (dd, J = 10.9, 1.8 Hz, 1H), 3.61 (dd, 
J = 10.7, 8.31 Hz, 1H), 2.14–1.79 (complex m, 5H), 
1.57–1.35 (complex m, 4H), 1.27–1.06 (complex m, 
4H), 0.85 (s, 3H), 0.84 (s, 3H), 0.72 (s, 3H).  
13C NMR (100 MHz, CDCl3): δ  137.0, 127.1, 67.3, 61.2, 54.5, 49.5, 42.1, 39.4, 35.6, 
33.3, 33.0, 23.6, 22.0, 18.9, 14.6.  
Maceration of T. lanceolata leaf material from Diemen Pepper  
Dried, ground T. lanceolata leaves (15 g) were added to 35% EtOH/H2O (200 mL) and the 
ensuing mixture heated at reflux for 1 h. The mixture was then cooled to r.t. then filtered 
through Celite™. The resulting green mixture was then extracted with CH2Cl2 (2 × 100 
mL). The organic fractions were combined, dried (MgSO4), filtered, and the solvent 
removed under reduced pressure to provide a viscous, dark green oil (180 mg).  
Maceration of T. lanceolata leaf material from Diemen Pepper  
Dried, finely ground T. lanceolata leaves (15 g) were stirred in 35% EtOH/H2O (200 mL) 
for 24 h. The mixture was then filtered through Celite™ and the ensuing green mixture 
was then extracted with CH2Cl2 (2 × 100 mL). The organic fractions were combined, dried 
(MgSO4), filtered, and the solvent removed under reduced pressure to provide a viscous, 
dark green oil (210 mg).  
Maceration of T. lanceolata leaf material from Diemen Pepper 
Dried, finely ground T. lanceolata leaves (15 g) were stirred in CH2Cl2 (200 mL) for 24 h. 
The mixture was then filtered through Celite™ and the filtrate was then concentrated 
under reduced pressure to provide a viscous, dark green residue (1.10 g). Purification via 
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automated gradient flash chromatography (silica; 0 → 25% EtOAc/hexane) provided the 
title compound as a dark green oil (164 mg, 1.1% yield w/w).  
Dionex ASE200 extraction experiments performed at 500 psi 
Dried, ground T. lanceolata leaves (∼7 g. Diemen Pepper sample) and Celite™ (∼3 g) were 
packed into a Dionex ASE200 extraction cell (22 mL). Experiments were performed using 
15, 25, and 35% EtOH/H2O extraction solutions at 70, 90, and 110 °C, respectively. The 
following instrument-specific parameters were kept constant across all experiments: - 
Pressure 500 psi - Preheat time: 0 min - Heat time: 5 min - Static time: 5 min - Flush: 60% 
- Cycles: 2 - Purge: 90 s - Total extraction time: ∼20–25 min - Overall extraction volume: 
∼35–40 mL  
Dionex ASE200 extraction experiments performed at 1500 psi  
Dried, ground T. lanceolata leaves (∼7 g. Diemen Pepper sample) and Celite™ (∼3 g) were 
packed into a Dionex ASE200 extraction cell (22 mL). Experiments were performed using 
15, 25, and 35% EtOH/H2O extraction solutions at 70, 90, 110, and 150 °C. The following 
instrument-specific parameters were kept constant across all extractions: - Pressure 1500 
psi - Preheat time: 0 min - Heat time: 5 min (7 min for 150 °C run) - Static time: 5 min - 
Flush: 60% - Cycles: 2 - Purge: 90 s - Total extraction time: ∼20–25 min - Overall 
extraction volume: ∼35–40 mL  
Representative work-up procedure for each extract obtained from each Dionex ASE200 
extraction experiment  
The extract was concentrated to a volume of ∼20 mL under reduced pressure to in order 
to remove EtOH (40 °C water bath temperature). The ensuing mixture was extracted with 
CH2Cl2 (3 × 20 mL) and the organic fractions were combined, dried (MgSO4) and filtered. 
1,3,5-Trimethoxybenzene (internal standard, 10.0 mL of a 1.20 M solution in EtOH) was 
added and the solvent removed under reduced pressure to provide a green residue. The 
1H NMR spectrum (CDCl3) of the extract thus obtained enabled the yield of polygodial to 
be determined. The ratio of polygodial (12) to 9-epipolygodial (80) was estimated by 
integration of the two aldehyde signals (9.53 & 9.45 ppm, and 9.84 & 9.40 ppm) 
respectively relative to the singlet (6.08 ppm) corresponding to 1,3,5-trimethoxybenzene. 
 
Chapter 5: Experimental Details 
 172 
Shikimic acid and derivatives 
Shikimic acid  
 
Dried Chinese star anise (Illicium verum) pods (20 g) were finely ground using a coffee 
bean grinder. This material was mixed with sand (2 g), placed into the portafilter (sample 
compartment) of an espresso machine and extracted using 30% EtOH/H2O (200 mL of a 
hot solution). This was repeated with another sample of star anise (20 g). The extracts 
were combined and silica gel (20 g) was added. The ensuing suspension was evaporated 
to dryness under reduced pressure (50 °C water bath temperature). The ensuing brown 
solid was then loaded onto a sintered glass funnel and washed with CH2Cl2 (150 mL) then 
EtOAc (150 mL) in order to remove anethole and p-anisaldehyde. These washings were 
discarded. The resulting solid was then extracted with 10% AcOH/EtOAc (250 mL) and the 
filtrate was evaporated to dryness. The ensuing solid was then washed with CH2Cl2 and 
then dried under reduced pressure to provide the title compound as an off-white solid 
(2.21 g, 5.50% yield w/w). The spectroscopic data obtained was consistent with data 
reported in the literature.311 
1H NMR (400 MHz, D2O): δ  6.81 (m, 1H), 4.47 (m, 1H), 4.05 (m, 1H), 3.80 (dd, J = 8.2, 
4.2 Hz, 1H), 2.77 (ddt, J = 18.1, 5.2, 1.4 Hz, 1H), 2.24 (ddt, J 
= 18.2, 6.5, 1.8 Hz, 1H).  
13C NMR (100 MHz, D2O): δ  171.1, 136.8, 130.8, 71.5, 66.9, 66.1, 30.9.  
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Methyl 3,4-O-isopropylideneshikimate  
 
Dried Chinese star anise (Illicium verum) pods (15 g) were finely ground using a coffee 
bean grinder. This material was mixed with sand (2 g), placed into the portafilter of an 
espresso machine and extracted using 30% EtOH/H2O (200 mL of a hot solution). This 
was repeated with a further 5 samples of star anise (15 g). The extracts were combined 
and were reduced to 800 mL under reduced pressure (to remove EtOH). The ensuing 
aqueous phase was washed with CH2Cl2 (4 x 80 mL) and the organic phases were 
discarded. The aqueous layer was then evaporated to dryness under reduced pressure 
(50 °C water bath temperature) to yield a red/brown sticky solid. MeOH (300 mL) was 
added to the ensuing residue and then SOCl2 (5 mL) was added dropwise. The mixture 
was heated at reflux for 1.5 h, cooled and then the solvent was a removed under reduced 
pressure. Acetone (100 mL), 2,2-dimethoxypropane (80 mL), and Amberlyst® 15 acidic 
ion exchange resin (0.8 g) were added to ensuing dark red/black oil. After 3 h at r.t., the 
mixture was filtered and evaporated to dryness to provide a dark red/black residue which 
was then dissolved in CH2Cl2 (100 mL) and loaded onto a silica plug (4.5 inch diameter, 
1.5 inch depth). 7 fractions were collected: (20 % EtOAc:hexanes (5 x 100 mL), EtOAc (1 x 
250 mL, 1 x 100 mL). The title compound was present in the final 2 fractions. After the 
solvent was removed under reduced pressure, purification via automated gradient flash 
chromatography (silica; 0  70% EtOAc/hexane) provided the title compound as a red oil 
(4.76 g, equivalent to 4.0 % yield of shikimic acid w/w). The spectroscopic data obtained 
was consistent with data reported in the literature.312 
1H NMR (400 MHz, CDCl3): δ  6.91 (m, 1H), 4.74 (m, 1H), 4.08 (m, 1H), 3.89 (m, 
1H), 3.76 (s, 3H), 2.78 (dd, J = 17.46, 4.7 Hz, 1H), 
2.22 (ddt, J = 17.4, 8.4, 1.8 Hz, 1H), 2.20 (br s, 1H, 
OH), 1.44 (s, 3H), 1.39 (s, 3H).  
O O
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13C NMR (100 MHz, CDCl3): δ  166.8, 134.2, 130.9, 110.0, 78.2, 72.5, 69.1, 52.4, 
29.6, 28.2, 26.0. 
Ethyl 3,4-O-(3-pentylidene)shikimate 
 
Dried Chinese star anise (Illicium verum) pods (20 g) were finely ground using a coffee 
bean grinder. This material was mixed with sand (2 g), placed into the portafilter of an 
espresso machine and extracted using 30% EtOH/H2O (200 mL of a hot solution). This 
was repeated with a further 9 samples of star anise (20 g). The extracts were combined 
and were reduced to 800 mL under reduced pressure (to remove EtOH). The ensuing 
aqueous phase was washed with CH2Cl2 (4 x 100 mL) and the organic phases were 
discarded. The aqueous layer was then evaporated to dryness under reduced pressure 
(50 °C water bath temperature) to yield a red/brown sticky solid. EtOH (300 mL) was 
added to the ensuing residue and then SOCl2 (10 mL) was added dropwise. The mixture 
was heated at reflux for 1.5 h, cooled and then the solvent was a removed under reduced 
pressure. 3-Pentanone (200 mL), and Amberlyst® 15 acidic ion exchange resin (1.6 g) 
were added to ensuing dark red/black oil. After 2.5 h at r.t., the mixture was evaporated 
to dryness to provide a dark red/black residue which was then dissolved in CH2Cl2 (100 
mL) and loaded onto a silica plug (4.5 inch diameter, 2 inch depth). 7 fractions were 
collected: (30% EtOAc/hexanes (2 x 150 mL), 50% EtOAc/hexanes (2 x 200 mL), EtOAc (1 x 
100 mL). Evaporation of fractions 2–4 provided the title compound as a yellow oil (13.15 
g, equivalent to 4.2 % yield of shikimic acid w/w). The spectroscopic data obtained was 
consistent with data reported in the literature.313 
1H NMR (400 MHz, CDCl3): δ  6.93 (m, 1H), 4.75 (m, 1H), 4.21 (q, J = 7.1 Hz, 2H), 
4.11 (m, 1H), 3.91 (m, 1H), 2.77 (dd, J = 17.3, 4.6 Hz, 
1H), 2.25 (ddt, J = 17.3, 8.2, 1.9 Hz, 1H), 1.67 (q, J = 
O O
OHO
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7.5 Hz 4H), 1.65 (q, J = 7.5 Hz, 2H), 1.29 (t, J = 7.1 Hz, 
3H), 0.92 (t, J = 7.5 Hz, 3H), 0.88 (t, J = 7.5 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ  166.4, 134.3, 130.6, 113.9, 78.1, 72.5, 69.2, 61.3, 
29.9, 29.5, 29.3, 14.4, 8.7, 8.1.  
Methyl shikimate 
 
Dried Chinese star anise (Illicium verum) pods (20 g) were finely ground using a coffee 
bean grinder. This material was mixed with sand (2 g), placed into the portafilter of an 
espresso machine and extracted using 30% EtOH/H2O (200 mL of a hot solution). This 
was repeated with another sample of star anise (20 g). The extracts were combined and 
were reduced to 200 mL under reduced pressure (to remove EtOH). The ensuing aqueous 
phase was washed with CH2Cl2 (3 x 80 mL) and the organic phases were discarded. The 
aqueous layer was then evaporated to dryness under reduced pressure (50 °C water bath 
temperature) to yield a red/brown sticky solid. MeOH (100 mL) was added to the ensuing 
residue and then SOCl2 (3 mL) was added dropwise. The mixture was heated at reflux for 
1.5 h, cooled and then the solvent was a removed under reduced pressure. The resulting 
dark red/black oil was dissolved in 30% MeOH/EtOAc, filtered through a silica plug 
eluting with 30% MeOH/EtOAc (300 mL) and the solvent removed under reduced 
pressure. Purification via automated gradient flash chromatography (silica; 0  20% 
MeOH/EtOAc) provided the title compound as a light-pink solid (2.03 g, equivalent to 4.7 
% yield of shikimic acid w/w). The spectroscopic data obtained was consistent with data 
reported in the literature.80  
1H NMR (400 MHz, D2O): δ  6.72 (m, 1H), 4.35 (m, 1H), 3.93 (m, 1H), 3.68 (m, 
1H), 3.66 (s, 3H), 2.65 (dd, J = 18.2, 5.0 Hz, 1H), 2.14 
(dd, J = 18.3, 6.3 Hz, 1H).  
13C NMR (100 MHz, DMSO-d6): δ  166.7, 139.8, 127.3, 70.0, 66.8, 65.4, 51.5, 29.6.  
O O
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Ethyl shikimate 
 
Dried Chinese star anise (Illicium verum) pods (20 g) were finely ground using a coffee 
bean grinder. This material was mixed with sand (2 g), placed into the portafilter of an 
espresso machine and extracted using 30% EtOH/H2O (200 mL of a hot solution). This 
was repeated with another sample of star anise (20 g). The extracts were combined and 
were reduced to 200 mL under reduced pressure (to remove EtOH). The ensuing aqueous 
phase was washed with CH2Cl2 (3 x 80 mL) and the organic phases were discarded. The 
aqueous layer was then evaporated to dryness under reduced pressure (50 °C water bath 
temperature) to yield a red/brown sticky solid. EtOH (100 mL) was added to the ensuing 
residue and then SOCl2 (3 mL) was added dropwise. The mixture was heated at reflux for 
1.5 h, cooled and then the solvent was a removed under reduced pressure. The resulting 
dark red/black oil was dissolved in 30% MeOH/EtOAc, filtered through a silica plug 
eluting with 30% MeOH/EtOAc (300 mL) and the solvent removed under reduced 
pressure. Purification via automated gradient flash chromatography (silica; 0  10% 
MeOH/EtOAc) provided the title compound as a light-brown solid (2.49 g, equivalent to 
5.4 % yield of shikimic acid w/w). The spectroscopic data obtained was consistent with 
data reported in the literature.81 
1H NMR (400 MHz, DMSO-d6): δ  6.62 (m, 1H), 4.82 (m, 2H, OH), 4.61 (d, J = 4.3 Hz, 
1H, OH), 4.23 (m, 1H), 4.12 (q, J = 7.1 Hz, 2H), 3.86 
(m, 1H), 3.57 (m, 1H), 2.43 (m, 1H), 2.05 (m, 1H), 
1.22 (t, J = 7.1 Hz, 3H).  
13C NMR (100 MHz, DMSO-d6): δ 166.7, 140.0, 128.1, 70.5, 67.3, 65.9, 60.5, 30.1, 
14.6.  
 
 
O O
HO
OH
OH
24 
Chapter 5: Experimental Details 
 177 
Methyl 3,4-O-benzylideneshikimate (mixture of diastereomers) 
Dried Chinese star anise (Illicium verum) pods (20 g) were finely ground using a coffee 
bean grinder. This material was mixed with sand (2 g), placed into the portafilter of an 
espresso machine and extracted using 30% EtOH/H2O (200 mL of a hot solution). This 
was repeated with another sample of star anise (20 g). The extracts were combined and 
were reduced to 200 mL under reduced pressure (to remove EtOH). The ensuing aqueous 
phase was washed with CH2Cl2 (3 x 80 mL) and the organic phases were discarded. The 
aqueous layer was then evaporated to dryness under reduced pressure (50 °C water bath 
temperature) to yield a red/brown sticky solid. MeOH (100 mL) was added to the ensuing 
residue and then SOCl2 (3 mL) was added dropwise. The mixture was heated at reflux for 
1.5 h, cooled and then the solvent was a removed under reduced pressure. THF (100 mL), 
benzaldehyde (3 mL), and Amberlyst® 15 acidic ion exchange resin (1.6 g) were added to 
ensuing black oil. After 2 h at r.t., the mixture was evaporated to dryness to provide a 
black residue which was then and loaded onto a silica plug (4.5 inch diameter, 1.5 inch 
depth). 4 fractions were collected: 50% EtOAc/hexanes (3 x 150 mL), 70 % 
EtOAc/hexanes (1 x 150 mL). The title compound was present in fractions 2–4. After the 
solvent was removed under reduced pressure, purification via automated gradient flash 
chromatography (silica; 0  100% EtOAc/hexane) provided the title compound as a 
mixture of diastereomers as a yellow oil (2.34 g, equivalent to 3.5 % yield of shikimic acid 
w/w). These diastereomers were partially separable by chromatography. The 
spectroscopic data obtained was consistent with data reported in the literature.314 
(S)-Methyl 3,4-O-benzylideneshikimate  
 
1H NMR (400 MHz, CDCl3): δ  7.45 (m, 2H), 7.38 (m, 3H), 6.93 (m, 1H), 5.97 (s, 1H), 
4.87 (m, 1H), 4.34 (m, 1H), 4.14 (m, 1H), 3.79 (s, 3H), 
2.84 (dd, J = 17.3, 4.5 Hz, 1H), 2.34 (ddt, J = 17.5, 
7.2, 1.8 Hz, 1H).  
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13C NMR (100 MHz, CDCl3): δ  166.7, 137.9, 133.7, 131.3, 129.5, 128.6, 126.5, 
102.9, 78.1, 72.7, 67.3, 52.4, 29.1. 
(R)-Methyl 3,4-O-benzylideneshikimate  
 
1H NMR (400 MHz, CDCl3): δ  7.43 (m, 2H), 7.37 (m, 3H), 7.00 (m, 1H), 5.94 (s, 1H), 
4.80 (m, 1H), 4.18 (m, 1H), 3.93 (m, 1H), 3.78 (s, 3H), 
2.83 (dd, J = 17.4, 4.8 Hz, 1H), 2.27 (ddt, J = 17.5, 
9.0, 1.9 Hz, 1H). 
13C NMR (100 MHz, CDCl3): δ  166.6, 136.6, 133.0, 131.7, 129.9, 128.7, 127.0, 
104.6, 78.8, 74.2, 69.3, 52.4, 29.7. 
Correa spp. 
Correa reflexa extraction 
Correa reflexa leaves were dried in an oven overnight at 40 °C. Finely ground leaves (10 
g) were mixed with sand (2 g), placed in to the portafilter (sample compartment) of an 
espresso machine and extracted with 35% EtOH/H2O (200 mL of a hot solution). This was 
repeated with a further 9 samples of C. reflexa (10 g). The extracts were combined and 
concentrated to a volume of ~1 L under reduced pressure in order to remove EtOH (50 °C 
water bath temperature). The ensuing mixture was extracted with EtOAc (1 x 200 mL, 5 x 
100 mL), the extracts combined, dried (MgSO4), filtered, and the solvent removed to yield 
a green oil (3.9 g). Purification via automated gradient flash chromatography (silica; 0  
100% EtOAc/hexane) provided seselin (29) as an off-white solid (1.00 g, 1.00% yield w/w) 
and (+)-epoxysuberosin (30) as an off–white solid (1.15 g, 1.15% yield w/w).  
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Correa alba extraction 
Correa alba leaves were dried in an oven overnight at 40 °C. Finely ground leaves (10 g) 
were mixed with sand (2 g), placed in to the portafilter (sample compartment) of an 
espresso machine and extracted with 35% EtOH/H2O (200 mL of a hot solution). This was 
repeated with a further 2 samples of C. alba (10 g). The extracts were combined and 
concentrated to a volume of ~300 mL under reduced pressure in order to remove EtOH 
(55 °C water bath temperature). The ensuing mixture was extracted with EtOAc (3 x 100 
mL), the extracts combined, dried (MgSO4), filtered, and the solvent removed to yield a 
green oil (0.8 g). Purification via automated gradient flash chromatography (silica; 0  
15% EtOAc/CH2Cl2) provided alosin (31) as a white solid (268 mg, 0.89% yield w/w), and 
(–)-meranzin (32) as an off-white solid (94 mg, 0.31% yield w/w).  
Correa backhouseana extraction 
Correa backhouseana leaves were dried in an oven overnight at 40 °C. Finely ground 
leaves (10 g) were mixed with sand (2 g), placed in to the portafilter (sample 
compartment) of an espresso machine and extracted with 35% EtOH/H2O (200 mL of a 
hot solution). This was repeated with a further 9 samples of C. backhouseana (10 g). The 
extracts were combined and concentrated to a volume of ~1 L under reduced pressure in 
order to remove EtOH (55 °C water bath temperature). The ensuing mixture was 
extracted with EtOAc (4 x 100 mL), the extracts combined, dried (MgSO4), filtered, and 
the solvent removed to yield a green oil (1.1 g). Purification via automated gradient flash 
chromatography (silica; 0  15% EtOAc/CH2Cl2) provided alosin (31) as a white solid (65 
mg, 0.065% yield w/w) and meranzin (32) as an off–white solid (50 mg, 0.050% yield 
w/w). The heraclenin fractions contained impurities, further purification via automated 
gradient flash chromatography (silica; 0  8 % EtOAc/CH2Cl2) provided heraclenin (33) as 
a pale yellow oil (41 mg, 0.041% yield w/w). 
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Seselin  
The spectroscopic data obtained was consistent with data reported in the literature.140 
 
1H NMR (600 MHz, CDCl3): δ  7.59 (d, J = 9.5 Hz, 1H), 7.20 (d, J = 8.5 Hz, 1H), 6.87 
(dd, J = 10.1, 0.6 Hz, 1H), 6.71 (dd, J = 8.5 and 0.6 Hz, 
1H), 6.21 (d, J = 9.5 Hz, 1H), 5.72 (d, J = 10.1 Hz, 1H), 
1.47 (s, 6H). 
13C NMR (150 MHz, CDCl3): δ  161.0, 156.5, 150.3, 144.0, 130.9, 127.9, 115.1, 
113.7, 112.75, 112.73, 109.4, 77.8, 28.3.  
(+)-Epoxysuberosin 
The spectroscopic data obtained was consistent with data reported in the literature. 
315,316 
 
1H NMR (600 MHz, CDCl3): δ  7.62 (d, J = 9.4 Hz, 1H), 7.30 (s, 1H), 6.80 (s, 1H), 6.24 
(d, J = 9.4 Hz, 1H), 3.90 (s, 3H), 2.99 (m, 2H), 2.74 (m, 
1H), 1.39 (s, 3H), 1.33 (s, 3H).  
13C NMR (150 MHz, CDCl3): δ  161.4, 160.8, 155.1, 143.6, 128.6, 124.3, 113.3, 
112.2, 98.9, 63.4, 59.0, 56.1, 29.3, 24.9, 19.1.  
[α]D28      +19 (c 2.6, CHCl3), lit. [α]D +34 (c 0.07, CHCl3)316  
 
 
 
O OO
O
O OO
29 
30 
Chapter 5: Experimental Details 
 181 
Alosin 
The spectroscopic data obtained was consistent with data reported in the literature.317 
 
1H NMR (600 MHz, CDCl3): δ  7.61 (d, J = 9.5 Hz, 1H), 7.41 (d, J = 8.6 Hz, 1H), 6.87 
(d, J = 8.6 Hz, 1H), 6.26 (d, J = 9.5 Hz, 1H), 5.29 (m, 
1H), 5.07 (m, 1H), 3.98 (d, J = 2.4 Hz, 1H), 3.96 (s, 
3H), 3.91 (d, J = 2.4 Hz, 1H), 1.87 (m, 3H). 
13C NMR (150 MHz, CDCl3): δ  162.1, 160.4, 154.1, 143.5, 141.5, 129.1, 113.63, 
113.61, 113.0, 112.8, 107.7, 60.8, 56.5, 51.9, 17.6.  
[α]D28      13 (c 1.27, CHCl3)* 
 (–)-Meranzin 
The spectroscopic data obtained was consistent with data reported in the literature.318 
 
1H NMR (600 MHz, CDCl3): δ  7.63 (d, J = 9.5 Hz, 1H), 7.35 (d, J = 8.6 Hz, 1H), 6.86 
(d, J = 8.6 Hz, 1H), 6.24 (d, J = 9.5 Hz, 1H), 3.93 (s, 
3H), 3.20 (m, 1H), 3.11 (m, 2H), 1.49 (s, 3H), 1.28 (s, 
3H). 
13C NMR (150 MHz, CDCl3): δ  161.1, 160.9, 153.6, 143.8, 127.3, 114.4, 113.3, 
113.1, 107.5, 63.1, 59.4, 56.3, 24.9, 22.6, 19.3.  
[α]D28      +43 (c 2.4, CHCl3), lit. [α]D −46 (c 0.063, CHCl3)318 
                                                          
* See Deans et al. (2017) for discussion of optical rotations for coumarins from Correa spp.46 
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Heraclenin  
The spectroscopic data obtained was consistent with data reported in the literature.157 
 
1H NMR (600 MHz, CDCl3): δ  7.77 (d, J = 9.6 Hz, 1H), 7.69 (d, J = 2.0 Hz, 1H), 7.40 
(s, 1H), 6.82 (d, J = 2.0 Hz, 1H), 6.37 (d, J = 9.6 Hz, 
1H), 4.58 (m, 2H), 3.32 (t, J = 5.6 Hz, 1H), 1.34 (s, 
3H), 1.28 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ  160.4, 148.5, 147.0, 144.4, 143.8, 131.6, 126.1, 
116.7, 115.0, 114.0, 107.0, 72.6, 61.5, 58.3, 24.7, 
19.0.  
[α]D28      +1.8 (c 1.3, CHCl3), –6.5 (c 1.3, C5H5N)*
                                                          
* See Deans et al. (2017) for discussion of optical rotations for coumarins from Correa spp.46 
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5.3 Chapter 3 Experimental 
Crofton weed (Eupatorium adenophorum) extraction – first extraction 
Dried, ground E. adenophorum leaves (10 g) were mixed with sand (5 g) placed into the 
portafilter (sample compartment) of an espresso machine and extracted with 35% 
EtOH/H2O (200mL of a hot solution). This process was repeated with a further 2 x 10 g of 
leaf material. This green mixture was evaporated to ~half volume at 50 °C under reduced 
pressure before being extracted with heptane (3 x 100 mL), and the combined organic 
fractions dried over MgSO4, filtered and evaporated to dryness to yield a crude pale 
green oil (506 mg). Purification via multiple automated gradient flash column 
chromatography runs yielded the compounds described in Chapter 3. The residual 
aqueous fraction was then extracted with EtOAc (2 x 50 mL), dried over MgSO4, filtered 
and evaporated to dryness to yield a crude dark green flaky solid (751 mg). Purification 
via automated gradient flash column chromatography (silica; 0  60 % EtOAc/hexane) in 
normal phase provided compounds 56 and 57 as a mixture (120 mg, 0.40 % yield w/w). 
Further purification of a small portion via automated gradient flash column 
chromatography in reversed-phase (C18 silica; 0  30% water:CH3CN) yielded the 
compounds isolated for characterisation. 
Crofton weed (Eupatorium adenophorum) extraction – second extraction 
Dried, ground E. adenophorum leaves (10.0 g) were mixed with sand (5 g) placed into the 
portafilter (sample compartment) of an espresso machine and extracted with 35% 
EtOH/H2O (200mL of a hot solution). This process was repeated with a further 2 x 10.0 g 
and 1 x 7.5 g of leaf material. This combined green mixture (800 mL) was evaporated to 
~half volume at 50 °C under reduced pressure before being extracted with heptane (3 x 
100 mL), and the combined organic fractions dried over MgSO4, filtered and evaporated 
to dryness to yield 900 mg of a crude pale green oil. Purification via automated gradient 
flash column chromatography (silica; 0  25 % EtOAc/hexane) provided compounds as 
pure compounds or mixtures as appropriate. 
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1-(7-methoxy-2,2-dimethyl-2H-chromen-6-yl)ethanone 
The spectroscopic data obtained was consistent with data reported in the literature.183 
 
1H NMR (600 MHz, CDCl3): δ  7.53 (s, 1H), 6.38 (s, 1H), 6.30 (d, J = 9.9 Hz, 1H), 5.52 
(d, J = 9.9 Hz, 1h), 3.87 (s, 3H), 2.56 (s, 3H), 1.44 (s, 
6H). 
13C NMR (150 MHz, CDCl3): δ  197.8, 161.3, 158.6, 129.2, 128.5, 121.5, 120.8, 
114.1, 99.8, 77.8, 55.8, 32.1, 28.6. 
(4aR,5S,8R,8aS)-5-isopropyl-3,8-dimethyl-6-oxo-1,2,4a,5,6,7,8,8a-octahydronaphthalen-2-yl 
acetate 
The spectroscopic data obtained was consistent with data reported in the literature.165 
 
1H NMR (600 MHz, CDCl3): δ  5.34 (s, 1H), 5.18 (d, J = 4.6 Hz, 1 H), 2.72 (m, 1H) 
2.30 (m, 1H), 2.23 (m, 1H), 2.15 (d, J = 8.7 Hz, 2H), 
2.07–1.99 (complex m, 4H), 1.91–1.83 (complex m, 
3H), 1.63 (s, 3H), 1.02 (d, J = 6.5 Hz, 3H), 0.97 (d, J = 
6.5 Hz, 3H), 0.85 (d, J = 6.6 Hz, 3H). 
Compound Yield (mg) Yield (% w/w) 
50 4 0.01 
34, 46 77 0.21 
37, 51, 35 428 1.14 
38 43 0.11 
Total (excl 50) 548 1.46 
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13C NMR (150 MHz, CDCl3): δ  214.4, 170.9, 132.5, 130.4, 69.4, 64.5, 46.7, 41.7, 
35.3, 32.2, 30.7, 28.5, 21.4, 21.3, 20.5, 20.4, 20.2. 
(4aR,8R,8aS)-3,8-dimethyl-6-oxo-5-(propan-2-ylidene)-1,2,4a,5,6,7,8,8a-octahydronaphthalen-
2-yl acetate 
The spectroscopic data obtained was consistent with data reported in the literature.168 
 
1H NMR (600 MHz, CDCl3): δ  5.24 (s, 1H), 5.18 (d, J = 4.9 Hz, 1H), 3.57 (m, 1H), 
2.39 (m, 1H), 2.34 (m, 1H), 2.28 (m, 1H), 2.08–2.02 
(complex m, 4H), 1.97 (s, 3H), 1.91 (dt, J = 15.2, 4.6 
Hz, 1H), 1.81 (s, 3H), 1.77 (m, 1H), 1.63 (s, 3H), 0.96 
(d, J = 6.3 Hz, 3H). 
13C NMR (150 MHz, CDCl3): δ  204.3, 170.9, 141.7, 135.8, 131.9, 129.4, 68.3, 51.2, 
42.1, 38.5, 30.4, 29.5, 23.0, 21.6, 21.2, 20.1, 20.0. 
(1S,4R,4aS,8aR)-1-isopropyl-4,7-dimethyl-1,3,4,4a,5,8a-hexahydronaphthalene-2,6-dione 
The spectroscopic data obtained was consistent with data reported in the literature.164 
 
1H NMR (600 MHz, CDCl3): δ  6.38 (m, 1H), 3.37 (m, 1H), 2.76 (dd, J = 16.6, 2.5 Hz, 
1H), 2.57 (dd, J = 16.8, 4.6 Hz, 1H), 2.32 (dd, J = 10.5, 
5.5 Hz, 1H), 2.29–2.22 (complex m, 2H), 2.19 (m, 
1H), 2.12 (t, J = 12.2 Hz, 1H), 1.96 (m, 1H), 1.70 (m, 
3H), 0.99 (d, J = 6.4 Hz, 3H), 0.93 (d, J = 6.2 Hz, 3H), 
0.89 (d, J = 6.8 Hz, 3H). 
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13C NMR (150 MHz, CDCl3): δ  210.8, 198.2, 141.5, 136.8, 60.3, 50.4, 45.2, 43.8, 
41.8, 33.3, 23.3, 22.6, 20.1, 19.1, 15.9. 
(1R,4R,4aS,8aR)-1-isopropyl-4,7-dimethyl-1,3,4,4a,5,8a-hexahydronaphthalene-2,6-dione 
The spectroscopic data obtained was consistent with data reported in the literature.164 
 
1H NMR (600 MHz, CDCl3): δ  6.34 (s, 1H), 3.21 (s, 1H), 2.79 (dd, J = 16.5, 3.0 Hz, 
1H), 2.52 (dd, J = 16.6, 4.3 Hz, 1H), 2.27 (m, 1H), 2.19 
(m, 2H), 2.11–1.96 (complex m, 3H), 1.73 (s, 3H), 
1.07 (d, J = 5.6 Hz, 3H), 1.01 (d, J = 6.4 Hz, 3H), 0.88 
(d, J = 5.8 Hz, 3H) 
13C NMR (150 MHz, CDCl3): δ  213.1, 198.3, 147.1, 136.4, 64.2, 46.1, 42.4, 41.3, 
39.5, 32.0, 28.4, 21.1, 20.5, 20.2, 15.7. 
(4R,4aS,8aR)-4,7-dimethyl-1-(propan-2-ylidene)-1,3,4,4a,5,8a-hexahydronaphthalene-2,6-dione 
The spectroscopic data obtained was consistent with data reported in the literature.168 
 
1H NMR (600 MHz, CDCl3): δ  6.22 (m, 1H), 4.06 (sept, J = 2.4 Hz, 1H), 2.81 (dd, J = 
16.3, 2.7 Hz, 1H), 2.62 (dd, J = 16.3, 4.5 Hz, 1H), 2.44 
(d, J = 10.4 Hz, 1H), 2.19 (m, 1H), 2.14–2.05 
(complex m, 2H), 2.02 (s, 3H), 1.89 (s, 3H), 1.73 (dd, 
J = 2.7, 1.3 Hz, 3H), 0.98 (d, J = 5.9 Hz, 3H). 
13C NMR (150 MHz, CDCl3): δ  203.0, 197.9, 146.5, 143.9, 136.2, 134.5, 50.8, 43.9, 
43.1, 41.7, 29.4, 23.3, 22.2, 19.8, 15.6. 
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(4aR,5S,6R,8R,8aS)-6-hydroxy-5-isopropyl-3,8-dimethyl-4a,5,6,7,8,8a-hexahydronaphthalen-
2(1H)-one 
The spectroscopic data obtained was consistent with data reported in the literature.164 
  
1H NMR (600 MHz, CDCl3): δ  6.81 (s, 1H), 4.14 (m, 1H), 2.95 (m, 1H), 2.77 (dd, J = 
16.4, 2.5 Hz, 1H), 2.45 (dd, J = 16.3, 4.7 Hz, 1H), 2.10 
(m, 1H), 1.87–1.77 (complex m, 1H), 1.75 (m, 3H), 
1.66 (m, 1H), 1.22 (m, 1H), 1.14 (ddd, J = 10.6, 5.1, 
1.9 Hz, 1H), 1.05 (d, J = 6.6 Hz, 3H), 0.98 (d, J = 6.6 
Hz, 3H), 0.89 (d, J = 6.4 Hz, 3H). 
13C NMR (150 MHz, CDCl3): δ  199.6, 146.4, 133.5, 67.4, 51.8, 45.7, 43.0, 42.8, 
37.5, 25.3, 23.1, 21.1, 20.7, 19.3, 16.1. 
(1R,4R,4aS,7R)-7-hydroperoxy-1-isopropyl-4,7-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-
1-ol 
 
crystal only - data presented in X-ray crystallography section 
 
 
 
 
 
O
H
H
OH
H
O
O
H
OH
38 
54 
Chapter 5: Experimental Details 
 188 
(1S,4R,4aS,8aR)-1-hydroperoxy-4,7-dimethyl-1-(prop-1-en-2-yl)-1,3,4,4a,5,8a-
hexahydronaphthalene-2,6-dione 
 
HRMS Found [M+Na]+ 287.1254, C15H20O4Na+ requires M+ 
287.1254.  
νmax (NaCl):  3308 (broad O-OH), 2963, 2926, 2876, 1724 (C=O), 
1674 (C=O), 1452, 1373, 1207, 1113 1090, 1024, 
976, 924, 754 cm-1. 
1H NMR (600 MHz, CDCl3): δ  8.18 (s, 1H, O-OH), 6.34 (s, 1H), 5.61 (s, 1H), 5.52 (m, 
1H), 3.38 (sept, J = 2.5 Hz, 1H), 2.86 (t, J = 12.2 Hz, 
1H), 2.74 (dd, J = 16.6, 3.6 Hz, 1H), 2.55 (m, 1H), 2.50 
(dd, J = 16.6, 4.6 Hz, 1H), 2.28 (dd, J = 12.6, 5.1 Hz, 
1H), 2.04 (m, 1H), 1.87 (s, 3H), 1.75 (dd, J = 2.6, 1.5 
Hz, 3H), 1.06 (s, 3H). 
13C NMR (150 MHz, CDCl3):  208.4, 198.0, 139.5, 138.0, 137.7, 121.7, 91.9, 46.4, 
45.6, 40.9, 39.6, 33.2, 20.1, 19.9, 16.0 
[α]D22      +82 (c 0.6, CHCl3)  
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(1S,4R,4aS,8aR)-1-hydroxy-4,7-dimethyl-1-(prop-1-en-2-yl)-1,3,4,4a,5,8a-
hexahydronaphthalene-2,6-dione 
 
The spectroscopic data obtained was consistent with data reported in the literature.180 
1H NMR (600 MHz, CDCl3): δ  6.71 (m, 1H), 5.08 (m, 1H), 4.83 (s, 1H), 3.10 (br s, 
1H, OH), 3.04 (s, J = 2.8 Hz, 1H), 2.63 (dd, J = 16.8, 
7.2 Hz, 1H), 2.58 (dd, J = 14.7, 6.7 Hz, 1H), 2.54 (dd, J 
= 17.1, 5.1 Hz, 1H), 2.45 (dd, J = 14.6, 8.2 Hz, 1H), 
2.33 (m, 1H), 2.14 (m, 1H), 1.85 (s, 3H), 1.82 (dd, J = 
2.3, 1.4 Hz, 3H), 1.54 (s, 3H), 1.03 (d, J = 6.7 Hz, 1H). 
13C NMR (150 MHz, CDCl3): δ  213.3, 198.6, 145.4, 142.8, 136.8, 115.8, 81.5, 46.3, 
44.3, 41.4, 38.6, 32.4, 20.2, 19.9, 16.2. 
(1aR,4R,4aS,8aS)-4,7-dimethyl-1a-(prop-1-en-2-yl)-3,4,4a,5-tetrahydro-1aH-naphtho[1,8a-
b]oxirene-2,6-dione 
 
HRMS      Found M+ 246.1254, C15H18O3 requires M+ 246.1260. 
νmax (NaCl):  2961, 2924, 2880, 1717 (C=O), 1684 (C=O), 1449, 
1424, 1383, 997, 916 cm-1. 
1H NMR (600 MHz, CDCl3): δ  6.01 (m, 1H, H4), 5.26 (pent, J = 1.5 Hz, 1H, H13a), 
5.12 (m, 1H, H13b), 2.90–2.83 (complex m, 2H, H1a + 
H8a), 2.46 (ddd, J = 13.6, 8.7, 5.1 Hz, 1H, H10), 2.32 
(dd, J = 15.8, 13.7 Hz, 1H, H1b), 2.15 (dd, J = 13.2, 3.8 
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Hz, 1H, H8b), 1.87–1.79 (complex m, 7H, H9 + H12 + 
H15), 1.10 (d, J = 6.6 Hz, 3H, H14).  
13C NMR (150 MHz, CDCl3): δ  204.9, 197.2, 141.6, 141.5, 136.4, 116.9, 71.8, 70.3, 
42.6, 42.5, 40.6, 39.0, 20.8, 20.5, 15.9. 
MS (EI) m/z     246, 231, 191, 177, 163, 161, 149, 123, 107, 96, 79. 
[α]D22      +412 (c 0.05, CHCl3)  
(E)-((2R,3S,4S,5R,6S)-6-((2-(3,4-dihydroxyphenyl)-3,7,8-trihydroxy-4-oxo-4H-chromen-5-yl)oxy)-
3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl 3-(3,4-dihydroxyphenyl)acrylate 
The spectroscopic data obtained was consistent with data reported in the literature.185 
 
1H NMR (600 MHz, MeOD): δ  7.71 (d, J = 2.2 Hz, 1H), 7.60 (dd, J = 8.5, 2.0 Hz, 1H), 
7.43 (d, J = 15.8 Hz, 1H), 6.83 (d, J = 8.6 Hz, 1H), 6.80 
(s, 1H), 6.74 (d, J = 1.8 Hz, 1H), 6.56 (dd, J = 8.2, 1.8 
Hz, 1H), 6.53 (d, J = 8.2 Hz, 1H), 6.18 (d, J = 15.9 Hz, 
1H), 5.08 (d, J = 7.6 Hz, 1H), 4.65 (dd, J = 12.0, 2.4 
Hz, 1H), 4.33 (dd, J = 11.9, 7.1 Hz, 1H), 3.86 (m, 1H), 
3.63 (t, J = 8.0 Hz, 1H), 3.58 (t, J = 9.2 Hz, 1H), 3.47 
(t, J = 9.2 Hz, 1H). 
13C NMR (150 MHz, MeOD): δ 177.5, 169.1, 152.6, 150.3, 149.4, 148.93, 148.87, 
147.6, 146.9, 146.5, 146.1, 136.2, 130.9, 127.4, 
124.1, 122.2, 121.9, 116.5, 116.19, 116.18, 115.6, 
114.5, 106.6, 102.1, 95.0, 77.4, 75.6, 74.5, 72.1, 
64.6. 
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(E)-((2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-((3,7,8-trihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-
chromen-5-yl)oxy)tetrahydro-2H-pyran-2-yl)methyl 3-(3,4-dihydroxyphenyl)acrylate 
The spectroscopic data obtained was consistent with data reported in the literature.185 
 
1H NMR (600 MHz, MeOD): δ  8.02 (d, J = 8.9 Hz, 2H), 7.43  (d, J = 15.8 Hz, 1H), 
6.84–6.81 (complex m, 2H), 6.72 (d, J = 1.4 Hz, 1H), 
6.58–6.50 (complex m, 2H), 6.15 (d, J = 15.9 Hz, 1H),  
5.09 (d, J = 7.5 Hz, 1H), 4.69 (dd, J = 12.1, 2.3 Hz, 
1H), 4.30 (dd, J = 12.1, 7.1 Hz, 1H), 3.87 (m, 1H), 3.63 
(t, J = 8.2 Hz, 1H), 3.58 (t, J = 8.9 Hz, 1H), 3.46 (t, J = 
9.3 Hz, 1H). 
13C NMR (150 MHz, MeOD): δ 177.5, 169.0, 160.6, 152.7, 150.3, 149.4, 149.0, 
147.5, 146.9, 146.5, 137.1, 130.9, 130.8, 127.4, 
123.6, 122.3, 116.4, 116.2, 115.4, 114.5, 106.7, 
102.1, 95.0, 77.4, 75.6, 74.5, 72.1, 64.6. 
 
Pyrethrin Extraction 
Pyrethrin (Chrysanthemum cinerariaefolium) representative extraction  
Dried, ground C. cinerariaefolium flowers (15.0 g) were placed into the portafilter 
(sample compartment) of an espresso machine and extracted with 35% EtOH/H2O 
(200mL of a hot solution). This process was repeated a further two times, and the 
extracts combined before being extracted with heptane (3 x 200 mL). The combined 
organic fractions were dried over MgSO4, filtered and evaporated to dryness to yield a 
crude pale green oil. These extracts were used for reactions without further purification. 
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o-Nitrobenzenesulfonylhydrazide (NBSH) 
 
To hydrazine hydrate (3.0 mL, 60 mmol, excess) at 0 °C was added o-
nitrobenzenesulfonyl chloride 69 (2.0 g, 9.0 mmol) in THF (6 mL) dropwise. The reaction 
was warmed to rt and stirred for 30 min. Water (100 mL) was added, and the resulting 
suspension filtered to collect the precipitate. The resulting off–white crystals were 
washed with ice-cold water (2 x 20 mL) before being dried in a vacuum desiccator to 
provide the title compound as off–white crystals (1.56 g, 7.2 mmol, 80 %). The 
spectroscopic data obtained was consistent with data reported in the literature.202 
1H NMR (600 MHz, CD3CN): δ  8.10 (m, 1H), 7.92–7.83 (complex m, 3H), 6.94 (br s, 
-NH, 1H), 4.02 (br s, -NH2, 2H) 
13C NMR (150 MHz, CD3CN): δ  149.2, 135.1, 133.1, 132.9, 130.6, 125.5. 
Diimide test reactions 
Eugenol 
To o-nitrobenzenesulfonylhydrazide (217 mg, 1.0 mmol) and K3PO4 (106 mg, 0.5 mmol) in 
CH3CN (4 mL) was added eugenol (164 mg, 1.0 mmol) dropwise. The reaction was stirred 
at rt for 20 h before water (50 mL) was added and the reaction extracted with heptane (3 
x 15 mL). The combined organic fractions were dried over MgSO4, filtered and 
evaporated to dryness to yield a crude pale green oil (169 mg). 
Anethole 
To o-nitrobenzenesulfonylhydrazide (217 mg, 1.0 mmol) and K3PO4 (106 mg, 0.5 mmol) in 
CH3CN (4 mL) was added anethole (148 mg, 1.0 mmol) dropwise. The reaction was stirred 
at rt for 20 h before water (50 mL) was added and the reaction extracted with heptane (3 
x 15 mL). The combined organic fractions were dried over MgSO4, filtered and 
evaporated to dryness to yield a crude pale green oil (107 mg). 
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Pyrethrin diimide reactions 
Test conditions I 
C. cinerariaefolium flowers (3 x 15.0 g) were extracted by the general method above to 
yield a pale yellow/green oil (590 mg). To o-nitrobenzenesulfonylhydrazide (659 mg, 3.04 
mmol) and K3PO4 (322 mg, 1.52 mmol) in CH3CN (8 mL) was added the extract in CH3CN 
(5 mL) dropwise. The reaction was stirred at rt for 21 h before water (50 mL) was added 
and the reaction extracted with heptane (3 x 15 mL). The combined organic fractions 
were dried over MgSO4, filtered and evaporated to dryness to yield a crude pale green oil 
(500 mg). 
Test conditions II 
C. cinerariaefolium flowers (3 x 15.0 g) were extracted by the general method above to 
yield a pale yellow/green oil (722 mg). To o-nitrobenzenesulfonylhydrazide (250 mg, 1.15 
mmol) and K3PO4 (250 mg, 1.18 mmol) in CH3CN (5 mL) was added the extract in CH3CN 
(10 mL) dropwise. The reaction was stirred at rt for 18 h before 0.2 mL was taken, diluted 
with water (1 mL) and extracted with heptane (2 mL). The solvent was evaporated and 
the sample analysed by NMR and GC-MS. To the rest of the reaction was added o-
nitrobenzenesulfonylhydrazide (150 mg, 0.69 mmol) and K3PO4 (150 mg, 0.71 mmol) and 
stirred for a further 48 h. Water (100 mL) was added and the reaction extracted with 
heptane (5 x 20 mL). The combined organic fractions were dried over MgSO4, filtered and 
evaporated to dryness to yield a crude pale green oil (546 mg). 
Optimised conditions 
C. cinerariaefolium flowers (3 x 15.0 g) were extracted by the general method above to 
yield a pale yellow/green oil (721 mg). To o-nitrobenzenesulfonylhydrazide (250 mg, 1.15 
mmol) and K3PO4 (250 mg, 1.18 mmol) in CH3CN (5 mL) was added the extract in CH3CN 
(10 mL) dropwise. The reaction was stirred at rt for 42 h. Water (100 mL) was added and 
the reaction extracted with heptane (5 x 20 mL). The combined organic fractions were 
dried over MgSO4, filtered and evaporated to dryness to yield a crude pale green oil (564 
mg). 
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Synthesis of Dihydro Derivatives 
C. cinerariaefolium flowers (3 x 15.0 g) were extracted by the general method above to 
yield a pale yellow/green oil (700 mg). To o-nitrobenzenesulfonylhydrazide (800 mg, 3.68 
mmol) and K3PO4 (600 mg, 2.83 mmol) in CH3CN (10 mL) was added the extract in CH3CN 
(10 mL) dropwise. The reaction was stirred at rt for 72 h. Water (100 mL) was added and 
the reaction extracted with heptane (5 x 20 mL). The combined organic fractions were 
dried over MgSO4, filtered and evaporated to dryness to yield a crude pale green oil (429 
mg). The ensuing mixture was fractionated via automated gradient flash chromatography 
(silica; 0  40 % EtOAc/hexane) to yield mixtures of dihydrojasmolin I dihydrocinerin I; 
and dihydrojasmolin II and dihydrocinerin II. These fractions were analysed by HRMS. 
Dihydro derivative HRMS 
Dihydrojasmolin I 
 
HRMS Found [M+Na]+ 355.2241, C21H32O3Na+ requires M+ 
355.2244. 
Dihydrojasmolin II 
 
 
HRMS Found [M+Na]+ 399.2135, C22H32O5Na+ requires M+ 
399.2142. 
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Dihydrocinerin I 
 
HRMS Found [M+Na]+ 341.2084, C20H30O3Na+ requires M+ 
341.2087. 
Dihydrocinerin II 
 
HRMS Found [M+Na]+ 385.1980, C21H30O5Na+ requires M+ 
385.1985. 
1β-acetoxypolygodial survey (Wielangta forest T. lanceolata) representative extraction  
Dried, ground T. lanceolata leaves (15 g) were mixed with sand (4 g), placed into the 
portafilter (sample compartment) of an espresso machine and extracted with 35% 
EtOH/H2O (200 mL of a hot solution). This process was completed 1–3 times depending 
on the mass of each specimen. The extract was concentrated to a ~half volume under 
reduced pressure in order to remove EtOH (50 °C water bath temperature). The ensuing 
mixture was extracted with heptane (4 × 50 or 4 x 100 mL). The organic fractions were 
then combined, dried (MgSO4), filtered, and the solvent removed under reduced 
pressure to provide a viscous, green oil. Purification via automated gradient flash column 
chromatography (silica; 0  100% EtOAc/hexane) provided the three compounds 12, 80 
and 81. 
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1β-Acetoxyisodrimeninol 
 
1H NMR (600 MHz, CDCl3): δ  5.52 (s, 1H), 5.44 (m, 1H), 4.62 (dd, J = 11.7, 4.3 Hz, 
1H), 4.40 (d, J = 11.1 Hz, 1H), 4.12 (m, 1H), 2.27 (m, 
1H), 2.16 (m, 1H), 2.05 (s, 3H), 2.01 (m, 1H), 1.73 
(dq, J = 12.9, 4.0 Hz, 1H), 1.64 (m, 1H), 1.52–1.41 
(complex m, 2H), 1.37 (dd, J = 11.6, 5.4 Hz, 1H), 0.94 
(s, 3H), 0.93 (s, 3H), 0.89 (s, 3H).  
13C NMR (150 MHz, CDCl3): δ  171.0, 136.5, 116.7, 99.7, 81.3, 68.3, 60.7, 49.1, 
39.8, 37.7, 32.6, 32.5, 24.3, 23.3, 21.5, 21.4, 9.2. 
[α]D20      –28 (c 0.35, CHCl3), lit. [α]D +10 (c 0.06, CHCl3)343* 
 
1β-Acetoxypolygodial 
 
1H NMR (600 MHz, CDCl3): δ  9.74 (d, J =  3.6 Hz, 1H), 9.37 (s, 1H), 7.08 (dt, J = 5.6, 
2.3 Hz, 1H), 4.74 (dd, J = 11.6, 4.2 Hz, 1H), 3.17 (m, 
1H), 2.49 (m, 1H), 2.40 (dddd, J = 20.0, 11.8, 3.6, 2.5 
Hz, 1H), 2.05 (s, 3H), 1.80 (dq, J = 13.1, 3.7 Hz, 1H), 
1.63 (m, 1H), 1.55 (dt, J = 13.7, 3.5 Hz, 1H), 1.48 (td, 
J = 13.7, 3.5 Hz, 1H), 1.38 (dd, J =11.8, 4.7 Hz, 1H), 
1.04 (s, 3H), 1.00 (s, 3H), 0.95 (s, 3H). 
                                                          
* Incorrectly assigned, corrected in this work. See Deans et. al 2014105 
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13C NMR (150 MHz, CDCl3): δ  200.1, 192.5, 170.3, 152.6, 139.5, 81.1, 59.5, 48.7, 
41.9, 39.1, 32.8, 32.6, 24.7, 24.1, 22.1, 21.4, 10.5. 
[α]D20      +16 (c 0.1, CHCl3). 
 
Marrubiin from White Horehound (Marrubium vulgare) 
 
Dried, ground M. vulgare (15.0 g) was placed into the portafilter (sample compartment) 
of an espresso machine and extracted with 35% EtOH:H2O (200 mL of a hot solution). 
This process was repeated on a further 3 x 15.0 g of material. The ensuing mixture was 
extracted with heptane (3 x 200 mL). The organic fractions were then combined, dried 
(MgSO4), filtered, and the solvent removed under reduced pressure to provide a viscous, 
green oil (862 mg). Purification via automated gradient flash column chromatography 
(silica; 0  60 % EtOAc/hexane) provided the title compound as a white amorphous solid 
(8 mg, 0.05 % w/w) with a further 228 mg of impure material. The spectroscopic data 
obtained was consistent with data reported in the literature.226 
1H NMR (600 MHz, CDCl3): δ  7.36 (m, 1H), 7.24 (s, 1H), 6.27 (s, 1H), 4.74 (m, 1H), 
2.53 (m, 2H), 2.23 (d, J = 4.7 Hz, 1H), 2.20–2.07 
(complex m, 3H), 1.90 (m, 1H), 1.80–1.64 (complex 
m, 4H), 1.56–1.41 (complex m, 2H), 1.36–1.25 
(complex m, 4H), 1.06 (s, 3H), 0.97 (d, J = 6.5 Hz, 
3H). 
13C NMR (150 MHz, CDCl3): δ  183.8, 143.1, 138.6, 125.1, 110.7, 76.2, 75.8, 44.9, 
43.8, 39.7, 35.1, 32.4, 31.5, 28.6, 28.4, 23.0, 22.3, 
21.0, 18.2, 16.6. 
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Crude Extract from Bitter Melon (Momordia charantia) 
Fresh whole M. charantia was sliced and dried in an oven at 35 °C. The slices were 
ground to a coarse powder and 4 g of this preparation was mixed with 12 g of acid 
washed sand, placed into the portafilter (sample compartment) of an espresso machine 
and extracted with H2O (200 mL). The extract was evaporated to dryness under reduced 
pressure at 50 °C. Typical yields were 1 g extract per 4 g (0.25 % w/w). 
Castanospermine from Moreton Bay Chestnuts (Castanospermum australe) 
 
Fresh C. australe seeds (20 g) were grated with a cheese grater and mixed with sand (10 
g), placed into the portafilter (sample compartment) of an espresso machine and 
extracted with 30% EtOH/H2O (200 mL of a hot solution). This process was completed on 
a further 4 samples. The ensuing mixture was concentrated to half volume under 
reduced pressure (bath temperature 60 °C) before being filtered through a sintered glass 
funnel. Amberlyst® 15 acidic ion exchange resin (30 g) was added and the mixture stirred 
for 45 min before being filtered and the resin washed with water. The resin was then 
eluted with 15% NH3:MeOH (5 x 60 mL), the solvents were removed under reduced 
pressure to yield a crude light orange oil (2.15 g). Purification via automated gradient 
flash chromatography (silica, 0  60% (5% NH3:MeOH):CH2Cl2) provided the title 
compound as a white amorphous solid (565 mg, 0.57% yield w/w). The spectroscopic 
data obtained was consistent with data reported in the literature.319 
1H NMR (400 MHz, D2O): δ  4.34 (m, 1H), 3.59–3.49 (complex m, 2H), 3.26 (t, J = 
9.2 Hz, 1H), 3.11 (dd, J = 10.9, 5.1 Hz, 1H), 3.02 (td, J 
= 8.9, 2.0 Hz, 1H), 2.27 (m, 1H), 2.15 (q, J = 9.1 Hz, 
1H), 2.04–1.94 (complex m, 2H), 1.64 (m, 1H). 
 13C NMR (100 MHz, D2O): δ   78.9, 71.3, 70.0, 69.5, 68.9, 55.3, 51.5, 32.7. 
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Glycosides from Drimys winteri 
Dried, ground D. winteri leaves (17.1 g) were placed into the portafilter (sample 
compartment) of an espresso machine and extracted with 35% EtOH/H2O (250 mL of a 
hot solution). The ensuing mixture was extracted with heptane (4 × 100 mL), followed by 
EtOAc (3 x 100 mL). The EtOAc fractions were then combined, dried (MgSO4), filtered and 
the solvent removed under reduced pressure to yield a crude yellow/brown solid (2.07 
g). This material was then partially purified by normal phase automated gradient flash 
chromatography (silica; 0  20 % MeOH/CH2Cl2) to yield a combined fraction of astilbin 
and quercitrin as a fine yellow powder (1.44 g) containing astilbin (1.0 g, 5.8 % w/w) and 
quercitrin (0.44 g, 2.6 % w/w). Purification of a small portion via reversed-phase 
automated gradient flash column chromatography (C18 silica; 0  40% CH3CN:H2O) 
yielded the products as white amorphous solids for characterisation. 
Astilbin 
The spectroscopic data obtained was consistent with data reported in the literature.242 
 
1H NMR (600 MHz, MeOD): δ  6.98 (d, J = 1.8 Hz, 1H), 6.87–6.82 (complex m, 2H), 
5.94 (d, J = 2.1 Hz, 1H), 5.92 (d, J = 2.1 Hz, 1H), 5.09 
(d, J = 10.7 Hz, 1H), 4.59 (d, J = 10.7 Hz, 1H), 4.27 (m, 
1H), 4.08 (m, 1H), 3.69 (dd, J = 9.6, 3.3 Hz, 1H), 3.57 
(dd, J = 3.1, 1.6 Hz, 1H), 3.33 (m, 1H), 1.21 (d, J = 6.3 
Hz, 3H). 
13C NMR (150 MHz, MeOD): δ  194.6, 167.2, 164.1, 162.7, 146.0, 145.1, 127.8, 
119.1, 115.0, 114.1, 101.1, 100.7, 96.0, 94.9, 82.5, 
77.2, 72.4, 70.8, 70.4, 69.1, 16.5.  
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Quercitrin 
The spectroscopic data obtained was consistent with data reported in the literature.243 
 
1H NMR (600 MHz, MeOD) δ  7.36 (d, J = 2.1 Hz, 1H), 7.33 (dd, J = 8.3, 2.1 Hz, 1H), 
6.93 (d, J = 8.3 Hz, 1H), 6.39 (d, J = 2.0 Hz, 1H), 6.22 
(d, J = 2.0 Hz, 1H), 5.37 (d, J = 1.3 Hz, 1H), 4.24 (d, J = 
3.2, 1.7 Hz, 1H), 3.77 (dd, J = 9.4, 3.3 Hz, 1H), 3.44 
(dq, J = 9.6, 6.1 Hz, 1H), 3.36 (d, J = 9.6 Hz, 1H), 0.96 
(d, J = 6.1 Hz, 3H). 
13C NMR (150 MHz, MeOD) δ  178.3, 164.6, 161.8, 157.9, 157.2, 148.1, 145.0, 
134.8, 121.6, 121.5, 115.5, 115.0, 104.5, 102.2, 98.4, 
93.3, 71.9, 70.7, 70.6, 70.5, 16.2. 
Eugenol from cloves (Syzygium aromaticum) 
 
Ground S. aromaticum flower buds (cloves) (15 g) were mixed with sand (2 g), placed into 
the portafilter (sample compartment) of an espresso machine and extracted with 25% 
EtOH/H2O (200 mL of a hot solution). The ensuing mixture was extracted with heptane (3 
x 50 mL). The organic fractions were then combined and extracted with NaOH (2 M aq., 3 
x 30 mL). The combined aqueous extracts were acidified with HCl (conc.) until cloudy, 
before being split into two portions. These portions were extracted with CH2Cl2 and 
heptane respectively (3 x 20 mL) before each was dried (MgSO4), filtered, and the solvent 
O
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removed under reduced pressure to provide a pale yellow oil (646 mg and 636 mg 
respectively, total combined yield of 8.5 % w/w). The spectroscopic data obtained was 
consistent with data reported in the literature.320 
1H NMR (400 MHz, CDCl3): δ  6.85 (m, 1H), 6.69 (m, 2H), 5.96 (m, 1H), 5.50 (s, 1h, 
OH), 5.07 (m, 2H), 3.88 (s, 2H), 3.33 (d, J = 6.8 Hz, 
2H). 
13C NMR (100 MHz, CDCl3): δ  146.6, 144.1, 138.0, 132.1, 121.4, 115.7, 114.4, 
111.3, 56.0, 40.1.  
Acetyleugenol from cloves (Syzygium aromaticum) 
 
Ground S. aromaticum flower buds (cloves) (15 g) were mixed with sand (2 g), placed into 
the portafilter (sample compartment) of an espresso machine and extracted with 25% 
EtOH/H2O (200 mL of a hot solution). The ensuing mixture was extracted with heptane (3 
x 50 mL). The organic fractions were then combined and extracted with NaOH (2 M aq., 3 
x 30 mL) which was then discarded. The remaining heptane fraction was dried (MgSO4), 
filtered, and the solvent removed under reduced pressure to provide a pale-yellow oil 
(181 mg, 1.2 % w/w). The spectroscopic data obtained was consistent with data reported 
in the literature.321,322 
1H NMR (400 MHz, CDCl3): δ  6.97 (d, J = 8.0 Hz, 1H), 6.80 (m, 2H), 5.99 (m, 1H),  
5.18–5.09 (complex m, 2H), 3.82 (s, 3H), 3.38 (d, J = 
6.7 Hz, 2H), 2.31 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ  169.2, 150.9, 139.0, 138.0, 137.0, 122.5, 120.7, 
116.2, 112.7, 55.8, 40.1, 20.7.  
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Crude extract from Star anise (Illicium verum) 
Dried, ground I. verum seed pods (15.0 g) were mixed with sand (2 g), placed into the 
portafilter (sample compartment) of an espresso machine and extracted with 25% 
EtOH/H2O (200 mL of a hot solution). The ensuing mixture was extracted with CH2Cl2 (3 x 
50 mL). The organic fractions were then combined, dried (MgSO4), filtered, and the 
solvent removed under reduced pressure to provide a yellow/green oil (574 mg). 
Crude extract from Caraway seeds (Carum carvi) 
Dried, ground C. carvi seeds (15.0 g) were mixed with sand (2 g), placed into the 
portafilter (sample compartment) of an espresso machine and extracted with 30% 
EtOH/H2O (200 mL of a hot solution). The ensuing mixture was extracted with CH2Cl2 (3 x 
50 mL). The organic fractions were then combined, dried (MgSO4), filtered, and the 
solvent removed under reduced pressure to provide a yellow oil (127 mg). 
Crude extract from Oregano (Origanum vulgare) I 
Dried, ground O. vulgare leaves (15.0 g) were mixed with sand (2 g), placed into the 
portafilter (sample compartment) of an espresso machine and extracted with 30% 
EtOH/H2O (200 mL of a hot solution). The ensuing mixture was extracted with CH2Cl2 (3 x 
50 mL). The organic fractions were then combined, dried (MgSO4), filtered, and the 
solvent removed under reduced pressure to provide a yellow/orange oil (204 mg). 
Crude extract from Oregano (Origanum vulgare) II 
Dried, ground O. vulgare leaves (12.5 g) were mixed with sand (2 g), placed into the 
portafilter (sample compartment) of an espresso machine and extracted with 25% 
EtOH/H2O (200 mL of a hot solution). The ensuing mixture was extracted with CH2Cl2 (3 x 
50 mL). The organic fractions were then combined, dried (MgSO4), filtered, and the 
solvent removed under reduced pressure to provide a yellow/orange oil (61 mg). 
Crude extract from Thyme (Thymus vulgaris) 
Dried, ground T. vulgaris leaves (15.0 g) were mixed with sand (2 g), placed into the 
portafilter (sample compartment) of an espresso machine and extracted with 30% 
EtOH/H2O (200 mL of a hot solution). The ensuing mixture was extracted with CH2Cl2 (3 x 
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50 mL). The organic fractions were then combined, dried (MgSO4), filtered, and the 
solvent removed under reduced pressure to provide a yellow oil (219 mg). 
Citral from Lemon Myrtle (Backhousia citriodora) 
 
Dried, ground B. citriodora leaves (15 g) were mixed with sand (2 g), placed into the 
portafilter (sample compartment) of an espresso machine and extracted with 35% 
EtOH/H2O (200 mL of a hot solution). The ensuing mixture was extracted with CH2Cl2 (3 × 
50 mL). The organic fractions were then combined, dried (MgSO4), filtered, and the 
solvent removed under reduced pressure to provide a pale yellow oil (1.21 g). 
Purification via automated gradient flash chromatography (silica; 0  60% 
EtOAc/hexane) provided the title mixture of compounds (~2:1 90:91) as pale yellow oil 
(630 mg, 4.2% yield w/w). The spectroscopic data obtained was consistent with data 
reported in the literature.323,324 
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5.4 Chapter 4 Experimental 
Polygodial derivatives 
(−)-Drimenol 
 
5% Pd/C (15 mg) was added to a solution of drimendiol (15) (180 mg, 0.76 mmol) in EtOH 
(25 mL). The resulting suspension was maintained under H2 (1 atm) for 1.25 h then 
filtered through Celite™ and the solvent was removed under reduced pressure. 
Purification via automated flash gradient column chromatography (silica; 0 → 25% 
EtOAc/hexane) provided the title compound as a colourless solid (107 mg, 64% yield). 
The spectroscopic data obtained was consistent with data reported in the literature.278 
1H NMR (400 MHz, CDCl3): δ  5.54 (m, 1H), 3.85 (dd, J = 11.3, 3.4 Hz, 1H), 3.73 (dd, 
J = 11.3, 4.9 Hz, 1H), 2.01–1.75 (complex m, 8H), 
1.64–1.38 (complex m, 4H), 1.29 (br s, 1H), 1.22–
1.12 (complex m, 1H), 1.06 (td, J = 13.2, 3.8 Hz, 1H), 
0.89 (s, 3H), 0.86 (s, 3H), 0.85 (s, 3H).  
13C NMR (100 MHz, CDCl3): δ  133.1, 124.1, 61.0, 57.3, 42.2, 39.9, 36.1, 33.4, 33.0, 
23.7, 22.1, 22.0, 18.9, 15.0.  
[α]D22      −13 (c 1.0, CHCl3), lit. [α]D −15 (c 1.0, CHCl3)278 
((1S,2R,4aS,8aS)-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl)methanol,  
((1S,2S,4aS,8aS)-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl)methanol 
A solution of drimendiol (15) (1.5 g, 6.29 mmol) in EtOH (40 mL) was subjected to a 
hydrogen atmosphere (1 atm) under a balloon with catalytic Pd/C for 5 h. The resulting 
mixture was filtered through Celite™ and the solvent evaporated to yield a pale-yellow oil 
(1.16 g). Purification via automated gradient flash column chromatography (silica; 0  10 
% EtOAc/hexane) yielded the title compounds as white solids (119 251 mg, 1.12 mmol, 
18 % yield and 120 164 mg, 0.73 mmol, 12 % yield) 
H
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((1S,2R,4aS,8aS)-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl)methanol  
The spectroscopic data obtained was consistent with data reported in the literature.281 
 
1H NMR (400 MHz, CDCl3): δ  3.78 (dd, J = 11.6, 3.2 Hz, 1H), 3.62 (dd, J = 11.6, 3.5 
Hz, 1H), 1.88 (m, 1H), 1.79 (dq, J = 13.0, 3.2 Hz, 1H), 
1.67–1.52 (complex m, 3H), 1.50–1.36 (complex m, 
2H), 1.30 (qd, J = 12.8, 3.7 Hz, 1H), 1.15 (td, J = 13.4, 
3.8 Hz, 1H), 1.08–0.95 (complex m, 4H), 0.87 (s, 3H), 
0.86–0.81 (complex m, 7H), 0.68 (dt, J = 11.2, 3.2 Hz, 
1H). 
13C NMR (100 MHz, CDCl3): δ  61.8, 60.6, 55.0, 42.1, 39.4, 37.6, 36.8, 33.6, 33.3, 
30.8, 21.9, 21.8, 21.0, 18.8, 15.6. 
((1S,2S,4aS,8aS)-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl)methanol 
 
The spectroscopic data obtained was consistent with data reported in the literature.280,281 
1H NMR (400 MHz, CDCl3): δ  3.85 (dd, J = 10.7, 4.5 Hz, 1H), 3.58 (dd, J = 10.6, 9.5 
Hz, 1H). 2.16 (m, 1H), 1.73–1.33 (complex m, 9H), 
1.17 (td, J = 13.9, 4.6 Hz, 1H), 1.02 (td, J = 13.0, 3.7, 
1H), 0.97 (d, J = 7.5 Hz, 3H), 0.90–0.85 (complex m, 
7H), 0.82 (s, 3H). 
H
OH
H
OH
119 
120 
Chapter 5: Experimental Details 
 206 
13C NMR (100 MHz, CDCl3): δ  60.9, 56.5, 55.7, 42.0, 39.9, 37.6, 34.5, 33.6, 33.2, 
28.5, 21.6, 18.4, 17.5, 17.0, 15.6. 
((1S,2R,4aS,8aS)-5,5,8a-trimethyldecahydronaphthalene-1,2-diyl)dimethanol,  
((1S,2S,4aS,8aS)-5,5,8a-trimethyldecahydronaphthalene-1,2-diyl)dimethanol 
To a solution of polygodial (12) (1.7 g, 7.25 mmol) in EtOH (40 mL) at 0 °C was added 
slowly NaBH4 (1.2 g, 31.7 mmol). The resulting mixture was stirred at 0 °C for 30 min and 
rt for 1 h. The solvent was evaporated and the residue taken up in water (50 mL) and 
extracted with CH2Cl2 (4 x 20 mL). The combined organic fractions were dried (MgSO4), 
filtered and evaporated to yield a pale-yellow oil containing drimendiol (15) (1.75 g) used 
without further purification.  
Crude drimendiol (15) (525 mg) was dissolved in EtOH and subjected to a hydrogen 
atmosphere (1 atm) under a balloon with catalytic Pd/C for 8 h. The resulting mixture 
was filtered through Celite™ and the solvent evaporated to yield a pale-yellow oil (490 
mg). Purification via automated gradient flash column chromatography (silica; 0  100 % 
EtOAc/hexane) provided the title compounds as white solids (122, 80 mg, 0.33 mmol, 15 
% over 2 steps and 123, 220 mg, 0.92 mmol, 41 % yield over 2 steps) 
((1S,2R,4aS,8aS)-5,5,8a-trimethyldecahydronaphthalene-1,2-diyl)dimethanol 
 
HRMS Found [M+Na]+ 263.1987, C15H28O2Na requires M+ 
263.1982. 
νmax (NaCl):  3233 (br, -OH), 2993, 2931, 2841, 1462, 1437, 1384, 
1367, 1056, 1021, 981, 949, 758 cm−1.  
1H NMR (400 MHz, CDCl3): δ  3.95 (dd, J = 11.0, 1.6 Hz, 1H), 3.78 (dd, J = 11.4, 2.8 
Hz, 1H), 3.58 (dd, J = 11.0, 6.9 Hz, 1H), 3.51 (dd, J = 
11.4, 5.1 Hz, 1H), 3.11 (br m, 2H, OH), 1.92 (m, 1H), 
H
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1.77–1.01 (complex m, 11H), 0.90–0.84 (complex m, 
7 H), 0.83 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ  67.5, 62.4, 56.4, 54.7, 42.0, 40.0, 39.1, 37.2, 33.5, 
33,4, 31.0, 21.7, 21.6, 18.7, 15.3. 
[α]D20  +26 (c 1.35, CHCl3), lit. [α]D +26 (c 3.1, CHCl3)325 
((1S,2S,4aS,8aS)-5,5,8a-trimethyldecahydronaphthalene-1,2-diyl)dimethanol 
The spectroscopic data obtained was consistent with data reported in the literature.282 
 
1H NMR (400 MHz, CDCl3): δ  3.85 (dd, J = 10.4, 6.2 Hz, 1H), 3.75 (dd, J = 11.1, 5.1 
Hz, 1H), 3.67 (dd, J = 11.1, 10.2 Hz, 1H), 3.52 (dd, J = 
10.4, 7.1 Hz, 1H), 2.11 (quint, J = 5.8 Hz, 1H), 1.85 
(m, 1H), 1.56 (m, 1H), 1.53–1.39 (complex m, 4H), 
1.38–1.28 (complex m, 2H), 1.18 (m, 1H), 1.10 (td, J 
= 13.5, 4.0 Hz, 1H), 0.95 (td, J = 9.1, 3.8 Hz, 1H), 0.83 
(dd, J = 12.1, 2.0 Hz, 1H), 0.80 (s, 3H), 0.79 (s, 3H), 
0.74 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ  64.2, 60.8, 56.4, 54.4, 41.9, 39.4, 37.9, 37.4, 33.5, 
33.2, 30.1, 21.6, 18.44, 18.42, 16.5. 
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(E)-Ethyl 3-((1R,4aS,8aS)-1-formyl-5,5,8a-trimethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalen-2-
yl)acrylate 
 
Ethyl (triphenylphosphoranylidene)acetate (123) (208 mg, 0.60 mmol) was added to a 
solution of polygodial (12) (101 mg, 0.43 mmol) in EtOH (15 mL). The reaction was heated 
to 40 °C and after 2.5 h, the mixture was cooled, and the solvent was removed under 
reduced pressure. The ensuing residue was purified via flash chromatography (silica; 0 → 
15% EtOAc/hexane) to provide the title compound as a colourless oil (102 mg, 79% yield).  
HRMS     Found M+ 304.2030, C19H28O3 requires M+ 304.2038. 
νmax (NaCl):     2928, 1713, 1627, 1368, 1311, 1712, 1040 cm−1.  
1H NMR (400 MHz, CDCl3): δ  9.46 (d, J = 4.8 Hz, 1H), 7.30 (d, J = 16.3 Hz, 1H), 6.49 
(m, 1H), 5.48 (d, J = 16.3 Hz, 1H), 4.15 (q, 7.2 Hz, 
2H), 2.81 (s, 1H), 2.31 (m, 1H), 2.20 (m, 1H), 1.83 (m, 
1H), 1.56–1.42 (complex m, 3 H), 1.38–1.13 
(complex m, 6H), 0.99 (s, 3H), 0.93 (s, 3H), 0.89 (2, 
3H).  
13C NMR (100 MHz, CDCl3): δ  205.4, 167.1, 146.4, 141.5, 130.5, 116.7, 62.9, 60.5, 
48.8, 41.8, 40.3, 37.5, 33.3, 33.2, 24.8, 22.3, 18.1, 
15.5, 14.2. 
MS (EI) m/z  304 (M+), 275, 259, 231, 229, 215, 103, 180, 166, 
145, 123, 109, 95, 91, 81, 69, 55.  
[α]D22      −8.4 (c 1.1, CHCl3).  
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(3aR,4S,6R,6aS,10aS,11aS,11bR)-Ethyl 6-formyl-6a,10,10- trimethyl-1,3-dioxo-2-phenyl-
2,3,3a,4,6,6a,7,8,9,10,10a,11,11a,11b-tetradecahydro-1H-naphtho[2,3-e]isoindole-4-
carboxylate 
 
N-Phenylmaleimide (127) (13.7 mg, 0.079 mmol) was added to a solution of Wittig 
product 124 (22 mg, 0.072 mmol) in toluene (10 mL) and the resulting solution was then 
heated at reflux. After 18 h, the reaction mixture was cooled, and the solvent was 
removed under reduced pressure. The ensuing residue was then purified by flash column 
chromatography (silica; 30% EtOAc/hexane) to provide the title compound as a light-
yellow oil (19 mg, 55% yield).  
HRMS Found M+ 477.2508, C29H35NO5 requires M+ 
477.2515. 
νmax (NaCl):  2928, 1737, 1712, 1500, 1386, 1207, 1195, 754 
cm−1.  
1H NMR (400 MHz, CDCl3): δ  9.58 (d, 4.7 Hz, 1H), 7.43 (m, 2H), 7.36 (m, 1H), 7.10 
(m, 2H), 5.98 (m, 1H), 4.29 (m, 2H), 3.84 (dd, J = 8.8, 
6.0 Hz, 1H), 3.34 (dd, J = 8.8, 6.0 Hz, 1H), 3.27 (m, 
1H), 2.74 (m, 1H), 2.52 (ddd, J = 14.4, 4.8, 1.3 Hz, 
1H), 2.47 (m, 1H), 1.99 (m, 1H), 1.57–1.39 (complex 
m, 4H), 1.31 (t, J = 7.1 Hz, 3H), 1.30–1.19 (m, 3H), 
1.10 (s, 3H), 0.98 (s, 3H), 0.92 (s, 3H).  
13C NMR (100 MHz, CDCl3): δ  202.5, 176.6, 175.7, 170.2, 137.1, 131.6, 129.4, 
129.0, 126.7, 123.5, 67.3, 61.6, 48.5, 45.7, 43.6, 
42.1, 41.8, 40.1, 36.8, 33.7, 33.6, 32.7, 22.4, 21.9, 
18.4, 17.3, 14.3.  
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MS (EI) m/z  477 (M+), 462, 459, 432, 403, 402, 374, 373, 304, 
174, 137, 123, 109, 91, 81, 79, 69, 55.  
 [α]D22      +73 (c 0.9, CHCl3).  
(E)-3-((1R,4aS,8aS)-1-(hydroxymethyl)-5,5,8a-trimethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalen-
2-yl)prop-2-en-1-ol 
 
To a solution of the Wittig product 124 (130 mg, 0.43 mmol) in dry THF under N2 at 0 °C 
was added LiAlH4 (130 mg, 3.43 mmol). The reaction was warmed to rt and stirred for 1 
h. The reaction was quenched at 0 °C with water (130 μL), KOH (130 μL, 3 M) and water 
(400 μL). The reaction mixture was then dried (MgSO4), filtered and evaporated to yield a 
colourless oil (92 mg). Purification via automated gradient flash column chromatography 
(silica; 0  80 % EtOAc/hexane) provided the title compound as an impure colourless oil 
(28 mg). 
1H NMR (600 MHz, CDCl3): δ  6.35 (d, 15.6 Hz, 1H), 5.93 (m, 1H), 5.90 (dt, J = 15.6, 
5.9 Hz, 1H), 4.16 (d, J = 5.8 Hz, 2H), 3.93 (dd, J = 
11.7, 3.8 Hz, 1H), 3.73 (dd, J = 11.7, 4.6 Hz, 1H), 2.13 
(m, 1H), 2.07 (s, 1H), 2.03–1.95 (complex m, 2H), 
1.59 (qt, J = 13.7, 3.1 Hz, 1H), 1.52–1.42 (complex m, 
2H), 1.24–1.16 (complex m, 2H), 1.09 (dd, J = 13.3, 
3.4 Hz, 1H), 0.92 (s, 3H), 0.89 (s, 3H), 0.88 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ  135.5, 133.2, 127.3, 127.2, 63.7, 60.3, 55.4, 49.5, 
42.1, 39.9, 36.0, 33.3, 32.9, 23.9, 22.1, 18.7, 14.7.  
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(2S,4aR,8aS)-3-((E)-3-hydroxyprop-1-en-1-yl)-4a,8,8-trimethyl-1,2,4a,5,6,7,8,8a-
octahydronaphthalen-2-yl acetate 
 
To a solution of diol 129 (28 mg, 0.11 mmol) in CH2Cl2 (10 mL) was added Pb(OAc)4 (50 
mg, 0.11 mmol). The reaction was stirred for 16 h before being filtered through a short 
silica plug eluting with EtOAc. Evaporation of the solvent yielded the crude product as a 
colourless oil (30 mg). Purification via automated gradient flash column chromatography 
(silica; 0  30 % EtOAc/hexane) provided the title compound as an impure colourless oil 
(16 mg). Used without full characterisation. Reaction product consistent with published 
reactions283 and NMR studies.326 
1H NMR (600 MHz, CDCl3): δ  6.07 (d, J = 16.4 Hz, 1H), 5.73 (s, 1H), 5.72–5.61 
(complex m, 2H), 4.16 (d, J = 5.9 Hz, 2H), 2.35 (dd, J 
= 12.9, 8.0, 2.0 Hz, 1H), 2.09 (s, 3H), 1.67 (m, 1H), 
1.56–1.43 (complex m, 4H), 1.26–1.17 (complex m, 
3H), 1.09 (s, 3H), 0.91 (s, 3H), 0.86 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ  171.0, 147.4, 131.0, 130.3, 127.0, 71.2, 63.9, 49.2, 
41.7, 39.2, 35.9, 32.8, 32.7, 26.1, 21.4, 21.1, 20.3, 
18.7.  
 
 
 
 
 
 
 
 
H
OH
O
O130 
Chapter 5: Experimental Details 
 212 
(3aR,4R,6S,7aS,11aS,11bS,11cS)-4-(hydroxymethyl)-8,8,11a-trimethyl-1,3-dioxo-2-phenyl-
2,3,3a,4,6,7,7a,8,9,10,11,11a,11b,11c-tetradecahydro-1H-naphtho[1,2-e]isoindol-6-yl acetate 
 
To a solution of hydroxy acetate 130 (16 mg, 0.054 mmol) in toluene (10 mL) was added 
N-phenylmaleimide (127) (20 mg, 0.12 mmol). The reaction was stirred under reflux for 
16 h before the solvent was evaporated. Purification via automated gradient flash 
column chromatography (silica; 0  75 % EtOAc/hexane) provided the title compound as 
a colourless oil (14 mg, 0.030 mmol, 7% yield over 3 steps). 
HRMS Found M+ 465.2509, C28H35O5N requires M+ 
465.2515. 
νmax (NaCl):  3460 (br, -OH), 2953, 2924, 2868, 1733, 1699 (C=O), 
1500, 1383, 1237, 1200, 1033, 752 cm−1.  
1H NMR (600 MHz, CDCl3): δ  7.48 (m, 2H), 7.41 (tt, J = 7.5, 1.2 Hz, 1H), 7.17 (m, 
2H), 5.59 (dt, J = 4.1, 2.4 Hz, 1H), 5.4 (m, 1H), 4.07 
(m, 1H), 3.93 (ddd, J = 12.0, 10.0, 5.7 Hz, 1H), 3.72 
(dd, J = 8.5, 3.9 Hz, 1H), 3.51 (t, J = 8.2 Hz, 1H), 3.04 
(dd, J = 8.6, 5.9 Hz, 1H), 2.74 (m, 1H), 2.19 (m, 1H), 
2.17–2.10 (complex m, 5H), 1.93 (ddd, J = 12.4, 7.0, 
1.5 Hz, 1H), 1.71–1.40 (complex m, 6H), 1.18 (s, 3H), 
0.96 (s, 3H), 0.90 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ  177.8, 177.3, 170.6, 140.4, 131.6, 129.4, 129.0, 
126.9, 124.0, 72.4, 62.6, 51.8, 43.6, 43.5, 43.4, 41.1, 
39.4, 37.5, 35.6, 33.6, 33.3, 26.42, 26.35, 22.5, 21.3, 
18.9.  
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MS (EI) m/z  465 (M+), 405, 375, 360, 306, 278, 232, 218, 175, 
161, 119, 109, 95, 93.  
[α]D20      –10 (c 0.7, CHCl3).  
(+)-Euryfuran 
 
NaBH4 (27 mg, 0.71 mmol) was added to a solution of polygodial (12) (83 mg, 0.35 mmol) 
in EtOH (20 mL) at 0 °C. After 0.33 h H2O (30 mL) was added and the resulting mixture 
was extracted with CH2Cl2 (3 × 30 mL) to provide a pale-yellow oil (74 mg). This residue 
was subjected to flash chromatography (silica; 0 → 30% EtOAc/hexane over 10 min) to 
afford lactol 132 (21 mg) which still contained impurities. HCl (2 M, 2 drops) was then 
added to a solution of lactol 132 in CH2Cl2 (5 mL). After 18 h, the solvent was removed 
under reduced pressure and the ensuing residue was purified by flash chromatography 
(silica; hexane) to provide the title compound as a pale-yellow oil (10 mg, 0.046 mmol, 
13% yield over two steps). The spectroscopic data obtained was consistent with data 
reported in the literature.288 
1H NMR (400 MHz, CDCl3): δ  7.08 (d, J = 1.5 Hz, 1H), 7.05 (q, J = 1.5 Hz, 1H), 2.77 
(dd, J = 16.4, 6.4 Hz, 1H), 2.50 (dddd, J = 16.4, 12.0, 
7.4, 1.8 Hz, 1H), 1.97 (m, 1H), 1.81 (dd, J = 13.5, 7.4 
Hz, 1H), 1.74–1.44 (complex m, 5H), 1.30–1.24 
(complex m, 2H), 1.21 (s, 3H), 0.94 (s, 3H), 0.91 (s, 
3H).  
13C NMR (100 MHz, CDCl3): δ  137.6, 137.1, 134.9, 120.1, 51.7, 42.2, 39.6, 34.0, 
33.7, 33.3, 25.1, 21.7, 20.6, 19.24, 19.18.  
[α]D22      +17 (c 0.2, CHCl3). Lit. [α]D +19 (c 1.0, CHCl3).288 
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(5aS,9R,9aS)-6,6,9a-trimethyl-3,5,5a,6,7,8,9,9a-octahydronaphtho[1,2-c]furan-9-yl acetate, 
(5aS,9R,9aS)-6,6,9a-trimethyl-4,5,5a,6,7,8,9,9a-octahydronaphtho[1,2-c]furan-9-yl acetate 
To a solution of 1β-acetoxyisodrimeninol (81) (200 mg, 0.68 mmol) in CH2Cl2 (10 mL) was 
added HCl (10 drops, 2 M). The reaction was stirred for 18 h before being evaporated to 
dryness. Purification via automated gradient flash column chromatography (silica; 0  
100 % EtOAc/hexane) provided furan 135 (25 mg, 0.090 mmol, 13%), intermediate 134 
(14 mg, 0.051 mmol, 7.4%), and recovered starting material (81) (84 mg, 0.29 mmol, 42% 
yield). 
(5aS,9R,9aS)-6,6,9a-trimethyl-3,5,5a,6,7,8,9,9a-octahydronaphtho[1,2-c]furan-9-yl acetate 
  
HRMS     Found M+ 276.1723, C17H24O3 requires M+ 276.1725.  
νmax (NaCl):  2953, 2922, 2968, 2853, 1740 (C=O), 1369, 1240, 
1032, 1010, 964, 922 cm−1.  
1H NMR (600 MHz, CDCl3): δ  5.60 (d, J = 1.7 Hz, 1H), 5.54 (m, 1H), 4.54 (dd, J = 
11.3, 4.5 Hz, 1H), 4.12 (m, 1H), 4.02 (d, J = 10.9 Hz, 
1H), 2.32 (s, 1H), 2.22 (m, 1H), 2.14 (s, 3H), 1.99 (m, 
1H), 1.91 (dq, J = 12.9, 4.3 Hz, 1H), 1.56 (m, 1H), 1.44 
(m, 2H), 1.38 (m, 1H), 0.91 (s, 3H), 0.88 (s, 3H), 0.86 
(2, 3H). 
13C NMR (150 MHz, CDCl3): δ  171.1, 136.4, 116.6, 100.8, 81.6, 68.0, 60.3, 49.0, 
39.6, 37.6, 32.8, 32.1, 24.0, 23.9, 22.2, 20.8, 9.9.  
MS (EI) m/z  276 (M+), 219, 201, 175, 145, 133, 87, 81.  
[α]D20       −121 (c 0.75, CHCl3).  
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(5aS,9R,9aS)-6,6,9a-trimethyl-4,5,5a,6,7,8,9,9a-octahydronaphtho[1,2-c]furan-9-yl acetate 
  
HRMS     Found M+ 276.1731, C17H24O3 requires M+ 276.1725. 
νmax (NaCl):  2953, 2925, 2871, 2851, 1735 (C=O), 1381, 1374, 
1239, 1044, 1038, 1030 cm−1.  
1H NMR (600 MHz, CDCl3): δ  7.09 (d, J = 1.3 Hz, 1H), 7.07 (m, 1H), 4.74 (dd, J = 
11.5, 4.1 Hz, 1H), 2.77 (dd, J = 16.2, 5.9 Hz, 1H), 2.48 
(m, 1H), 2.17 (s, 3H), 1.89 (dq, J = 13.0, 3.6 Hz, 1H), 
1.81 (ddt, J = 13.4, 7.0, 1.5 Hz, 1H), 1.79–1.66 
(complex m, 2H), 1.54 (dt, J = 13.7, 3.7 Hz, 1H), 1.48 
(td, J = 13.6, 4.0 Hz), 1.35 (dd, J = 12.0, 1.7 Hz, 1H), 
1.32 (s, 3H), 0.97 (s, 3H), 0.94 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ  170.5, 136.7, 136.0, 133.3, 119.9, 81.2, 51.4, 39.6, 
38.5, 33.0, 32.8, 24.3, 21.7, 21.6, 20.8, 19.7, 19.0.  
MS (EI) m/z  276 (M+, 50), 217 (35), 201 (24) 175 (35), 145 (22), 
133 (25), 119 (29), 105 (18), 87 (37), 81 (22). 
[α]D20      +10 (c 0.5, CHCl3).  
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(5aS,9R,9aS)-6,6,9a-trimethyl-4,5,5a,6,7,8,9,9a-octahydronaphtho[1,2-c]furan-9-ol 
 
To a solution of acetoxyeuryfuran (135) (10 mg, 0.036 mmol) in dry THF (10 mL) at 0 °C 
under N2 was added LiAlH4 (50 mg, 1.32 mmol, excess). The reaction was warmed to rt 
and stirred for 30 min water (150 μL) was added to quench the excess reagent. The 
reaction was diluted with CH2Cl2 (20 mL), dried (MgSO4), filtered and evaporated to yield 
a colourless oil (12 mg). Purification via automated gradient flash column 
chromatography (silica; 0  30 % EtOAc/hexane) provided the title compound (5 mg, 
0.021 mmol, 58% yield).  
HRMS Found M+H+ 235.1693, C15H23O2 requires M+ 
235.1693.  
νmax (NaCl):  3420 (br, -OH), 2949, 2928, 1458, 1389, 1368, 1084, 
1040, 1027, 988, 888, 789 cm−1.  
1H NMR (600 MHz, CDCl3): δ  7.57 (d, J = 1.5 Hz, 1H), 7.08 (m, 1H), 3.63 (dd, J = 
11.5, 4.4 Hz, 1H), 2.79 (dd, J = 16.2, 6.1 Hz, 1H), 2.49 
(m, 1H), 1.84–1.68 (complex m, 4H), 1.53 (dt, J = 
13.8, 3.5 Hz, 1H), 1.40 (td, J = 13.7, 4.3 Hz, 1H), 1.28 
(s, 1H), 1.26 (dd, J = 11.9, 2.0 Hz, 1H), 1.23, (s, 3H), 
0.96 (s, 3H), 0.92 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ  137.5, 136.3, 134.2, 120.0, 78.5, 51.1, 40.1, 39.9, 
33.0, 32.7, 29.0, 21.5, 20.7, 19.1, 18.2. 
[α]D20      negligible (c 0.2, CHCl3).  
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(6aS,10aS)-7,7,10a-Trimethyl-5,6,6a,7,8,9,10,10a-octahydrobenzo[f]phthalazine 
 
Hydrazine hydrate (150 mg, 3.00 mmol) was added to a solution of polygodial (12) (52 
mg, 0.22 mmol) in EtOH (10 mL). The reaction mixture was heated at reflux for 1.5 h then 
cooled and the mixture was concentrated under reduced pressure to provide the title 
compound as a colourless solid (51 mg, 0.22 mmol, >99% yield).  
HRMS      Found M+ 230.1789, C15H22N2 requires M+ 230.1783. 
νmax (NaCl):  2999, 2959, 2947, 2926, 2866, 1559, 1458, 1422, 
1383, 1175, 997, 909, 733 cm−1.  
1H NMR (400 MHz, CDCl3): δ  8.99 (s, 1H), 8.80 (s, 1H), 2.91 (dd, J = 18.5, 6.7 Hz, 
1H), 2.80 (ddd, J = 18.5, 11.1, 7.5 Hz, 1H), 2.34 (d, J = 
12.5 Hz, 1H), 2.00 (dd, J = 13.7, 7.5 Hz, 1H), 1.85–
1.62 (complex m, 3H), 1.53 (m, 1H), 1.41 (td, J = 
13.0, 4.0 Hz, 1H) 1.30–1.19 (complex m, 5H), 0.97 (s, 
3H), 0.94 (s, 3H).  
13C NMR (100 MHz, CDCl3): δ  152.3, 149.1, 148.4, 135.7, 49.6, 41.4, 37.1, 36.5, 
33.6, 33.2, 27.0, 24.3, 21.6, 18.8, 17.9.  
MS (EI) m/z     230 (M+), 215, 161, 159, 147, 145, 133, 119, 108, 91.  
[α]D22      +17 (c 0.7, CHCl3).  
(1S,1'R)-1,1'-((1R,4aS,8aS)-5,5,8a-trimethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalene-1,2-
diyl)bis(prop-2-en-1-ol),  
(1S,1'S)-1,1'-((1R,4aS,8aS)-5,5,8a-trimethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalene-1,2-
diyl)bis(prop-2-en-1-ol) 
To a solution of polygodial (12) (300 mg, 1.28 mmol) in dry THF (5 mL) at 0 °C under N2 
was added vinylmagnesium bromide (2.0 mL, 0.8 M in THF, 1.6 mmol, excess). The 
reaction was stirred for 72 h before sat. NH4Cl was added (10 mL) and the reaction 
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extracted with CH2Cl2 (3 x 10 mL). The combined organic fractions were dried (MgSO4), 
filtered and evaporated to yield a crude orange oil (447 mg). Purification via automated 
gradient flash column chromatography (silica; 0  20 % EtOAc/hexane) provided the title 
compounds in a total yield of 324 mg (0.113 mmol, 86 % yield). Clean fractions were 
combined to provide isomer 138 as a white amorphous solid (107 mg, 0.37 mmol) and 
isomer 139 as a white crystalline solid (174 mg, 0.61 mmol). 
(1S,1'R)-1,1'-((1R,4aS,8aS)-5,5,8a-trimethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalene-1,2-
diyl)bis(prop-2-en-1-ol)  
 
 
 
 
HRMS Found [M+Na]+ 313.2139, C19H30O2Na requires M+ 
313.2138.  
νmax (NaCl):  3269 (br, -OH), 3082, 2947, 2923, 2865, 2847, 1456, 
1389, 1133, 1112, 988, 915, 842, 758 cm−1.  
1H NMR (600 MHz, CDCl3): δ  6.20 (ddd, J = 17.3, 10.7, 4.1 Hz, 1H), 6.04 (ddd, J = 
17.3, 10.6, 4.8 Hz, 1H), 5.99 (dt, J = 6.8, 3.2 Hz, 1H), 
5.36–5.28 (complex m, 2H), 5.20 (dt, J = 10.6, 1.6 Hz, 
1H), 5.18 (ddd, J = 10.7, 2.3, 1.5 Hz, 1H), 4.94 (d, J = 
4.6 Hz, 1H), 4.60 (m, 1H), 2.38 (m, 1H), 2.04 (m, 2H), 
1.95 (m, 1H), 1.60 (qt, J = 13.8, 3.2 Hz, 1H), 1.53–
1.43 (complex m, 2H), 1.23–1.15 (complex m, 2H), 
1.08–1.01 (complex m, 4H), 0.94 (s, 3H), 0.89 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ  144.7, 139.7, 137.9, 129.9, 114.4, 112.8, 74.3, 69.5, 
57.2, 49.6, 42.0, 40.3, 37.1, 33.3, 32.9, 23.4, 22.3, 
18.7, 14.9.  
[α]D20      +2.0 (c 1.1, CHCl3).  
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(1S,1'S)-1,1'-((1R,4aS,8aS)-5,5,8a-trimethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalene-1,2-
diyl)bis(prop-2-en-1-ol) 
 
HRMS Found [M+Na]+ 313.2140, C19H30O2Na, requires M+ 
313.2138.  
νmax (NaCl):  3261 (br, -OH), 2981, 2948, 2923, 2865, 2846, 1457, 
1441, 1389, 1367, 1134, 1111, 987, 918, 756 cm−1.  
1H NMR (600 MHz, CDCl3): δ  6.10 (ddd, J = 17.2, 10.7, 3.3 Hz, 1H), 6.04 (dt, J = 
6.4, 2.4 Hz, 1H), 5.90 (ddd, J = 17.2, 10.6, 4.5 Hz, 
1H), 5.40 (dq, J = 17.2, 1.4 Hz, 1H), 5.30 (dt, J = 17.3, 
1.7 Hz, 1H), 5.16–5.11 (complex m, 2H), 4.84 (m, 
1H), 4.61 (q, J = 3 Hz, 1H), 2.20 (m, 1H), 2.09 (m, 1H), 
2.02–1.94 (complex m, 2H), 1.63 (qt, J = 13.7, 3.1 Hz, 
1H), 1.53–1.44 (complex m, 2H), 1.22–1.15 (complex 
m, 2H), 1.07 (s, 3H), 1.02 (td, J = 13.1, 3.5 Hz, 1H), 
0.93 (s, 3H), 0.90 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ  144.9, 140.0, 137.1, 131.0, 112.8, 112.1, 70.8, 69.4, 
60.2, 49.8, 42.1, 40.2, 37.3, 33.7, 32.9, 23.4, 22.2, 
18.8, 15.1.  
[α]D20      −64 (c 1.6, CHCl3).  
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1,1'-((1R,4aS,8aS)-5,5,8a-trimethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalene-1,2-diyl)bis(prop-2-
en-1-one) 
 
To a mixture of isomers 138 and 139 (98 mg, 0.34 mmol) at 0 °C in CH2Cl2 was added 
Dess-Martin periodinane (400 mg, 0.95 mmol) slowly. The reaction was warmed to rt and 
stirred for 15 min. Hexanes (15 mL) was added and the crude reaction mixture filtered on 
a silica plug eluting with 30 % EtOAc:hexanes to yield a colourless oil (105 mg). 
Purification via automated gradient flash column chromatography (silica; 0  20 % 
EtOAc/hexane) provided the title compound as a colourless oil (50 mg, 0.17 mmol, 50% 
yield) 
HRMS     Found M+ 286.1933, C19H26O2 requires M+ 283.1933.  
νmax (NaCl):  2926, 2867, 2848, 1693, 1656, 1645, 1608, 1458, 
1408, 1398, 1366, 1269, 1227, 1197, 1143, 1088, 
979, 961, 764 cm−1.  
1H NMR (600 MHz, CDCl3): δ  7.02 (dt, J = 5.8, 2.2 Hz, 1H), 6.85 (dd, J = 17.1, 10.6 
Hz, 1H), 6.55 (17.2, 10.4 Hz, 1H), 6.26–6.22 (complex 
m, 2H), 5.74 (dd, J = 10.6, 1.8 Hz, 1H), 5.66 (dd, J = 
10.5, 1.4 Hz, 1H), 3.72 (m, 1H), 2.35 (m, 1H), 2.26 
(dddd, J = 19.5, 12.0, 3.8, 2.6 Hz, 1H), 1.76 (m, 1H), 
1.60–1.41 (complex m, 4H), 1.34 (dd, J = 12.0, 4.7 
Hz, 1H), 1.26 (m, 1H), 0.97 (s, 3H), 0.92 (s, 3H), 0.90 
(s, 3H). 
13C NMR (150 MHz, CDCl3): δ  200.8, 191.5, 141.8, 140.3, 137.9, 131.6, 128.8, 
126.5, 61.1, 49.0, 41.8, 41.4, 36.6, 33.3, 33.0, 24.5, 
22.0, 18.4, 15.0.  
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MS (EI) m/z  286 (M+), 232, 217, 199, 175, 163, 162, 161, 149, 
135, 120, 118, 109, 95, 87, 84, 82. 
[α]D20      +125 (c 0.8, CHCl3).  
(1R,4S,4aR,4bS,8aS)-4b,8,8-trimethyl-1,4,4a,4b,5,6,7,8,8a,9-decahydrophenanthrene-1,4-diol 
 
To a solution of diol 138 (105 mg, 0.36 mmol) in dry CH2Cl2 (25 mL) was added Grubbs 
Catalyst™ C848 (Grubbs 2nd generation catalyst, CAS no. 246047-72-3) (25 mg, 0.029 
mmol, 8%) slowly. The reaction was stirred for 10 min before the solvent was removed 
under reduced pressure to yield a brown semi-solid material (130 mg). Purification via 
automated gradient flash column chromatography (silica; 0  70 % EtOAc/hexane) 
provided the title compound as an amorphous white solid (71 mg, 0.34 mmol, 94% yield) 
HRMS     Found M+ 262.1928, C17H26O2 requires M+ 262.1933.  
νmax (NaCl):  3314 (br, -OH), 3040, 2922, 2844, 1456, 1443, 1388, 
1366, 1114, 1096, 975, 918, 837, 756 cm−1.  
1H NMR (600 MHz, CDCl3): δ   6.55 (dd, J = 9.4, 6.6 Hz, 1H), 6.22 (dd, J = 9.4, 5.9 Hz, 
1H), 5.99 (m, 1H), 4.54 (d, J = 5.4 Hz, 1H), 4.41 (t, J = 
5.9 Hz, 1H), 2.82 (S, broad -OH, 2H), 2.22 (m, 1H), 
2.10–1.97 (complex m, 3H), 1.67 (qt, J = 13.7, 3.2 Hz, 
1H), 1.53 (d quint, J = 13.7, 3.6 Hz, 1H), 1.47 (m, 1H), 
1.26 (dd, J = 12.2, 5.1 Hz, 1H), 1.22–1.09 (complex 
m, 5H), 0.95 (s, 3H), 0.87 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ  138.4, 135.1, 131.6, 129.5, 67.1, 63.5, 56.0, 50.6, 
42.3, 38.9, 36.1, 33.4, 32.9, 24.5, 21.5, 18.7, 15.4. 
MS (EI) m/z     262 (M+), 244, 226, 211, 173, 159, 155, 141, 131, 
121, 120, 109, 107, 91, 87, 81. 
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[α]D20      +43 (c 0.8, CHCl3).  
(1S,4S,4aR,4bS,8aS)-4b,8,8-trimethyl-1,4,4a,4b,5,6,7,8,8a,9-decahydrophenanthrene-1,4-diol 
 
To a solution of diol 139 (96 mg, 0.33 mmol) in dry CH2Cl2 (25 mL) was added Grubbs 
Catalyst™ C848 (Grubbs 2nd generation catalyst, CAS no. 246047-72-3) (25 mg, 0.029 
mmol, 9%) slowly. The reaction was stirred for 10 min before the solvent was removed 
under reduced pressure to yield a brown semi-solid material (120 mg). Purification via 
automated gradient flash column chromatography (silica; 0  70 % EtOAc/hexane) 
provided the title compound as an amorphous white solid (60 mg, 0.29 mmol, 88% yield) 
HRMS     Found M+ 262.1934, C17H26O2 requires M+ 262.1933.  
νmax (NaCl):  3437, 3293, 2962, 2925, 2848, 1396, 1070, 1056, 
1028, 989, 965, 930, 833, 789, 779 cm−1.  
1H NMR (600 MHz, CDCl3): δ  6.25 (ddd, J = 9.7, 6.4, 2.2 Hz, 1H), 6.19 (m, 1H), 5.91 
(dd, J = 9.8, 2.4 Hz, 1H), 4.77 (s, 1H), 4.43 (s, 1H), 
2.20–2.06 (complex m, 3H), 2.02 (m, 1H), 1.66 (qt, J 
= 13.6, 3.0 Hz, 1H), 1.53–1.45 (complex m, 2H), 
1.30–1.10 (complex m, 6H), 0.96 (s, 3H), 0.89 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ  136.3, 133.2, 132.0, 128.5, 66.8, 63.2, 53.4, 50.7, 
42.1, 40.2, 36.1, 33.6, 32.9, 23.9, 22.1, 18.6, 16.3. 
MS (EI) m/z  262 (M+), 244, 226, 211, 173, 155, 141, 124, 123, 
121, 120, 109, 107, 87, 82. 
[α]D20      +210 (c 0.6, CHCl3).  
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(4bS,8aS)-4b,8,8-trimethyl-5,6,7,8,8a,9-hexahydrophenanthrene-1,4,10(4bH)-trione 
 
To a solution of diol 141 (71 mg, 0.27 mmol) in CH2Cl2 (15 mL) was added Dess-Martin 
periodinane (290 mg, 0.81 mmol) slowly. The reaction was stirred for 3 h before being 
diluted with hexane (30 mL) and filtered through a silica plug eluting with 30% 
EtOAc:hexane (100 mL). The solvent was removed under reduced pressure to yield a 
yellow oil (90 mg) Fractionation via automated gradient flash column chromatography 
yielded a quinone containing fraction. This fraction was redissolved in CH2Cl2 (5 mL) and 
Dess-Martin periodinane (50 mg, 0.14 mmol) was added and the resulting yellow mixture 
stirred for 1 h.  Sodium metabisulfite (sat. aq., 5 mL) was added, and the organic fraction 
separated. The aqueous mixture was extracted with CH2Cl2 (2 x 5 mL), before the 
combined organic fractions were washed with Na2CO3 (sat. aq., 2 x 10 mL). The organic 
phase was then dried (MgSO4), filtered, and the solvent removed under reduced pressure 
to yield a yellow oil (10 mg). Purification via automated gradient flash column 
chromatography (silica; 0  20 % EtOAc/hexane) provided the title compound as an 
amorphous pink semi-solid (2 mg, 0.0073 mmol, 3% yield) 
HRMS     Found M+ 272.1413, C17H20O3 requires M+ 272.1412.  
νmax (NaCl):  2926, 2866, 1704, 1660, 1653, 1329, 1278, 1124, 
1098, 841 cm−1.  
1H NMR (600 MHz, CDCl3): δ  6.71 (d, J = 10.1 Hz, 1H), 6.67 (d, J = 10.1 Hz, 1H), 
2.78 (m, 1H), 2.70 (dd, J = 18.1, 3.8 Hz, 1H), 2.56 (dd, 
J = 18.1, 4.7 Hz, 1H), 1.85–1.74 (complex m, 2H), 
1.63 (m, 1H), 1.53 (m, 1H), 1.43 (s, 3H), 1.30–1.24 
(complex m, 2H), 0.99 (s, 3H), 0.96 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ  197.0, 188.6, 184.7, 160.5, 137.3, 135.5, 130.8, 49.1, 
40.7, 40.2, 36.6, 35.6, 33.3, 32.7, 21.3, 18.5, 18.0. 
O
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MS (EI) m/z  272 (M+), 257, 239, 229, 215, 190, 189, 177, 176, 
175, 164, 163, 109, 95, 87, 77. 
[α]D20      −704 (c 0.01, CHCl3).  
9-Epipolygodial 
 
Polygodial (12) (300 mg) and K2CO3 (40 mg) were suspended in EtOH/H2O (5 mL of a 20% 
EtOH/H2O solution) in a 10 mL sealed microwave reactor tube. The resulting suspension 
was stirred at 110 °C in a microwave reactor for 50 min. H2O (15 mL) was added and the 
resulting mixture extracted with CH2Cl2 (3 x 5 mL), dried (MgSO4), filtered, and 
concentrated under reduced pressure to provide a yellow oil. Purification via automated 
gradient flash chromatography (silica; 0  20 % EtOAc/hexane) provided the title 
compound as a white amorphous solid, (14, 110 mg, 37% yield) and recovered starting 
material polygodial (12, 68 mg, 23% yield). The spectroscopic data obtained was 
consistent with data reported in the literature.240 
1H NMR (400 MHz, CDCl3) δ  9.82 (d, J 2.6, 1H), 9.38 (s, 1H), 7.07 (dd, J 4.9, 2.6, 
1H), 3.22 (m, 1H), 2.54 (dt, J 20.6, 5.0, 1H) 2.19 (ddt, 
J 20.6, 11.7, 2.1), 1.75 (m, 1H), 1.67–1.37 (complex 
m, 5H), 1.13 (td, J 13.2, 3.6, 1H), 0.93 (s, 3H), 0.90 (s, 
3H), 0.88 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ  202.3, 192.9, 153.6, 137.4, 58.5, 44.3, 42.1, 37.7, 
37.1, 32.9, 32.8, 25.6, 21.9, 21.5, 18.4.  
[α]D20  −436 (c = 0.55, 95% EtOH). −428 (c = 0.5, CHCl3) lit. 
[α]D −237 (95% EtOH)327 
 
H
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9-Epidrimendiol 
 
To a solution of 9-epipolygodial (14) (103 mg, 0.44 mmol) in EtOH (10 mL) at 0°C was 
added NaBH4 (63 mg, 1.67 mmol). The reaction was stirred at 0 °C for 5 min and rt for 2 
h. H2O (40 mL) was added, and the reaction extracted with CH2Cl2 (3 x 20 mL). The 
combined organic fractions were dried (MgSO4), filtered and evaporated to provide the 
title compound as a white amorphous solid (102 mg, 0.43 mmol, 98% yield) used without 
further purification. The spectroscopic data obtained was consistent with data reported 
in the literature.273 
1H NMR (400 MHz, CDCl3): δ  5.84 (t, J = 3.5 Hz, 1H), 4.14 (d, J = 12.0 Hz, 1H), 4.01 
(d, J = 12.0 Hz, 1H), 3.94 (dd, J = 11.0, 4.5 Hz, 1H), 
3.64 (dd, J = 11.0, 5.9 Hz, 1H), 2.99 (br s, 2H), 2.16 
(dt, J = 18.8, 5.1 Hz, 1H), 1.92 (m, 1H), 1.78 (m, 1H), 
1.72–1.33 (complex m, 7H), 0.92 (br s, 6H), 0.88 (s, 
3H). 
13C NMR (100 MHz, CDCl3): δ  136.9, 127.8, 67.7, 63.2, 54.0, 43.3, 42.7, 36.5, 36.0, 
33.1, 33.0, 24.3, 22.0, 21.7, 18.8. 
9-Epidrimenol 
 
A solution of 9-epidrimendiol (116) (54 mg, 0.23 mmol) in EtOH (15 mL) was subjected to 
a hydrogen atmosphere (1 atm) with catalytic Pd/C. The reaction was stirred at rt for 1 h 
before being filtered through Celite™ and evaporated to dryness to yield a colourless oil. 
Purification via automated gradient flash column chromatography (silica; 0  20 % 
H
OH
H
OH
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EtOAc/hexane) provided the title compound as a white amorphous solid (33 mg, 0.15 
mmol, 65 % yield). The spectroscopic data obtained was consistent with data reported in 
the literature.273 
1H NMR (400 MHz, CDCl3): δ  5.57 (br s, 1H), 3.74 (m, 2H), 2.02 (m, 1H), 1.84 (m, 
1H), 1.74 (s, 3H), 1.68–1.57 (complex m, 2H), 1.57–
1.41 (complex m, 4H), 1.37–1.20 (complex m, 2H), 
0.92 (s, 3H), 0.91 (s, 3H), 0.87 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ  131.4, 124.6, 61.3, 57.6, 43.5, 42.7, 36.8, 36.1, 33.2, 
33.0, 24.0, 23.0, 22.2, 21.7, 18.8.  
(4aS,5S,8aS)-5-(bromomethyl)-1,1,4a,6-tetramethyl-1,2,3,4,4a,5,8,8a-octahydronaphthalene  
 
To (–)-drimenol (118) (72 mg, 0.32 mmol) and PPh3 (119 mg, 0.45 mmol) in CH2Cl2 (10 
mL) at 0 °C was added N-bromosuccinimide (83 mg, 0.47 mmol). The reaction was stirred 
at rt for 1 h before the solvent was removed under reduced pressure to yield a crude 
white semi-solid. Filtration through a short silica plug eluting with hexanes and 
subsequent evaporation of the solvent provided a crude colourless oil (50 mg). 
Purification via flash column chromatography (silica; hexane) provided the title 
compound as a colourless oil (10 mg, 0.035 mmol, 11% yield)  
HRMS Found [M–H]+ 283.1059, C15H2479Br requires M+, 
240.1061.  
νmax (NaCl):  2959, 2924, 1456, 1387, 1366, 1271, 1229, 1217, 
1206, 1074 cm−1.  
1H NMR (600 MHz, CDCl3): δ  4.49 (m, 1H), 3.66 (dd, J = 10.8, 2.1 Hz, 1H), 3.29 (dd, 
J = 10.8, 6.7 Hz, 1H), 2.37 (m, 1H), 2.05–1.79 
(complex m, 6H), 1.63–1.39 (complex m, 3H), 1.23–
H
Br
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1.10 (complex m, 3H), 0.88 (s, 3H), 0.86 (s, 3H), 0.82 
(s, 3H). 
13C NMR (150 MHz, CDCl3): δ  132.6, 123.9, 57.7, 50.0, 42.0, 39.3, 37.7, 33.2, 33.0, 
31.4, 23.6, 21.9, 21.7, 18.7, 13.9.  
MS (EI) m/z  285 ([81Br–H]-M+), 283 ([79Br–H]-M+), 221, 205, 191, 
177, 153, 147, 135, 123, 109, 107, 95, 81, 69, 55, 43, 
41. 
[α]D20      +34 (c 0.5, CHCl3).  
(4aS,5S,8aS)-5-(chloromethyl)-1,1,4a,6-tetramethyl-1,2,3,4,4a,5,8,8a-octahydronaphthalene  
 
To (–)-drimenol (118) (180 mg, 0.81 mmol) in CCl4 (15 mL) was added pyridine (3 mL) and 
triphenylphosphine (1.0 g, 3.81 mmol, excess). The reaction was stirred at reflux for 1 h 
before the solvent was removed under reduced pressure to yield a crude white semi-
solid. Filtration through a short silica plug eluting with 50% CH2Cl2:hexanes provided a 
colourless oil (450 mg). Purification via automated gradient flash column 
chromatography (silica; 0  10 % EtOAc/hexane) provided the title compound as a 
colourless oil (80 mg, 0.33 mmol, 41% yield).  
HRMS Found M+ 240.1648, C15H2535Cl requires M+, 
240.1645.  
νmax (NaCl):  2963, 2945, 2923, 2905, 2865, 2847, 1456, 1442, 
1389, 1366, 750 cm−1.  
1H NMR (600 MHz, CDCl3): δ  5.53 (m, 1H) 3.78 (dd, J = 11.6, 2.5 Hz, 1H), 3.50 (dd, 
J = 11.6, 6.4, 1H), 2.23 (s, 1H), 2.03 (m, 1H), 1.96 (m, 
1H), 1.89 (m, 1H), 1.84 (m, 3H), 1.59 (qt, J = 13.6, 3.1 
H
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Hz, 1H), 1.51 (d quint, J = 13.9, 3.6 Hz, 1H), 1.45 (m, 
1H), 1.25–1.17 (complex m, 2H), 1.15 (td, J = 13.1, 
3.9 Hz, 1H), 0.91 (s, 3H), 0.89 (s, 3H), 0.86 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ  132.4, 124.0, 57.5, 50.0, 43.1, 42.0, 39.5, 37.1, 33.2, 
33.0, 23.6, 21.9, 21.7, 18.7, 14.3.  
MS (EI) m/z  240 (35Cl-M+), 225, 147, 135, 125, 124, 123, 122, 
120, 110, 109, 107, 105, 97, 96, 95, 93, 91, 87, 82, 
81, 79, 77. 
[α]D20      negligible (c 1.0, CHCl3).  
((1S,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)methyl 
methanesulfonate 
 
To (–)-drimenol (118) (100 mg, 0.45 mmol) in CH2Cl2 (10 mL) was added methanesulfonyl 
chloride (42 μL, 62 mg, 0.54 mmol). The reaction was stirred at rt for 1 h before HCl (2 M, 
20 mL) was added. The organic layer was then separated and washed with sat. Na2CO3 
and HCl (2 M) before being dried (MgSO4), filtered and evaporated to provide the title 
compound as a yellow oil (149 mg) used without further purification. The spectroscopic 
data obtained was consistent with data reported in the literature.328 
1H NMR (600 MHz, CDCl3): δ  5.56 (m, 1H), 4.44 (dd, J = 10.0, 3.2 Hz, 1H), 4.26 (dd, 
J = 10.0, 6.1 Hz, 1H), 3.02 (s, 3H), 2.16 (s, 1H), 2.04 
(m, 1H), 1.97 (m, 1H), 1.89 (m, 1H), 1.76 (m, 3H), 
1.63–1.48 (complex m, 2H), 1.46 (m, 1H), 1.26–1.12 
(complex m, 3H), 0.92 (s, 3H), 0.89 (s, 3H), 0.86 (s, 
3H). 
13C NMR (150 MHz, CDCl3): δ  131.2, 124.6, 68.1, 53.8, 49.7, 41.9, 39.6, 37.5, 36.1, 
33.3, 33.0, 23.5, 21.9, 21.7, 18.6, 14.6. 
H
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(4aS,8aS)-1,1,4a,6-tetramethyl-5-methylene-1,2,3,4,4a,5,8,8a-octahydronaphthalene 
 
To crude drimenyl mesylate 160 (149 mg) in dry THF (10 mL) under N2 was added KOtBu 
(103 mg, 0.92 mmol). The reaction mixture was stirred at rt for 3 h and 40 °C for 30 min. 
A further portion of KOtBu (100 mg, 0.89 mmol) was added and the reaction stirred at 40 
°C for a further 2.5 h. CH2Cl2 (50 mL) and H2O (50 mL) were added, the layers were 
separated, and the aqueous portion extracted with CH2Cl2 (2 x 15 mL). The combined 
organic fractions were dried (MgSO4), filtered and evaporated to provide the title 
compound as a colourless oil (66 mg, 0.32 mmol, 71% yield over 2 steps). Used without 
further purification. The spectroscopic data obtained was consistent with data reported 
in the literature.329 
1H NMR (400 MHz, CDCl3): δ  5.69 (br s, 1H), 4.83 (d, J = 16.4 Hz, 2H), 2.22–1.98 
(complex m, 2H), 1.90 (d, J = 12.2 Hz, 1H) 1.82 (s, 
3H), 1.73–1.13 (complex m, 6H), 0.99 (s, 3H), 0.95 (s, 
3H), 0.89 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ  158.2, 131.2, 126.5, 103.7, 48.7, 42.2, 37.8, 37.7, 
33.4, 32.9, 24.3, 22.1, 21.1, 20.6, 19.1.  
bis(((1S,2S,4aS,8aS)-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl)methyl) sulfite 
 
Syn-drimanol 120 (70 mg, 0.31 mmol) in 50% SOCl2:CH2Cl2 (6 mL) was stirred at rt for 20 h 
before the solvent was removed under reduced pressure to yield a crude oil (70 mg). 
Purification via automated gradient flash column chromatography (silica; 0  25 % 
H
H
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EtOAc/hexane) provided the title compound as a colourless crystalline solid (42 mg, 
0.085 mmol (0.17 mmol equiv of drimanol), 55 % yield) and recovered starting material 
(22 mg, 0.097 mmol, 31 % recovered). 
HRMS Found [M+Na]+ 517.3690, C30H53O3NaS requires M+ 
517.3686.  
νmax (NaCl):  2922, 2867, 2851, 1465, 1457, 1387, 1366, 1210, 
1200, 1191, 956, 949, 930, 920, 755, 705 cm−1. 
1H NMR (600 MHz, CDCl3): δ  4.25 (dd, J = 10.1, 4.5 Hz, 1H), 4.18 (dd, J = 10.1, 4.5 
Hz, 1H), 3.99 (t, J = 9.9 Hz, 1H), 3.88 (t, J = 9.9 Hz, 
1H), 2.15 (m, 2H), 1.72–1.66 (complex m, 4H), 1.65–
1.49 (complex m, 8H), 1.46–1.36 (complex m, 6H), 
1.19 (td, J = 13.3, 3.7 Hz, 2H), 1.06 (tt, J = 12.8, 4.2 
Hz, 2H), 0.99 (dd, J = 7.5, 3.9 Hz, 6H), 0.92–0.88 
(complex m, 14H), 0.84 (s, 6H).  
13C NMR (150 MHz, CDCl3): δ  61.5, 60.7, 56.5, 56.4, 52.7, 52.6, 41.92, 41.90, 
39.91, 39.84, 37.7 (2C), 34.21, 34.19, 33.54, 33.53, 
33.28, 33.27, 28.85, 28.80, 21.6 (2C), 18.33, 18.31, 
17.40, 17.39, 17.06, 17.04, 15.64, 15.60. 
 [α]D20      +31 (c 1.15, CHCl3).  
(4aS,5S,6R,8aS)-5-(chloromethyl)-1,1,4a,6-tetramethyldecahydronaphthalene  
 
To anti-drimanol (119) (200 mg, 0.89 mmol) in CCl4 (15 mL) was added pyridine (5 mL) 
and triphenylphosphine (1.2g, 4.56 mmol, excess). The reaction was stirred at reflux for 
50 min before the solvent was removed under reduced pressure to yield a crude white 
H
Cl
169 
Chapter 5: Experimental Details 
 231 
semi-solid. Purification via a short silica plug eluting with hexanes provided the title 
compound as a colourless oil (155 mg, 0.64 mmol, 72 % yield)  
HRMS Found M+ 242.1804, C15H2735Cl requires M+ 
242.1801.  
νmax (NaCl):  2924, 2868, 2846, 1464, 1442, 1389, 1368, 1302, 
1282, 1114, 1035, 975, 743, 630 cm−1.  
1H NMR (400 MHz, CDCl3): δ  3.68 (dd, J = 11.8, 3.3 Hz, 1H), 3.50 (dd, J = 11.8, 3.3, 
1H), 1.89–1.78 (complex m, 2H), 1.73–1.55 (complex 
m, 3H), 1.49 (d quint, J = 13.9, 3.6 Hz, 1H), 1.42 (m 
1H), 1.38–1.25 (complex m, 2H), 1.17 (td, J = 13.3, 
4.0 Hz, 1H), 1.12–1.03 (complex m, 3H), 1.01 (d, J = 
6.4 Hz, 3H), 0.92 (s, 3H), 0.90–0.83 (complex m, 7H). 
13C NMR (100 MHz, CDCl3): δ  60.0, 55.1, 43.7, 41.9, 39.3, 38.4, 36.5, 33.6, 33.3, 
31.6, 21.8, 21.7, 20.7, 18.7, 15.1.  
MS (EI) m/z  242 (35Cl-M+), 229, 227, 137, 124, 123, 122, 121, 
120, 119, 118, 117, 109, 95. 
[α]D20      −6.5 (c 0.65, CHCl3).  
 
2-((1S,2R,4aS,8aR)-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl)acetonitrile  
 
To a solution of anti-drimanyl chloride (169) (161 mg, 0.66 mmol) in DMF (20 mL) was 
added KCN (740 mg, 11.4 mmol, excess). The reaction was heated to 70 °C and stirred for 
18 h. Water (30 mL) was added and the reaction extracted with toluene (3 x 20 mL). The 
combined organic fractions were dried (MgSO4), filtered and evaporated to yield the 
crude product as a colourless oil (75 mg). Purification via automated gradient flash 
H
CN
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column chromatography (silica; 0  15 % EtOAc/hexane) provided the title compound as 
a colourless oil (15 mg, 0.064 mmol, 10% yield) and recovered starting material (42 mg, 
0.17 mmol, 26 % yield). 
HRMS     Found M+ 233.2141, C16H27N requires M+, 233.2143.  
νmax (NaCl):  2926, 2869, 2846, 2242 (CN), 1463, 1443, 1426, 
1389, 1369, 1205, 1116, 1036, 992, 976 cm−1.  
1H NMR (600 MHz, CDCl3): δ  2.41 (dd, J = 17.6, 5.0 Hz, 1H), 2.25 (dd, J = 17.6, 4.5 
Hz, 1H), 1.84 (dq, J = 13.3, 3.1 Hz, 1H), 1.73 (m, 1H), 
1.67 (m, 1H), 1.65–1.56 (complex m, 2H), 1.50 (d 
quint, J = 14.1, 3.6 Hz, 1H), 1.43 (m, 1H), 1.32 (dq, J = 
12.8, 3.8 Hz, 1H), 1.17 (td, J = 13.5, 4.0 Hz, 1H), 
1.12–1.03 (complex m, 2H), 1.03–0.95 (complex m, 
2H), 0.92 (s, 3H), 0.90–0.84 (complex m, 7H). 
13C NMR (150 MHz, CDCl3): δ  120.6, 54.9, 54.4, 41.7, 39.5, 38.1, 36.3, 33.5, 33.3, 
32.4, 21.8, 21.6, 20.9, 18.7, 15.1, 14.2.  
MS (EI) m/z  233 (M+), 219, 218, 123, 109, 95, 87, 82, 81.  
[α]D20      negligible (c 0.7, CHCl3).  
 
2-((1S,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)acetonitrile  
 
To a suspension of KCN (1.4 g, 21.5 mmol) in DMF (2 mL) was added drimenyl mesylate 
(160) (401 mg, 1.33 mmol) in DMF (3 mL). The resulting slurry was stirred at 70 °C for 18 
h before the crude material was filtered through a silica plug eluting with 30 % 
EtOAc:hexane to yield a yellow oil (262 mg). Purification via automated gradient flash 
H
CN
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column chromatography (silica; 0  12 % EtOAc:hexane) provided the title compound as 
a colourless oil (54 mg, 0.23 mmol, 17% yield). The spectroscopic data obtained was 
consistent with data reported in the literature.330  
1H NMR (400 MHz, CDCl3): δ  5.59 (m, 1H), 2.50 (dd, J = 16.9, 4.0 Hz, 1H), 2.27 (dd, 
J = 16.8, 7.0 Hz, 1H), 2.21 (m, 1H), 2.05 (m, 1H), 1.91 
(m, 1H), 1.87–1.78 (complex m, 4H), 1.63–1.42 
(complex m, 3H), 1.27–1.14 (complex m, 2H),1.06 
(dt, J = 12.8, 4.5 Hz, 1H), 0.92 (s, 3H), 0.90 (s, 3H), 
0.87 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ  131.2, 125.0, 121.0, 51.6, 49.7, 41.9, 39.6, 36.5, 
33.2, 32.9, 23.5, 21.9, 21.6, 18.6, 15.0, 13.8. 
Drimenal 
 
To a solution of (–)-drimenol (118) (160 mg, 0.72 mmol) at 0 °C in CH2Cl2 (5 mL) was 
added Dess–Martin periodinane (350 mg, 0.83 mmol) slowly. The reaction was warmed 
to rt and stirred for 15 min. Hexanes (10 mL) was added and the crude reaction mixture 
purified on a silica plug eluting with 60% CH2Cl2:hexanes to provide the title compound as 
a colourless oil (148 mg, 0.67 mmol, 93% yield). The spectroscopic data obtained was 
consistent with data reported in the literature.273 
1H NMR (600 MHz, CDCl3): δ  9.62 (d, J = 5.1 Hz, 1H), 5.62 (m, 1H), 2.52 (s, 1H), 
2.00 (m, 1H), 1.90 (m, 1H), 1.60 (dq, J = 13.3, 2.5 Hz, 
1H), 1.55 (m, 3H), 1.47 (m, 1H), 1.40–1.35 (complex 
m, 2H), 1.25–1.10 (complex m, 3H), 1.08 (dd, J = 
12.2, 4.7 Hz, 1H), 1.00 (s, 3H), 0.86 (s, 3H), 0.81 (s, 
3H). 
H
O H
155 
Chapter 5: Experimental Details 
 234 
13C NMR (100 MHz, CDCl3): δ  206.6, 127.8, 125.5, 67.6, 49.1, 42.0, 40.4, 37.0, 
33.2, 33.0, 23.7, 22.1, 21.6, 18.3, 15.7.  
(S)-2-phenyl-1-((1S,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalen-1-
yl)ethyl formate 
 
To a solution of drimenal (155) (50 mg, 0.28 mmol) in dry THF (5 mL) at 0 °C under N2 was 
added benzylmagnesium chloride (700 μL, 2 M in THF, 1.4 mmol, excess). The reaction 
was stirred for 18 h before sat. NH4Cl was added (5 mL) and the reaction extracted with 
CH2Cl2 (3 x 10 mL). The combined organic fractions were dried (MgSO4), filtered and 
evaporated to yield a colourless oil (88 mg). Purification via automated gradient flash 
column chromatography (silica; 0  20 % EtOAc/hexane) provided the title compound as 
a white amorphous solid (35 mg, 0.10 mmol, 36% yield). 
HRMS Found [M+Na]+ 363.2298, C23H32O2Na requires M+ 
335.2295.  
νmax (NaCl):  3027, 2948, 2923, 2866, 2848, 1721 (C=O), 1455, 
1389, 1173, 700 cm−1.  
1H NMR (600 MHz, CDCl3): δ  8.02 (s, 1H), 7.33–7.19 (complex m, 5H), 5.59 (m, 
1H), 5.43 (dd, J = 9.9, 5.3 Hz, 1H), 3.13 (dd, J = 13.0, 
5.3 Hz, 1H), 2.99 (dd, J = 13.0, 9.9 Hz, 1H), 2.02 (m, 
3H), 2.00 (br s, 1H), 1.93 (m, 1H), 1.85 (m, 1H), 1.52 
(m, 1H), 1.39 (dq, J = 13.8, 3.3 Hz, 1H), 1.32–1.21 
(complex m, 2H), 1.02–1.94 (complex m, 2H), 0.83 
(s, 3H), 0.80 (s, 3H), 0.73 (s, 3H), 0.18 (td, J = 13.3, 
3.6 Hz, 1H). 
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13C NMR (150 MHz, CDCl3): δ  160.9, 137.4, 132.0, 129.9, 128.5, 126.7, 125.8, 72.8, 
54.2, 49.7, 42.1, 41.8, 39.4, 36.6, 33.3, 32.8, 24.6, 
23.3, 22.2, 18.5, 13.9.  
 [α]D20      –46 (c 0.75, CHCl3).  
(R)-(2,5-dimethoxyphenyl)((1S,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,5,6,7,8,8a-
octahydronaphthalen-1-yl)methanol 
 
To Mg ribbon (200 mg) under N2 was added a small crystal of I2 which was allowed to sit 
for 5 min. Dry THF (5 mL) was added, followed by dropwise addition of 2-bromo-1,4-
dimethoxybenzene (1.0 g, 4.61 mmol). The flask was passively cooled to rt before sitting 
for 10 min. The resulting Grignard reagent in THF was added slowly to a solution of 
drimenal (155) (190 mg, 0.86 mmol) in dry THF (5 ml) at 0 °C under N2. The reaction was 
warmed to rt before being stirred for 1 h. Sat. NH4Cl (20 mL) was added and the reaction 
extracted with CH2Cl2 (3 x 20 mL). The combined organic fractions were dried (MgSO4), 
filtered and evaporated to yield a colourless oil (509 mg). Purification via automated 
gradient flash column chromatography (silica; 0  12 % EtOAc:hexane) provided the title 
compound as a colourless oil (290 mg, 0.81 mmol, 94% yield) 
HRMS     Found M+ 358.2505, C23H34O3 requires M+ 358.2508.  
νmax (NaCl):  3469 (br, -OH), 2924, 2865, 2847, 1493, 1465, 1441, 
1387, 1274, 1218, 1179, 1051, 1028, 835, 804, 757, 
729 cm−1.  
1H NMR (600 MHz, CDCl3): δ  7.26 (d, J = 2.9 Hz, 1H), 6.76 (d, J = 8.8 Hz, 1H), 6.73 
(dd, J = 2.9, 8.8 Hz, 1H), 5.60 (m, 1H), 5.25 (s, 1H), 
3.79 (s, 3H), 2.65 (s, 1H), 2.15 (m, 1H), 1.98 (m, 2H), 
1.65 (qt, J = 13.8, 3.0 Hz, 1H), 1.56 (m, 3H), 1.52 (m, 
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1H), 1.48 (m, 1H), 1.33–1.21 (complex m, 3H), 1.14 
(s, 3H), 0.96 (s, 3H), 0.91 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ  153.3, 150.2, 135.3, 133.2, 126.7, 114.5, 111.5, 
110.9, 67.5, 58.3, 55.8, 55.2, 50.2, 42.3, 40.0, 37.8, 
33.6, 33.1, 24.8, 23.5, 22.5, 19.1, 15.4.  
MS (EI) m/z  358 (M+), 340, 325, 311, 265, 217, 205, 191, 176, 
167, 151, 137, 123, 107, 95, 81.  
[α]D20      −15 (c 2.0, CHCl3).  
(R)-2-phenyl-1-((1S,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalen-1-
yl)ethanol 
 
To a solution of drimenal (155) (37 mg, 0.17 mmol) in dry THF (5 mL) at 0 °C under N2 was 
added benzylmagnesium chloride (600 μL, 2 M in THF, 1.2 mmol, excess). The reaction 
was stirred for 18 h before sat. NH4Cl was added (15 mL) and the reaction extracted with 
CH2Cl2 (3 x 10 mL). The combined organic fractions were dried (MgSO4), filtered and 
evaporated to yield a colourless oil (200 mg, containing by-products from the reagent). 
Purification via automated gradient flash column chromatography (silica; 0  50 % 
EtOAc:hexane) provided the title compound as a colourless oil (38 mg, 0.12 mmol, 71% 
yield) 
HRMS Found [M+Na]+ 335.2346, C22H32ONa requires M+ 
335.2345.  
H
HO
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νmax (NaCl):  3589, 3483 (br, -OH), 3026, 2947, 2922, 2903, 2863, 
2848, 1495, 1453, 1441, 1388, 1365, 1212, 1116, 
1081, 1055, 1035, 837, 752, 719, 700 cm−1.  
1H NMR (400 MHz, CDCl3): δ  7.40 (m, 1H), 7.34 (t, 7.2 Hz, 2H), 7.26 (t, 7.2 Hz, 2H), 
5.66 (m, 1H), 4.18 (t, J = 7.7 Hz, 1H), 3.16 (dd, J = 
13.3, 8.9 Hz, 1H), 2.84 (dd, J = 13.4, 5.9 Hz, 1H), 2.04 
(s, 3H), 2.03–1.87 (complex m, 3H), 1.75 (d, J = 13.0 
Hz, 1H), 1.53 (m, 1H), 1.43–1.36 (complex m, 2H), 
1.15–1.08 (complex m, 2H), 0.96 (s, 3H), 0.90 (s, 3H), 
0.88 (s, 3H), 0.65 (dt, J = 13.3, 3.0 Hz, 1H). 
13C NMR (150 MHz, CDCl3): δ  139.4, 132.5, 129.6, 128.5, 126.5, 126.4, 71.0, 58.1, 
49.9, 45.6, 42.1, 39.8, 36.9, 33.4, 32.9, 25.0, 23.4, 
22.3, 18.7, 14.4.  
 [α]D20  +32 (c 0.75, CHCl3). 
(S)-1-((1S,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)prop-2-en-
1-ol 
 
To a solution of drimenal (155) (50 mg, 0.23 mmol) in dry THF (4 mL) at 0 °C under N2 was 
added vinylmagnesium bromide (800 μL, 0.8M in THF, 0.64 mmol, excess). The reaction 
was stirred for 18 h before sat. NH4Cl was added (15 mL) and the reaction extracted with 
CH2Cl2 (3 x 15 mL). The combined organic fractions were dried (MgSO4), filtered and 
evaporated to yield a colourless oil (64 mg). Purification via automated gradient flash 
column chromatography (silica; 0  10 % EtOAc:hexane) provided the title compound as 
a colourless oil (44 mg, 0.20 mmol, 87% yield) 
HRMS     Found M+ 248.2137, C17H28O requires M+ 248.2140]. 
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νmax (NaCl):  3465 (br, -OH), 2949, 2923, 2865, 2847, 1455, 1441, 
1388, 1365, 1134, 1052, 987, 915, 836 cm−1.  
1H NMR (400 MHz, CDCl3): δ  6.10 (ddd, J = 17.3, 10.6, 4.7 Hz, 1H), 5.61 (m, 1H), 
5.22 (dt, J = 17.3, 1.7 Hz, 1H), 5.06 (ddd, J = 10.6, 
2.0, 1.5 Hz, 1H), 4.55 (m, 1H), 2.07 (s, 1H), 2.00–1.90 
(complex m, 2H), 1.78 (m, 3H), 1.60 (qt, J = 13.6, 3.2 
Hz, 1H), 1.52–1.41 (complex m, 2H), 1.24–1.14 
(complex m, 2H), 1.05–0.99 (complex m, 4H), 0.93 
(s, 3H), 0.89 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ  144.4, 132.3, 126.5, 112.8, 70.0, 60.8, 50.0, 42.1, 
40.3, 36.9, 33.4, 32.9, 24.3, 23.4, 22.3, 18.8, 15.0.  
MS (EI) m/z  248 (M+), 193, 192, 177, 149, 135, 123, 121, 110, 
109, 107, 97, 95, 81.  
[α]D20      −22 (c 1.75, CHCl3).  
9-Epidrimenal 
 
To a solution of 9-epidrimenol (117) (34 mg, 0.15 mmol) at 0 °C in CH2Cl2 (5 mL) was 
added Dess–Martin periodinane (100 mg, 0.24 mmol) slowly. The reaction was warmed 
to rt and stirred for 30 min. Hexanes (10 mL) was added and the crude reaction mixture 
purified on a silica plug eluting with 60% CH2Cl2:hexanes to provide the title compound as 
a colourless oil (28 mg, 0.13 mmol, 87 % yield). Used without full characterisation.  
1H NMR (400 MHz, CDCl3): δ  9.61 (d, J = 5.3 Hz, 1H), 5.77 (m, 1H), 2.29–2.19 
(complex m, 2H), 1.98 (m, 1H) 1.71 (dd, J = 11.8, 5.2 
Hz, 1H), 1.68–1.56 (complex m, 4H), 1.55–1.44 
H
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(complex m, 2H), 1.33–1.15 (complex m, 3H), 0.95 
(s, 3H), 0.94 (s, 3H), 0.93 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ  202.5, 126.6, 126.4, 68.3, 44.6, 42.4, 37.9, 35.9, 
33.01, 32.97, 24.2, 22.4, 22.0, 21.1, 18.5. 
1-((1R,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)prop-2-en-1-
ol 
 
To a solution of 9-epidrimenal (180) (28 mg, 0.13 mmol) in dry THF (5 mL) at 0 °C under 
N2 was added vinylmagnesium bromide (500 μL, 0.8M in THF, 0.40 mmol, excess). The 
reaction was stirred for 72 h before sat. NH4Cl was added (15 mL) and the reaction 
extracted with CH2Cl2 (3 x 15 mL). The combined organic fractions were dried (MgSO4), 
filtered and evaporated to yield a colourless oil (43 mg) Purification via automated 
gradient flash column chromatography (silica; 0  10 % EtOAc/hexane) provided the title 
compound as a colourless oil (7 mg, 0.028 mmol, 22% yield) 
HRMS  Found M+ 248.2137, C17H28O requires M+ 248.2140.  
νmax (NaCl):  3497 (br, -OH), 2938, 2909, 1462, 1388, 1379, 1365, 
1124, 1111, 1048, 992, 917, 831 cm−1.  
1H NMR (600 MHz, CDCl3): δ  5.95 (ddd, J = 17.1, 10.5, 4.1 Hz, 1H), 5.73 (m, 1H), 
5.28 (dt, J = 17.1, 1.9 Hz, 1H), 5.06 (dt, J = 10.5, 1.9 
Hz, 1H), 4.53 (m, 1H), 2.11 (m, 1H), 1.88 (m, 1H), 
1.78 (dd, J = 11.4, 6.0 Hz, 1H), 1.73–1.65 (complex 
m, 6H), 1.51 (m, 1H), 1.45 (m, 1H), 1.27–1.19 
(complex m, 2H), 0.91 (s, 3H), 0.90 (s, 3H), 0.87 (s, 
3H). 
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13C NMR (150 MHz, CDCl3): δ  144.1, 131.0, 126.9, 112.1, 68.5, 60.6, 42.6, 42.1, 
36.9, 35.9, 33.1, 32.8, 25.6, 24.7, 22.2, 21.8, 18.8.  
MS (EI) m/z  248 (M+), 192, 191, 177, 149, 135, 121, 109, 107, 95, 
87, 82.  
[α]D20      −143 (c 0.35, CHCl3).  
Indole synthesis 
6-Bromoveratraldehyde 
 
To veratraldehyde (184) (3,4-dimethoxybenzaldehyde, 10.0 g, 60.2 mmol) in MeOH (250 
mL) was added bromine (3.2 mL, 62 mmol, 1.1eq). The reaction was stirred under air at rt 
for 2 h. The MeOH was evaporated under reduced pressure and the remaining residue 
dissolved in CH2Cl2 (150 mL), and washed with saturated sodium thiosulfate (200 mL) and 
brine (200 mL). The resulting organic fraction was dried (Na2SO4), filtered, and the 
solvent removed under reduced pressure. NMR analysis showed residual starting 
material, so the material was resubjected to identical reaction conditions with a further 
0.5 mL of bromine. Subsequent work up provided the title compound as a white 
amorphous solid (15.0 g, 61.2 mmol, >99% yield). Used without further purification. The 
spectroscopic data obtained was consistent with data reported in the literature.331 
1H NMR (400 MHz, CDCl3): δ   10.18 (s, 1H), 7.41 (s, 1H), 3.95 (s, 3H), 3.91 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ  190.9, 154.7, 149.1, 126.7, 120.5, 115.6, 110.6, 56.6, 
56.3. 
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Methyl 2-azidoacetate  
 
Sodium azide (4.2 g, 64.6 mmol) was added to methyl 2-bromoacetate (186) (3.0 mL, 
4.86 g, 31.8 mmol) in acetone:water (3:1, 80 mL). The mixture was stirred in air at rt for 
30 min before being diluted with water (100 mL), and extracted with CH2Cl2 (3 x 30 mL). 
The combined organic fractions were dried (MgSO4), filtered, and the solvent removed 
under reduced pressure to provide the title compound as a colourless oil (3.66 g, 31.8 
mmol, >99% yield). Used without further purification. The spectroscopic data obtained 
was consistent with data reported in the literature.332 
1H NMR (400 MHz, CDCl3): δ   3.88 (s, 2H), 3.80 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ   168.9, 52.7, 50.4. 
(Z)-Methyl 2-azido-3-(2-bromo-4,5-dimethoxyphenyl)acrylate 
 
Methyl 2-azidoacetate (187) (3.0 g, 26.1 mmol) and 6-bromoveratraldehyde (185) (2.56 
g, 10.4 mmol) were combined with dry MeOH (15 mL), and the resulting suspension 
cooled to -8 °C in an ice/salt bath. To this suspension was added a solution of sodium 
methoxide (sodium metal (620 mg, 26.97 mmol) in MeOH (15 mL)). The suspension was 
stirred at -8 °C for 10 mins, before dry THF was added until the majority of the starting 
materials had dissolved. The resulting solution was stirred at -8 °C for 90 min, before the 
flask was sealed and warmed to 4 °C for 16 h (without stirring). The resulting suspension 
of fine needles in a yellow solution was then poured onto ice cold saturated NH4Cl 
solution (100 mL), and the solid collected by filtration on a Buchner funnel. The pale-
yellow solid was washed with ice-cold water (2 x 50 mL), then collected by dissolution in 
CH2Cl2. The CH2Cl2 was dried (MgSO4), filtered, and the solvent removed under reduced 
O
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pressure to provide the title compound as an off-white amorphous solid (2.01 g, 5.9 
mmol, 57 % yield) used without further purification. 
HRMS Found M+ 341.0000, C12H12N3O479Br requires M+ 
341.0011. 
νmax (NaCl):  2106, 1701, 1501, 1433, 1387, 1265, 1209, 1167, 
862, 806, 758 cm−1. 
1H NMR (400 MHz, CDCl3): δ  7.84 (s, 1H), 7.23 (s, 1H), 7.06 (s, 1H), 3.92 (s, 3H), 
3.91 (s, 3H), 3.89 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ  164.1, 150.4, 150.0, 125.22, 125.21, 123.8, 117.4, 
115.5, 113.4, 56.30, 56.27, 53.2. 
MS (EI) m/z  343 (81Br-M+), 341 (79Br-M+), 300, 298, 283, 281, 
268, 266, 256, 254, 235, 159, 144, 132, 102, 59. 
Methyl 4-bromo-6,7-dimethoxy-1H-indole-2-carboxylate 
 
Azidoacrylate 188 (2.01 g, 5.9 mmol) was refluxed under N2 in dry m-xylene for 1 hr. The 
mixture turned bright yellow, and was evaporated to dryness under reduced pressure to 
yield a yellow oil. Purification via automated gradient flash chromatography (silica; 0  
30 % EtOAc:hexane) provided the title compound as an amorphous white solid (962 mg, 
2.8 mmol, 47 % yield) 
HRMS Found M+ 312.9953, C12H12NO479Br requires M+ 
312.9950. 
νmax (NaCl):  3322, 2938, 2837, 1705, 1628, 1508, 1441, 1321, 
1258, 1206, 1130, 1067, 827, 750 cm−1. 
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1H NMR (400 MHz, CDCl3): δ  9.10 (br s, 1H, N-H), 7.16 (d, J = 2.4 Hz, 1H), 7.07 (s, 
1H), 3.98 (s, 3H), 3.94 (s, 3H), 3.92 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ  162.1, 149.4, 133.9, 131.9, 127.5, 124.8, 113.1, 
109.8, 109.5, 61.2, 57.5, 52.3. 
MS (EI) m/z  315 (81Br-M+), 313 (79Br-M+), 300, 298, 283, 281, 
268, 266, 254, 252, 240, 238, 159, 144, 120, 118, 87, 
84, 82.  
(4-Bromo-6,7-dimethoxy-1H-indol-2-yl)methanol 
 
Methyl 4-bromo-6,7-dimethoxy-1H-indole-2-carboxylate (189) (962 mg, 2.8 mmol) was 
added to a suspension of LiAlH4 (200 mg, 5.3 mmol) in t-butyl methyl ether and stirred at 
35 °C for 30 min. The reaction mixture was then cooled to 0 °C, before being quenched 
by the subsequent addition of water (200 μL), NaOH (1 M aq., 200 μL), and water (600 
μL), and stirred for 15 min. The reaction mixture was then dried (MgSO4), and filtered 
through Celite™ with CH2Cl2 (100 mL). The solvents were removed under reduced 
pressure to provide the title compound as a white amorphous solid (843 mg, 2.9 mmol, 
>99 % yield). Used without further purification. 
HRMS Found M+ 284.9990, C11H12NO379Br requires M+ 
285.0001. 
νmax (NaCl):  3426, 1632, 1512, 1422, 1333, 1248, 1229, 1123, 
1015, 789 cm−1. 
1H NMR (400 MHz, DMSO-d6): δ  6.99 (s, 1H), 6.17 (s, 1H), 5.14 (t, J = 6.0 Hz , 1H, O-
H), 4.55 (d, J = 5.6 Hz, 2H), 3.84 (s, 3H), 3.82 (s, 3H). 
13C NMR (100 MHz, DMSO-d6): δ  146.5, 141.5, 133.9, 130.3, 125.0, 110.4, 106.0, 98.8, 
60.5, 57.4, 56.6. 
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MS (EI) m/z  287 (81Br-M+), 285 (79Br-M+), 272, 270, 254, 252, 
226, 224, 117, 99, 87, 84, 82, 79.  
4-bromo-6,7-dimethoxy-1H-indole-2-carbaldehyde 
 
(4-Bromo-6,7-dimethoxy-1H-indol-2-yl)methanol (190) (843 mg, 2.9 mmol) was 
suspended in CH2Cl2 (15mL), and slowly added (~20 min) to a suspension of Dess-Martin 
periodinane (2.4 g, 5.7 mmol) and NaHCO3 (1.8 g, 21.4 mmol) in CH2Cl2 (15 mL) at 0 °C. 
The resulting suspension was stirred for 45 min at 0 °C before water (50 mL) was added, 
followed by solid sodium metabisulfite until the mixture stopped producing bubbles. The 
organic fraction was separated, and extracted further with CH2Cl2 (2 x 10 mL). The 
combined organic phase was washed with saturated NaHCO3 (50 mL), before being dried 
(MgSO4), filtered, and evaporated under reduced pressure to yield a crude brown solid. 
The crude material was filtered through a plug of silica eluting with EtOAc:hexanes (3:7, 
100 mL) to provide the title compound as a pale yellow amorphous solid (796 mg, 2.8 
mmol, 97 % yield). 
HRMS Found M+ 282.9838, C11H10NO379Br requires M+ 
282.9844. 
νmax (NaCl):     3298, 1663, 1622, 1508, 1321, 1244, 1136 cm−1. 
1H NMR (400 MHz, CDCl3): δ  9.79 (s, 1H), 9.17 (br s, 1H, N-H), 7.20 (d, J = 2.2 Hz, 
1H), 7.10 (s, 1H), 3.98 (s, 3H), 3.94 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ  181.4, 150.6, 136.2, 133.9, 133.2, 124.7, 115.2, 
113.4, 110.9, 61.2, 57.5. 
MS (EI) m/z  285 (81Br-M+), 283 (79Br-M+), 270, 268, 161, 146, 
133, 118, 105, 87. 
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Chlorocarbonylbis(triphenylphosphine)rhodium(I) 
 
Rhodium(III) chloride (0.41 g, 1.91 mmol) was added to a solution of water (0.2 mL, 10.2 
mmol) in DMF (15 mL) in a sealed tube. The suspension was refluxed for 1 h, sonicated 
for 30 min at rt, then refluxed again for 1.5 h until the solid dissolved and the solution 
turned yellow. The solution was filtered to remove residual solid material, and PPh3 (0.97 
g, 3.7 mmol) was added slowly, liberating CO from the complex, and forming a solid 
yellow crystalline product. The suspension was poured onto ice cold water (50 mL), and 
the supernatant decanted away. The resulting solid was washed with hot diethyl ether (4 
x 5 mL), and dried under reduced pressure to provide the title compound as a fine yellow 
powder (910 mg, 1.32 mmol, 69 %). The spectroscopic data obtained was consistent with 
data reported in the literature.333 
νmax (NaCl):     1973, 1481, 1435, 1096, 745, 692 cm−1. 
1H NMR (400 MHz, CDCl3): δ   7.78–7.69 (m, 12H), 7.35–7.35 (m, 18H). 
13C NMR (100 MHz, CDCl3): δ  134.9 (t, J = 6.3 Hz), 133.1 (t, J = 28.1 Hz), 130.2 (s), 
128.3 (t, J = 4.9 Hz) (carbonyl not observed by 13C 
NMR). 
31P NMR (162 MHz, CDCl3): δ   29.0 (d, J = 127.2 Hz). 
4-bromo-6,7-dimethoxyindole 
 
To freshly distilled m-xylene (15 mL) was added 
chlorocarbonylbis(triphenylphosphine)rhodium(I) (193) (17 mg, 0.025 mmol) and the 
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suspension stirred at 80 °C until the complex had completely dissolved to form a pale 
yellow solution (~15 min). dppp (20 mg, 0.048 mmol) was added and the solution turned 
bright yellow. After 15 mins, a fine yellow precipitate was formed (cis-
chlorocarbonyl(dppp)rhodium(I)). 4-bromo-6,7-dimethoxyindole-2-carboxaldehyde (92, 
60 mg, 0.21 mmol) was added and the suspension was heated to reflux. After 18 h 
stirring at reflux, the resulting light-brown solution was evaporated to dryness under 
reduced pressure, dissolved in EtOAc:hexanes 1:1, and filtered through a plug of silica 
eluting with EtOAc:hexanes (1:1, 100 mL) to yield 63 mg of crude material. Purification 
via automated gradient flash chromatography (silica; 0  60 % EtOAc/hexane) provided 
the title compound as an off-white amorphous solid (22 mg, 0.086 mmol, 41 %). 
HRMS Found M+ 254.9886, C10H10NO279Br requires M+ 
254.9895. 
νmax (NaCl):  3354, 2938, 1504, 1410, 1337, 1294, 1233, 1082, 
949, 882, 826, 772, 729 cm−1. 
1H NMR (400 MHz, CDCl3): δ  8.33 (br s, 1H, N-H), 7.18 (t, J = 2.5 Hz, 1H), 7.02 (s, 
1H), 6.49 (t, J = 2.5 Hz, 1H), 3.98 (s, 3H), 3.91 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ  147.4, 134.2, 130.6, 125.2, 124.4, 111.8, 107.8, 
103.3, 61.1, 57.8. 
MS (EI) m/z  257 (81Br-M+), 255 (79Br-M+), 242, 240, 227, 133, 
122, 121, 120, 119, 118, 117. 
X-ray crystallography data 
X-ray data was collected and processed by Dr. Nathan Kilah at the University of Tasmania 
and at the Australian Synchrotron. 
X-ray diffraction data for compounds 12, 14, 54, 116, 118, 121, 139, 168, and 174 were 
collected with monochromated Cu Kα radiation (λ = 1.54178 Å) from an Incoatec IS 
Cu microsource on a Bruker D8 Quest, equipped with a PHOTON 100 CMOS detector. 
Single crystals were mounted on nylon loops with viscous immersion oil, and placed into 
a chilled nitrogen stream (Oxford Cryosystems Cobra), and the data were collected at 
100(2) K with the APEX3 software. Series of  and  scans were performed to a 
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maximum resolution of 0.79 Å. X-ray diffraction data for compounds 15, 122, and 137 
were collected on the MX1 beamline of the Australian Synchrotron,334,335 with silicon 
double crystal monochromated radiation (λ = 0.71073 Å). All structures were solved using 
charge flipping methods in SUPERFLIP,336 or Intrinsic Phasing with SHELXT,337 and refined 
using full-matrix least-squares on F2 with SHELXL within the OLEX2 suite.338,339 
Comparisons with the known stereochemistry of the polygodial starting material, 12, 
refinement of the Flack parameter,340 and analysis of the Bayesian statistics of the Bijvoet 
pairs in PLATON,341,342 were used to assign absolute configuration of the stereogenic 
carbon centers. Non-hydrogen atoms were refined with anisotropic displacement 
parameters. Hydrogen atoms on carbon were generally visible in the diffraction map, but 
were included at calculated positions and ride on the atoms to which they are attached. 
Hydrogen atoms on the oxygen atoms, with the exception of those in 122, were visible in 
the difference map and their positions were refined. The alcohol hydrogen atoms in 122 
were not easily identified, and a combination of electron density and anticipated 
hydrogen bonding patterns were used to place the hydrogen atoms. Molecular graphics 
were produced with OLEX2.339 Crystallographic data have been deposited with the 
Cambridge Crystallographic Data Centre (1570561–1570569, 1571233). 
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Compound # 12 14 15 
    
formula C15H22O2 C15H22O2 C15H26O2 
formula weight 234.32 234.32 238.36 
crystal habit, color needle, colorless plate, colorless plate, colorless 
crystal size, mm 0.05 x 0.10 x 0.20 0.06 x 0.28 x 0.28 0.01 x 0.04 x 0.04 
temperature, K 100 100 100 
crystal system orthorhombic orthorhombic monoclinic 
space group P212121 P212121 P21 
a,  Å 7.5624(2) 6.6675(2) 7.3930(15) 
b,  Å 15.3693(4) 6.7401(2) 10.397(2) 
c,  Å 22.9240(6) 29.3269(8) 18.193(4) 
,    95.29(3) 
Volume, Å3 2664.43(12) 1317.94(7) 1392.4(5) 
Z 8 4 4 
Z’ 2 1 2 
Dcalc g.cm–3 1.168 1.181 1.137 
radiation Cu K ( = 
1.54178) 
Cu K ( = 
1.54178) 
Mo K ( = 
0.71073) 
, mm–1 0.592 0.598 0.073 
GOF 1.066 1.097 1.044 
independent reflns 4597 2608 7719 
obs reflns (I > 2.0σ(I)), Rint 4480 (0.0263) 2602 (0.0231) 6601 (0.0698) 
2θ range,  6.924–132.386 12.07–144.798 4.518–63.452 
final R, wR (I > 2.0σ(I)) 0.0266, 0.0665 0.0313, 0.0819 0.0553, 0.1309 
R, wR (all data) 0.0275, 0.0659 0.0313, 0.0820 0.651, 0.1389 
largest diff peak and hole, e Å–3 0.263, -0.146 0.198, -0.176 0.330, –0.261 
Flack parameter –0.03(3) 0.05(2) 0.4(5)b 
CCDC No. 1570561 1570562 1570563 
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Compound # 116 121 122 
    
formula C15H26O2 C15H28O2 C15H28O2 
formula weight 238.36 240.37 240.37 
crystal habit, color plate, colorless rod, colorless plate, colorless 
crystal size, mm 0.01 x 0.10 x 0.12 0.10 x 0.10 x 0.30 0.005 x 0.05 x 0.05 
temperature, K 100 100 100 
crystal system orthorhombic orthorhombic orthorhombic 
space group P212121 P212121 C2221 
a,  Å 6.4338(2) 7.0240(2) 8.3986(17) 
b,  Å 13.4695(3) 8.5288(2) 12.780(3) 
c,  Å 32.2541(8) 22.6967(5) 26.660(5) 
,     
Volume, Å3 2795.14(13) 1359.68(6) 2861.6(10) 
Z 8 4 8 
Z’ 2 1 1 
Dcalc g.cm–3 1.133 1.174 1.116 
radiation Cu K ( = 
1.54178) 
Cu K ( = 
1.54178) 
Mo K ( = 
0.71073) 
, mm–1 0.565 0.581 0.071 
GOF 1.056 1.088 1.075 
independent reflns 4794 2687 3938 
obs reflns (I > 2.0σ(I)), Rint 4131 (0.0565) 2599 (0.0351) 3772 (0.0443) 
2θ range,  7.112–132.832 7.790–144.234 7.072–63.400 
final R, wR (I > 2.0σ(I)) 0.0460, 0.0992 0.0313, 0.0800 0.0544, 0.1416 
R, wR (all data) 0.0584, 0.1042 0.0324, 0.0808 0.0568, 0.1433 
largest diff peak and hole, e Å–3 0.203, -0.223 0.157, –0.205 0.285, -0.226 
Flack parameter 0.14(12) 0.02(6) 0.0(3)b 
CCDC No. 1570564 1570565 1570566 
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Compound # 118 168 174 
    
formula C15H26O C30H54O3S C23H32O2 
formula weight 222.36 494.79 340.48 
crystal habit, color plate, colorless needle, colorless plate, colorless 
crystal size, mm 0.18 x 0.18 x 0.18 0.04 x 0.04 x 0.20 0.06 x 0.10 x 0.10 
temperature, K 100 100 100 
crystal system monoclinic orthorhombic orthorhombic 
space group P21 P212121 P212121 
a,  Å 7.3963(2) 21.9131(5) 7.3487(2) 
b,  Å 22.4145(5) 7.3410(2) 12.9019(3) 
c,  Å 12.2947(2) 7.3410(2) 20.5850(5) 
,  93.7600(10)   
Volume, Å3 2033.88(8) 2777.09(12) 1951.71 (8) 
Z 6 4 4 
Z’ 3 1 1 
Dcalc g.cm–3 1.089 1.183 1.159 
radiation Cu K ( = 
1.54178) 
Cu K ( = 
1.54178) 
Cu K ( = 
1.54178) 
, mm–1 0.0493 1.241 0.553 
GOF 1.045 1.161 1.062 
independent reflns 8286 5925 3410 
obs reflns (I > 2.0σ(I)), Rint 7996 (0.0321) 5844 (0.0741) 3260 (0.0297) 
2θ range,  7.206–149.274 6.518–158.546 8.088–133.318 
final R, wR (I > 2.0σ(I)) 0.0339, 0.0897 0.0538, 0.1371 0.0316, 0 
0786 
R, wR (all data) 0.0352, 0.0907 0.0544, 0.1375 0.0334, 0.0801 
largest diff peak and hole, e Å–3 0.377, –0.195 0.379, –0.420 0.143, –0.167 
Flack parameter 0.16(7)b 0.212(7)b 0.11(10)b 
CCDC No. 1570567 1570568 1570569 
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Compound # 139 54 137 
    
formula C19H30O2 C15H26O3 C15H22N2 
formula weight 290.43 254.36 230.35 
crystal habit, color plate, colorless plate, colorless plate, colorless 
crystal size, mm 0.05 x 0.1 x 0.3 0.2 x 0.12 x 0.04 0.1 x 0.1 x 0.05 
temperature, K 100 100 100 
crystal system monoclinic monoclinic monoclinic 
space group I2 P21  P21  
a,  Å 12.6828(6) 11.1931(3) 6.5540(14) 
b,  Å 8.2885(3) 9.2227(3) 29.644(6) 
c,  Å 16.2674(10) 14.9319(4) 7.3710(15) 
,  99.441(2) 102.9282(13) 115.95(3) 
Volume, Å3 1686.89(14) 1502.36(8) 1287.7(6) 
Z 4 4 4 
Z’ 1 2 2 
Dcalc g.cm–3 1.144 1.125 1.188 
radiation Cu K ( = 
1.54178) 
Cu K ( = 
1.54178) 
Mo K ( = 
0.71073) 
, mm–1 0.554 0.61 0.07 
GOF 1.061 1.052 1.126 
independent reflns 2768 6031 5395 
obs reflns (I > 2.0σ(I)), Rint 2583 (0.049) 5726 (0.057) 5272 (0.027) 
2θ range,  8.218–133.242 6.072–149.070 6.734–55.918 
final R, wR (I > 2.0σ(I)) 0.0376, 0.0927 0.0404, 0.1021 0.0420, 0.1249 
R, wR (all data) 0.0409, 0.0953 0.0427, 0.1041 0.0429, 0.1254 
largest diff peak and hole, e Å–3 0.169, –0.188 0.38, –0.23 0.301, –0.200 
Flack parameter –0.12(18) 0.18(7) –0.4(7) 
CCDC No. 1571233 N/A N/A 
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